TW201806942A - Piperidine derivatives, liquid-crystal composition, and liquid-crystal display element - Google Patents

Piperidine derivatives, liquid-crystal composition, and liquid-crystal display element Download PDF

Info

Publication number
TW201806942A
TW201806942A TW106129135A TW106129135A TW201806942A TW 201806942 A TW201806942 A TW 201806942A TW 106129135 A TW106129135 A TW 106129135A TW 106129135 A TW106129135 A TW 106129135A TW 201806942 A TW201806942 A TW 201806942A
Authority
TW
Taiwan
Prior art keywords
diyl
compound
liquid crystal
group
carbons
Prior art date
Application number
TW106129135A
Other languages
Chinese (zh)
Inventor
齋藤将之
遠藤浩史
井上大輔
Original Assignee
捷恩智股份有限公司
捷恩智石油化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 捷恩智股份有限公司, 捷恩智石油化學股份有限公司 filed Critical 捷恩智股份有限公司
Publication of TW201806942A publication Critical patent/TW201806942A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3066Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom

Abstract

The present invention addresses the problem of providing a liquid crystal composition that satisfies at least one characteristic from among such characteristics as a high upper limit temperature, a low lower limit temperature, low viscosity, appropriate optical anisotropy, a large negative dielectric anisotropy, a high specific electrical resistance, high stability against ultraviolet rays, and high stability against heat, or that has a suitable balance of at least two such characteristics. A liquid crystal composition with negative dielectric anisotropy that has the advantage of including, as a first additive, a compound that is highly soluble in the liquid crystal composition and has the effect of suppressing display defects in a liquid crystal display element.

Description

哌啶衍生物、液晶組成物和液晶顯示元件Piperidine derivative, liquid crystal composition, and liquid crystal display element

本發明是有關於一種哌啶衍生物、含有該化合物的液晶組成物、含有該組成物的液晶顯示元件等。特別是有關於一種介電各向異性為負的液晶組成物、及含有該組成物並具有IPS、VA、FFS、FPA等模式的元件。本發明亦有關於一種聚合物穩定配向型的元件。The present invention relates to a piperidine derivative, a liquid crystal composition containing the compound, a liquid crystal display element containing the composition, and the like. In particular, the present invention relates to a liquid crystal composition having a negative dielectric anisotropy, and an element containing the composition and having a mode such as IPS, VA, FFS, and FPA. The invention also relates to a polymer stable alignment type device.

液晶顯示元件中,基於液晶分子的運作模式的分類為相變(phase change,PC)、扭轉向列(twisted nematic,TN)、超扭轉向列(super twisted nematic,STN)、電控雙折射(electrically controlled birefringence,ECB)、光學補償彎曲(optically compensated bend,OCB)、面內切換(in-plane switching,IPS)、垂直配向(vertical alignment,VA)、邊緣場切換(fringe field switching,FFS)、電場感應光反應配向(field-induced photo-reactive alignment,FPA)等模式。基於元件的驅動方式的分類為被動矩陣(passive matrix,PM)與主動矩陣(active matrix,AM)。PM被分類為靜態式(static)、多工式(multiplex)等,AM被分類為薄膜電晶體(thin film transistor,TFT)、金屬-絕緣體-金屬(metal insulator metal,MIM)等。TFT的分類為非晶矽(amorphous silicon)及多晶矽(polycrystal silicon)。後者根據製造步驟而分類為高溫型與低溫型。基於光源的分類為利用自然光的反射型、利用背光的透過型、以及利用自然光與背光兩者的半透過型。In liquid crystal display elements, the operation modes based on liquid crystal molecules are classified into phase change (PC), twisted nematic (TN), super twisted nematic (STN), and electrically controlled birefringence ( electrically controlled birefringence (ECB), optically compensated bend (OCB), in-plane switching (IPS), vertical alignment (VA), fringe field switching (FFS), Field-induced photo-reactive alignment (FPA) and other modes. The component-based driving methods are classified into a passive matrix (PM) and an active matrix (AM). PM is classified as static, multiplex, etc. AM is classified as thin film transistor (TFT), metal-insulator-metal (MIM), and the like. TFTs are classified into amorphous silicon and polycrystal silicon. The latter is classified into a high temperature type and a low temperature type according to manufacturing steps. The classification based on the light source is a reflection type using natural light, a transmission type using backlight, and a semi-transmission type using both natural light and backlight.

液晶顯示元件含有具有向列相的液晶組成物。該組成物具有適當的特性。藉由提高該組成物的特性,可獲得具有良好特性的AM元件。將該些特性中的關聯歸納於下述表1中。基於市售的AM元件來對組成物的特性進一步進行說明。向列相的溫度範圍與元件可使用的溫度範圍相關聯。向列相的較佳上限溫度為約70℃以上,而且向列相的較佳下限溫度為約-10℃以下。組成物的黏度與元件的響應時間相關聯。為了以元件顯示動態影像,較佳為響應時間短。理想為短於1毫秒的響應時間。因而,較佳為組成物的黏度小。尤佳為低溫下的黏度小。The liquid crystal display element contains a liquid crystal composition having a nematic phase. This composition has appropriate characteristics. By improving the characteristics of the composition, an AM device having good characteristics can be obtained. The correlation among these characteristics is summarized in Table 1 below. The characteristics of the composition will be further described based on a commercially available AM device. The temperature range of the nematic phase is related to the temperature range in which the element can be used. The preferable upper limit temperature of the nematic phase is about 70 ° C or higher, and the preferable lower limit temperature of the nematic phase is about -10 ° C or lower. The viscosity of a composition is related to the response time of the element. In order to display a moving image with a component, it is preferable that the response time is short. Ideally a response time shorter than 1 millisecond. Therefore, the viscosity of the composition is preferably small. Especially preferred is low viscosity at low temperatures.

組成物的光學各向異性與元件的對比度相關聯。根據元件的模式,而需要大的光學各向異性或小的光學各向異性,即適當的光學各向異性。組成物的光學各向異性(Δn)與元件的單元間隙(d)的積(Δn×d)被設計成使對比度為最大。適當的積的值依存於運作模式的種類。VA模式的元件中,該值為約0.30 μm至約0.40 μm的範圍,IPS模式或FFS模式的元件中,該值為約0.20 μm至約0.30 μm的範圍。該些情況下,對單元間隙小的元件而言較佳為具有大的光學各向異性的組成物。組成物的大的介電各向異性有助於元件中的低臨限電壓、小的消耗電力與大的對比度。因而,較佳為大的介電各向異性。組成物的大的比電阻有助於元件的大的電壓保持率與大的對比度。因此,較佳為在初始階段中具有大的比電阻的組成物。較佳為於長時間使用後仍具有大的比電阻的組成物。組成物對紫外線或熱的穩定性與元件的壽命相關聯。於該穩定性高時,元件的壽命長。此種特性對用於液晶投影儀、液晶電視等的AM元件而言較佳。The optical anisotropy of the composition is related to the contrast of the element. Depending on the mode of the element, a large optical anisotropy or a small optical anisotropy is required, that is, an appropriate optical anisotropy. The product (Δn × d) of the optical anisotropy (Δn) of the composition and the cell gap (d) of the element is designed to maximize the contrast. The value of the appropriate product depends on the type of operation mode. In the VA mode device, the value ranges from about 0.30 μm to about 0.40 μm, and in the IPS mode or FFS mode devices, the value ranges from about 0.20 μm to about 0.30 μm. In these cases, a composition having a large optical anisotropy is preferred for a device having a small cell gap. The large dielectric anisotropy of the composition contributes to low threshold voltage, small power consumption, and large contrast in the device. Therefore, a large dielectric anisotropy is preferred. The large specific resistance of the composition contributes to the large voltage holding ratio and large contrast of the device. Therefore, a composition having a large specific resistance in the initial stage is preferred. A composition having a large specific resistance after long-term use is preferred. The stability of the composition to ultraviolet rays or heat is related to the life of the device. When the stability is high, the life of the device is long. Such characteristics are preferred for AM elements used in liquid crystal projectors and liquid crystal televisions.

通用的液晶顯示元件中,液晶分子的垂直配向可利用特定的聚醯亞胺配向膜達成。聚合物穩定配向(polymer sustained alignment,PSA)型的液晶顯示元件中,使聚合物與配向膜加以組合。首先,將添加有少量聚合性化合物的組成物注入至元件中。其次,一面對該元件的基板之間施加電壓,一面對組成物照射紫外線。聚合性化合物進行聚合而於組成物中生成聚合物的網狀結構。該組成物中,可利用聚合物來控制液晶分子的配向,故元件的響應時間縮短,圖像的殘像得到改善。具有TN、ECB、OCB、IPS、VA、FFS、FPA般的模式的元件中可期待聚合物的此種效果。In a general-purpose liquid crystal display device, vertical alignment of liquid crystal molecules can be achieved by using a specific polyimide alignment film. In a polymer sustained alignment (PSA) type liquid crystal display device, a polymer and an alignment film are combined. First, a composition to which a small amount of a polymerizable compound is added is injected into a device. Next, a voltage is applied between the substrates facing the element, and the composition is irradiated with ultraviolet rays. The polymerizable compound is polymerized to form a polymer network structure in the composition. In this composition, a polymer can be used to control the alignment of liquid crystal molecules, so the response time of the device is shortened, and the afterimage of the image is improved. Such an effect of a polymer can be expected in a device having a mode such as TN, ECB, OCB, IPS, VA, FFS, and FPA.

具有TN模式的AM元件中使用具有正的介電各向異性的組成物。具有VA模式的AM元件中使用具有負的介電各向異性的組成物。具有IPS模式或FFS模式的AM元件中使用具有正或負的介電各向異性的組成物。聚合物穩定配向型的AM元件中使用具有正或負的介電各向異性的組成物。A composition having a positive dielectric anisotropy is used for an AM device having a TN mode. A composition having a negative dielectric anisotropy is used for an AM device having a VA mode. A composition having a positive or negative dielectric anisotropy is used for an AM device having an IPS mode or an FFS mode. A polymer stabilized alignment type AM device uses a composition having a positive or negative dielectric anisotropy.

下述化合物(A-1)為受阻胺系光穩定劑(HALS)的一種。該化合物具有極性基>N-CH3 。於該化合物中,兩個極性基相同。[現有技術文獻] [專利文獻]The following compound (A-1) is a kind of hindered amine light stabilizer (HALS). This compound has a polar group> N-CH 3 . In this compound, the two polar groups are the same. [Prior Art Literature] [Patent Literature]

[專利文獻1]國際公開第2012/76105號說明書 [專利文獻2]日本專利特開2014-84460號公報[Patent Document 1] International Publication No. 2012/76105 [Patent Document 2] Japanese Patent Laid-Open No. 2014-84460

[發明所欲解決之課題] 本發明的一個目的為提供一種化合物,其相對於液晶組成物而具有高溶解性,且具有抑制液晶顯示元件的顯示不良的效果。另一目的為提供一種液晶組成物,其滿足向列相的上限溫度高、向列相的下限溫度低、黏度小、光學各向異性適當、負的介電各向異性大、比電阻大、對紫外線的穩定性高、對熱的穩定性高般的特性中的至少一種。另一目的為提供一種於該些特性的至少兩種之間具有適當平衡的液晶組成物。另一目的為提供一種含有此種組成物的液晶顯示元件。又一目的為提供一種具有響應時間短、電壓保持率大、臨限電壓低、對比度大、壽命長般的特性的AM元件。 [解決課題之手段][Problems to be Solved by the Invention] An object of the present invention is to provide a compound which has high solubility with respect to a liquid crystal composition and has an effect of suppressing display defects of a liquid crystal display element. Another object is to provide a liquid crystal composition which satisfies a high upper temperature of the nematic phase, a low lower temperature of the nematic phase, a low viscosity, a suitable optical anisotropy, a large negative dielectric anisotropy, a large specific resistance, At least one of the characteristics of high stability to ultraviolet light and high stability to heat. Another object is to provide a liquid crystal composition having an appropriate balance between at least two of these characteristics. Another object is to provide a liquid crystal display element containing such a composition. Still another object is to provide an AM device having characteristics such as short response time, large voltage holding ratio, low threshold voltage, large contrast, and long life. [Means for solving problems]

本發明是有關於一種化合物、含有該化合物且具有負的介電各向異性的液晶組成物、以及含有該組成物的液晶顯示元件,所述化合物具有至少兩個式(S)所表示的一價基,該些一價基中,由R1 所表示的基與由其他R1 所表示的基不同。式(S)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基;R為碳數1至12的烷基。 [發明的效果]The present invention relates to a compound, a liquid crystal composition containing the compound and having a negative dielectric anisotropy, and a liquid crystal display element containing the composition. The compound has at least two formulas (S) divalent group, the plurality monovalent group, represented by R 1 group is represented by the other group represented by R 1 are different. In the formula (S), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons; R is an alkyl group having 1 to 12 carbons. [Effect of the invention]

本發明的一個優點為提供一種化合物,其相對於液晶組成物而具有高溶解性,且具有抑制液晶顯示元件的顯示不良的效果。另一目的為提供一種液晶組成物,其滿足向列相的上限溫度高、向列相的下限溫度低、黏度小、光學各向異性適當、負的介電各向異性大、比電阻大、對紫外線的穩定性高、對熱的穩定性高般的特性中的至少一種。另一目的為提供一種於該些特性的至少兩種之間具有適當平衡的液晶組成物。另一目的為提供一種含有此種組成物的液晶顯示元件。又一目的為提供一種具有響應時間短、電壓保持率大、臨限電壓低、對比度大、壽命長般的特性的AM元件。An advantage of the present invention is to provide a compound which has high solubility with respect to a liquid crystal composition and has an effect of suppressing display failure of a liquid crystal display element. Another object is to provide a liquid crystal composition which satisfies a high upper temperature of the nematic phase, a low lower temperature of the nematic phase, a low viscosity, a suitable optical anisotropy, a large negative dielectric anisotropy, a large specific resistance, At least one of the characteristics of high stability to ultraviolet light and high stability to heat. Another object is to provide a liquid crystal composition having an appropriate balance between at least two of these characteristics. Another object is to provide a liquid crystal display element containing such a composition. Still another object is to provide an AM device having characteristics such as short response time, large voltage holding ratio, low threshold voltage, large contrast, and long life.

該說明書中的用語的使用方法如下所述。有時將「液晶組成物」及「液晶顯示元件」的用語分別簡稱為「組成物」及「元件」。「液晶顯示元件」是液晶顯示面板及液晶顯示模組的總稱。「液晶性化合物」是具有向列相、層列相等液晶相的化合物,以及雖不具有液晶相但出於調節向列相的溫度範圍、黏度、介電各向異性般的特性的目的而混合於組成物中的化合物的總稱。該化合物具有例如1,4-伸環己基或1,4-伸苯基般的六員環,其分子結構為棒狀(rod like)。「聚合性化合物」是出於使組成物中生成聚合物的目的而添加的化合物。具有烯基的液晶性化合物於其意義方面並非為聚合性。The terms used in this specification are described below. The terms "liquid crystal composition" and "liquid crystal display element" may be simply referred to as "composition" and "element", respectively. "Liquid crystal display element" is a generic term for liquid crystal display panels and liquid crystal display modules. A "liquid crystal compound" is a compound having a nematic phase, a smectic phase, and a liquid crystal phase, and is mixed for the purpose of adjusting the temperature range, viscosity, and dielectric anisotropy of a nematic phase, although it does not have a liquid crystal phase Generic term for compounds in a composition. The compound has a six-membered ring such as 1,4-cyclohexyl or 1,4-phenylene, and its molecular structure is rod-like. The "polymerizable compound" is a compound added for the purpose of forming a polymer in the composition. The liquid crystal compound which has an alkenyl group is not polymerizable in the meaning.

液晶組成物是藉由將多種液晶性化合物進行混合來製備。於該液晶組成物中視需要添加光學活性化合物、抗氧化劑、紫外線吸收劑、色素、消泡劑、聚合性化合物、聚合起始劑、聚合抑制劑、極性化合物般的添加物。即便於添加有添加物的情況下,液晶性化合物的比例亦是由基於不包含添加物的液晶組成物的重量的重量百分率(重量%)來表示。添加物的比例是由基於不包含添加物的液晶組成物的重量的重量百分率(重量%)來表示。即,液晶性化合物或添加物的比例是基於液晶性化合物的總重量而算出。有時使用重量百萬分率(ppm)。聚合起始劑及聚合抑制劑的比例是例外地基於聚合性化合物的重量來表示。The liquid crystal composition is prepared by mixing a plurality of liquid crystal compounds. To this liquid crystal composition, additives such as an optically active compound, an antioxidant, an ultraviolet absorber, a pigment, an antifoaming agent, a polymerizable compound, a polymerization initiator, a polymerization inhibitor, and a polar compound are added as necessary. That is, when it is convenient to add an additive, the proportion of the liquid crystal compound is expressed by a weight percentage (% by weight) based on the weight of the liquid crystal composition not containing the additive. The ratio of the additive is expressed by a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additive. That is, the ratio of the liquid crystal compound or the additive is calculated based on the total weight of the liquid crystal compound. Sometimes parts per million by weight (ppm) is used. The ratio of the polymerization initiator and the polymerization inhibitor is exceptionally expressed based on the weight of the polymerizable compound.

有時將「向列相的上限溫度」簡稱為「上限溫度」。有時將「向列相的下限溫度」簡稱為「下限溫度」。「比電阻大」是指組成物在初始階段中具有大的比電阻,而且,於長時間使用後仍具有大的比電阻。「電壓保持率大」是指元件在初始階段中不僅在室溫下,而且在接近於上限溫度的溫度下亦具有大的電壓保持率,而且,在長時間使用後不僅於室溫下,而且於接近於上限溫度的溫度下亦具有大的電壓保持率。有時藉由經時變化試驗來研究組成物或元件的特性。「提高介電各向異性」的表述於介電各向異性為正的組成物時,是指其值正向地增加,於介電各向異性為負的組成物時,是指其值負向地增加。The "upper limit temperature of the nematic phase" may be simply referred to as the "upper limit temperature". The "lower limit temperature of the nematic phase" may be simply referred to as the "lower limit temperature". "High specific resistance" means that the composition has a large specific resistance in the initial stage, and also has a large specific resistance after long-term use. "Large voltage holding rate" means that the element has a large voltage holding rate not only at room temperature but also at a temperature close to the upper limit temperature in the initial stage, and not only at room temperature after long-term use, but also It also has a large voltage holding ratio at a temperature close to the upper limit temperature. The characteristics of a composition or an element are sometimes studied by a change over time test. The expression "improving dielectric anisotropy" refers to a composition with a positive dielectric anisotropy, which means that its value increases positively, and a composition with a negative dielectric anisotropy means a negative value. Increase to the ground.

「至少一個-CH2 -可經-O-取代」般的表述於該說明書中使用。該情況下,-CH2 -CH2 -CH2 -可藉由不鄰接的-CH2 -經-O-取代而轉換為-O-CH2 -O-。然而,鄰接的-CH2 -不會經-O-取代。這是因為該取代中生成-O-O-CH2 -(過氧化物)。即,該表述是指「一個-CH2 -可經-O-取代」與「至少兩個不鄰接的-CH2 -可經-O-取代」兩者。該規則不僅適用於取代為-O-的情況,亦適用於取代為-CH=CH-或-COO-般的二價基的情況。The expression "at least one -CH 2 -may be substituted with -O-" is used in this specification. In this case, -CH 2 -CH 2 -CH 2 -can be converted to -O-CH 2 -O- by non-adjacent -CH 2 -substituted with -O-. However, adjacent -CH 2 -will not be replaced by -O-. This is because -OO-CH 2- (peroxide) is formed during the substitution. That is, the expression refers to both "one -CH 2 -may be substituted with -O-" and "at least two non-adjacent -CH 2 -may be substituted with -O-". This rule applies not only to the case of substitution with -O-, but also to the case of substitution with a divalent group like -CH = CH- or -COO-.

成分化合物的化學式中,將末端基R3 的記號用於多種化合物。該些化合物中,任意的兩個R3 所表示的兩個基可相同,或者亦可不同。例如,有化合物(2-1)的R3 為乙基,且化合物(2-2)的R3 為乙基的情況。亦有化合物(2-1)的R3 為乙基,而化合物(2-2)的R3 為丙基的情況。該規則亦適用於其他記號。式(2)中,於下標‘b’為2時,存在兩個環B。該化合物中,兩個環B所表示的兩個環可相同,或者亦可不同。該規則亦適用於下標‘b’大於2時的任意兩個環B。該規則亦適用於其他記號。該規則亦適用於化合物具有由相同記號所表示的取代基的情況。In the chemical formula of the component compound, the symbol of the terminal group R 3 is used for various compounds. In these compounds, two groups represented by any two R 3 may be the same or different. For example, there may be a case where R 3 of the compound (2-1) is an ethyl group and R 3 of the compound (2-2) is an ethyl group. In some cases, R 3 of the compound (2-1) is ethyl, and R 3 of the compound (2-2) is propyl. This rule also applies to other tokens. In formula (2), when the subscript 'b' is 2, there are two rings B. In this compound, the two rings represented by the two rings B may be the same or different. This rule also applies to any two rings B with subscript 'b' greater than 2. This rule also applies to other tokens. This rule also applies when the compound has a substituent represented by the same symbol.

以六邊形包圍的A、B、C、D等記號分別與環A、環B、環C、環D等環對應,表示六員環、縮合環等環。化合物(4)中,將該六邊形的一邊橫切的斜線表示環上的任意氫可經-Sp1 -P1 等基取代。‘f’等下標表示經取代的基的數量。於下標‘f’為0(零)時,不存在此種取代。於下標‘f’為2以上時,於環G上存在多個-Sp1 -P1 。-Sp1 -P1 所表示的多個基可相同,或者亦可不同。「環A及環B獨立地為X、Y、或Z」的表述中,由於主語為多個,故使用「獨立地」。於主語為「環A」時,由於主語為單數,故不使用「獨立地」。Symbols A, B, C, and D surrounded by hexagons correspond to rings such as ring A, ring B, ring C, and ring D, respectively, and represent rings such as six-membered rings and condensed rings. In compound (4), a diagonal line crossing one side of the hexagon indicates that any hydrogen on the ring may be substituted with a group such as -Sp 1 -P 1 . Subscripts such as 'f' indicate the number of substituted groups. When the subscript 'f' is 0 (zero), there is no such substitution. When the subscript 'f' is 2 or more, there are multiple -Sp 1 -P 1 on the ring G. The multiple radicals represented by -Sp 1 -P 1 may be the same or different. In the expression "ring A and ring B are independently X, Y, or Z", since there are multiple subjects, "independently" is used. When the subject is "ring A", "independently" is not used because the subject is singular.

2-氟-1,4-伸苯基是指下述的兩種二價基。化學式中,氟可為朝左(L),亦可為朝右(R)。該規則亦適用於四氫吡喃-2,5-二基般的藉由自環中去除兩個氫而生成的左右非對稱的二價基。該規則亦適用於羰氧基(-COO-或-OCO-)般的二價鍵結基。 2-Fluoro-1,4-phenylene refers to two types of divalent groups described below. In the chemical formula, fluorine may be leftward (L) or rightward (R). This rule also applies to left-right asymmetric divalent radicals like tetrahydropyran-2,5-diyl, which are generated by removing two hydrogens from the ring. This rule also applies to divalent bonding groups like carbonyloxy (-COO- or -OCO-).

液晶性化合物的烷基為直鏈狀或分支狀,不包含環狀烷基。直鏈狀烷基優於分支狀烷基。該些情況對於烷氧基、烯基等末端基亦相同。為了提高上限溫度,與1,4-伸環己基相關的立體構型是反式構型優於順式構型。The alkyl group of the liquid crystal compound is linear or branched, and does not include a cyclic alkyl group. Linear alkyl groups are preferred over branched alkyl groups. The same applies to terminal groups such as an alkoxy group and an alkenyl group. In order to raise the upper limit temperature, the stereo configuration associated with 1,4-cyclohexyl is a trans configuration that is better than a cis configuration.

本發明為下述項等。The present invention includes the following items.

項1. 一種化合物,其具有至少兩個式(S)所表示的一價基,該些一價基中,由R1 所表示的基與由其他R1 所表示的基不同,式(S)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基;R為碳數1至12的烷基。Item 1. A compound having a divalent group represented by at least two of formula (S), the plurality monovalent group, the other group with a group represented by R 1 is represented by R 1 by a different, In the formula (S), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons; R is an alkyl group having 1 to 12 carbons.

項2. 如項1所述的化合物,其中如項1所述的式(S)所表示的一價基中,R為甲基。Item 2. The compound according to Item 1, wherein in the monovalent group represented by formula (S) according to Item 1, R is a methyl group.

項3. 如項1或項2所述的化合物,其是由式(1)所表示,式(1)及式(S-1)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基,此處,由R1 所表示的基與由其他R1 所表示的基不同;環A為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、或吡啶-2,5-二基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者式(S-1)所表示的基取代;Z1 及Z2 獨立地為單鍵或碳數1至20的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟、氯、或式(S-1)所表示的基取代;Z3 為單鍵或碳數1至20的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟或氯取代;a為0、1、2、或3。Item 3. The compound according to item 1 or item 2, which is represented by formula (1), In Formula (1) and Formula (S-1), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons. Here, the group represented by R 1 and Other R 1 groups are different; ring A is 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-phenyl, naphthalene-1,2-diyl, naphthalene-1 , 3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl Naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2, 5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings, at least one hydrogen may be passed through fluorine, chlorine, alkyl having 1 to 12 carbons, carbon 1 Alkoxy to 12, at least one hydrogen substituted with fluorine or chlorine, an alkyl group having 1 to 12 carbons, or a group represented by formula (S-1); Z 1 and Z 2 are independently a single bond or carbon 1 to 20 alkylene groups, at least one of which is -CH 2 -may be substituted with -O-, -COO-, -OCO-, or -OCOO-, and among these groups, at least one hydrogen may be Substituted by fluorine, chlorine, or a group represented by formula (S-1); Z 3 is a single bond or an alkylene group having 1 to 20 carbon atoms, and at least one -CH of the alkylene group 2 -may be substituted with -O-, -COO-, -OCO-, or -OCOO-, in which at least one hydrogen may be substituted with fluorine or chlorine; a is 0, 1, 2, or 3.

項4. 如項1至項3中任一項所述的化合物,其是由式(1-1)至式(1-9)的任一者所表示, 式(1-1)至式(1-9)中,R2 為碳數1至12的烷基或碳數1至12的烷氧基;Z4 為碳數1至15的伸烷基;Z5 及Z6 獨立地為碳數1至5的伸烷基;Z7 及Z8 獨立地為單鍵或碳數1至20的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟或氯取代;X1 為氫或氟。Item 4. The compound according to any one of Items 1 to 3, which is represented by any one of Formulas (1-1) to (1-9), In formulas (1-1) to (1-9), R 2 is an alkyl group having 1 to 12 carbons or an alkoxy group having 1 to 12 carbons; Z 4 is an alkylene group having 1 to 15 carbons; Z 5 and Z 6 are independently an alkylene group having 1 to 5 carbon atoms; Z 7 and Z 8 are independently a single bond or an alkylene group having 1 to 20 carbon atoms, and at least one of the alkylene groups is -CH 2 -May be substituted with -O-, -COO-, -OCO-, or -OCOO-, in which at least one hydrogen may be substituted with fluorine or chlorine; X 1 is hydrogen or fluorine.

項5. 一種液晶組成物,其含有至少一種如項1至項4中任一項所述的化合物作為第一添加物,且具有負的介電各向異性。Item 5. A liquid crystal composition containing at least one compound according to any one of Items 1 to 4 as a first additive, and having a negative dielectric anisotropy.

項6. 如項5所述的液晶組成物,其中第一添加物的比例為0.005重量%至1重量%的範圍。Item 6. The liquid crystal composition according to Item 5, wherein the ratio of the first additive is in a range of 0.005% to 1% by weight.

項7. 如項5或項6所述的液晶組成物,其含有選自式(2)所表示的化合物的群組中的至少一種化合物作為第一成分,式(2)中,R3 及R4 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、或碳數2至12的烯氧基;環B及環D獨立地為1,4-伸環己基、1,4-伸環己烯基、四氫吡喃-2,5-二基、1,4-伸苯基、至少一個氫經氟或氯取代的1,4-伸苯基、萘-2,6-二基、至少一個氫經氟或氯取代的萘-2,6-二基、色原烷-2,6-二基、或者至少一個氫經氟或氯取代的色原烷-2,6-二基;環C為2,3-二氟-1,4-伸苯基、2-氯-3-氟-1,4-伸苯基、2,3-二氟-5-甲基-1,4-伸苯基、3,4,5-三氟萘-2,6-二基、或7,8-二氟色原烷-2,6-二基;Z9 及Z10 獨立地為單鍵、伸乙基、羰氧基、或亞甲氧基;b為1、2、或3,c為0或1,而且b與c之和為3以下。Item 7. The liquid crystal composition according to Item 5 or 6, which contains, as a first component, at least one compound selected from the group of compounds represented by formula (2), In formula (2), R 3 and R 4 are independently an alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, an alkenyl group having 2 to 12 carbons, or an olefin having 2 to 12 carbons Oxygen; ring B and ring D are independently 1,4-cyclohexyl, 1,4-cyclohexenyl, tetrahydropyran-2,5-diyl, 1,4-phenylene, at least 1,4-phenylene substituted with fluorine or chlorine, naphthalene-2,6-diyl, at least one hydrogen substituted with fluorine or chlorine, naphthalene-2,6-diyl, chromogen-2,6 -Diyl, or chromogen-2,6-diyl in which at least one hydrogen is replaced by fluorine or chlorine; ring C is 2,3-difluoro-1,4-phenylene, 2-chloro-3-fluoro -1,4-phenylene, 2,3-difluoro-5-methyl-1,4-phenylene, 3,4,5-trifluoronaphthalene-2,6-diyl, or 7,8 -Difluorochroman-2,6-diyl; Z 9 and Z 10 are independently a single bond, ethylene, carbonyloxy, or methyleneoxy; b is 1, 2, or 3, and c is 0 or 1, and the sum of b and c is 3 or less.

項8. 如項5至項7中任一項所述的液晶組成物,其含有選自式(2-1)至式(2-22)所表示的化合物的群組中的至少一種化合物作為第一成分, 式(2-1)至式(2-22)中,R3 及R4 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、或碳數2至12的烯氧基。Item 8. The liquid crystal composition according to any one of Items 5 to 7, which contains at least one compound selected from the group of compounds represented by formula (2-1) to formula (2-22) as First ingredient, In the formulae (2-1) to (2-22), R 3 and R 4 are independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, and an alkenyl group having 2 to 12 carbon atoms. Or an alkenyloxy group having 2 to 12 carbon atoms.

項9. 如項7或項8所述的液晶組成物,其中第一成分的比例為10重量%至90重量%的範圍。Item 9. The liquid crystal composition according to Item 7 or Item 8, wherein the ratio of the first component is in a range of 10% by weight to 90% by weight.

項10. 如項5至項9中任一項所述的液晶組成物,其含有選自式(3)所表示的化合物的群組中的至少一種化合物作為第二成分,式(3)中,R5 及R6 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數2至12的烯基;環E及環F獨立地為1,4-伸環己基、1,4-伸苯基、2-氟-1,4-伸苯基、或2,5-二氟-1,4-伸苯基;Z11 為單鍵、伸乙基、羰氧基、或亞甲氧基;d為1、2、或3。Item 10. The liquid crystal composition according to any one of Items 5 to 9, comprising at least one compound selected from the group of compounds represented by formula (3) as a second component, In formula (3), R 5 and R 6 are independently an alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, an alkenyl group having 2 to 12 carbons, and at least one hydrogen is substituted with fluorine or chlorine Alkyl group having 1 to 12 carbon atoms, or alkenyl group having 2 to 12 carbon atoms in which at least one hydrogen is replaced by fluorine or chlorine; ring E and ring F are independently 1,4-cyclohexyl, 1,4-cyclohexyl Phenyl, 2-fluoro-1,4-phenylene, or 2,5-difluoro-1,4-phenylene; Z 11 is a single bond, ethylene, carbonyloxy, or methyleneoxy ; D is 1, 2, or 3.

項11. 如項5至項10中任一項所述的液晶組成物,其含有選自式(3-1)至式(3-13)所表示的化合物的群組中的至少一種化合物作為第二成分, 式(3-1)至式(3-13)中,R5 及R6 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數2至12的烯基。Item 11. The liquid crystal composition according to any one of Items 5 to 10, which contains at least one compound selected from the group of compounds represented by formula (3-1) to formula (3-13) as The second component, In the formulae (3-1) to (3-13), R 5 and R 6 are independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, and an alkenyl group having 2 to 12 carbon atoms. , At least one hydrogen having 1 to 12 carbons substituted with fluorine or chlorine, or at least one hydrogen having 2 to 12 carbons substituted with fluorine or chlorine.

項12. 如項10或項11所述的液晶組成物,其中第二成分的比例為10重量%至90重量%的範圍。Item 12. The liquid crystal composition according to Item 10 or Item 11, wherein the ratio of the second component is in a range of 10% by weight to 90% by weight.

項13. 如項5至項12中任一項所述的液晶組成物,其含有選自式(4)所表示的聚合性化合物的群組中的至少一種化合物作為第二添加物,式(4)中,環G及環J獨立地為環己基、環己烯基、苯基、1-萘基、2-萘基、四氫吡喃-2-基、1,3-二噁烷-2-基、嘧啶-2-基、或吡啶-2-基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代;環I為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、或吡啶-2,5-二基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代;Z12 及Z13 獨立地為單鍵或碳數1至10的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-CO-、-COO-、或-OCO-取代,至少一個-CH2 CH2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-、或-C(CH3 )=C(CH3 )-取代,該些基中,至少一個氫可經氟或氯取代;P1 、P2 、及P3 獨立地為聚合性基;Sp1 、Sp2 、及Sp3 獨立地為單鍵或碳數1至10的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,至少一個-CH2 CH2 -可經-CH=CH-或-C≡C-取代,該些基中,至少一個氫可經氟或氯取代;e為0、1、或2;f、g、及h獨立地為0、1、2、3、或4,而且f、g、及h之和為1以上。Item 13. The liquid crystal composition according to any one of Items 5 to 12, comprising at least one compound selected from the group of polymerizable compounds represented by Formula (4) as a second additive, In formula (4), ring G and ring J are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxane Alk-2-yl, pyrimidin-2-yl, or pyridin-2-yl, in which at least one hydrogen may pass through fluorine, chlorine, alkyl having 1 to 12 carbons, and alkoxy having 1 to 12 carbons Or at least one hydrogen substituted with fluorine or chlorine and 1 to 12 carbon alkyl groups; ring I is 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-phenylene Naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1, 7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5- Diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings, at least one hydrogen may be passed through fluorine, chlorine , An alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, or an alkyl group having 1 to 12 carbons in which at least one hydrogen is replaced with fluorine or chlorine; Z 12 and Z 13 are independently a single bond Or an alkylene group having 1 to 10 carbon atoms, in which at least one -CH 2 -may be substituted with -O-, -CO-, -COO-, or -OCO-, at least one -CH 2 CH 2 -can be replaced by -CH = CH-, -C (CH 3 ) = CH-, -CH = C (CH 3 )-, or -C (CH 3 ) = C (CH 3 )-, these In the group, at least one hydrogen may be substituted by fluorine or chlorine; P 1 , P 2 , and P 3 are independently polymerizable groups; Sp 1 , Sp 2 , and Sp 3 are independently a single bond or a carbon number of 1 to 10 Alkenyl, at least one -CH 2 -may be substituted by -O-, -COO-, -OCO-, or -OCOO-, and at least one -CH 2 CH 2 -may be -CH = CH -Or -C≡C- substitution, in these groups, at least one hydrogen may be substituted by fluorine or chlorine; e is 0, 1, or 2; f, g, and h are independently 0, 1, 2, 3, Or 4, and the sum of f, g, and h is 1 or more.

項14. 如項13所述的液晶組成物,其中式(4)中,P1 、P2 、及P3 獨立地為選自式(P-1)至式(P-5)所表示的聚合性基的群組中的基,式(P-1)至式(P-5)中,M1 、M2 、及M3 獨立地為氫、氟、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。Item 14. The liquid crystal composition according to Item 13, wherein in the formula (4), P 1 , P 2 , and P 3 are independently selected from the group consisting of the formulae (P-1) to (P-5) Groups in a group of polymerizable groups, In the formulae (P-1) to (P-5), M 1 , M 2 , and M 3 are independently hydrogen, fluorine, an alkyl group having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine. Alkyl having 1 to 5 carbons.

項15. 如項13或項14所述的液晶組成物,其含有選自式(4-1)至式(4-27)所表示的聚合性化合物的群組中的至少一種化合物作為第二添加物, 式(4-1)至式(4-27)中,P4 、P5 、及P6 獨立地為選自式(P-1)至式(P-3)所表示的聚合性基的群組中的基,此處,M1 、M2 、及M3 獨立地為氫、氟、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;Sp1 、Sp2 、及Sp3 獨立地為單鍵或碳數1至10的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,至少一個-CH2 CH2 -可經-CH=CH-或-C≡C-取代,該些基中,至少一個氫可經氟或氯取代。Item 15. The liquid crystal composition according to item 13 or item 14, which contains at least one compound selected from the group of polymerizable compounds represented by formula (4-1) to formula (4-27) as the second Additives, In Formulas (4-1) to (4-27), P 4 , P 5 , and P 6 are independently selected from the group consisting of polymerizable groups represented by Formulas (P-1) to (P-3) Base in group, Here, M 1 , M 2 , and M 3 are independently hydrogen, fluorine, an alkyl group having 1 to 5 carbons, or an alkyl group having 1 to 5 carbons in which at least one hydrogen is replaced with fluorine or chlorine; Sp 1 , Sp 2 and Sp 3 are independently a single bond or an alkylene group having 1 to 10 carbon atoms. At least one -CH 2 -in this alkylene group may be passed through -O-, -COO-, -OCO-, or- OCOO- substituted, at least one -CH 2 CH 2 -may be substituted with -CH = CH- or -C≡C-, and among these groups, at least one hydrogen may be substituted with fluorine or chlorine.

項16. 如項13至項15中任一項所述的液晶組成物,其中第二添加物的比例為0.03重量%至10重量%的範圍。Item 16. The liquid crystal composition according to any one of Items 13 to 15, wherein the ratio of the second additive is in a range of 0.03% by weight to 10% by weight.

項17. 一種液晶顯示元件,其含有如項5至項16中任一項所述的液晶組成物。Item 17. A liquid crystal display element comprising the liquid crystal composition according to any one of Items 5 to 16.

項18. 如項17所述的液晶顯示元件,其中液晶顯示元件的運作模式為IPS模式、VA模式、FFS模式、或FPA模式,液晶顯示元件的驅動方式為主動矩陣方式。Item 18. The liquid crystal display element according to item 17, wherein the operation mode of the liquid crystal display element is an IPS mode, a VA mode, an FFS mode, or an FPA mode, and the driving method of the liquid crystal display element is an active matrix method.

項19. 一種聚合物穩定配向型的液晶顯示元件,其含有如項13至項16中任一項所述的液晶組成物,且該液晶組成物中所含有的第二添加物進行聚合。Item 19. A polymer stabilized alignment type liquid crystal display device comprising the liquid crystal composition according to any one of items 13 to 16, and a second additive contained in the liquid crystal composition is polymerized.

項20. 一種液晶組成物的用途,所述液晶組成物為如項5至項16中任一項所述的液晶組成物,其用於液晶顯示元件中。Item 20. Use of a liquid crystal composition, which is the liquid crystal composition according to any one of Items 5 to 16, and is used in a liquid crystal display element.

項21. 一種液晶組成物的用途,所述液晶組成物為如項5至項16中任一項所述的液晶組成物,其用於聚合物穩定配向型的液晶顯示元件中。Item 21. Use of a liquid crystal composition, which is the liquid crystal composition according to any one of Items 5 to 16, and is used in a polymer-stable alignment type liquid crystal display element.

本發明亦包括以下項。(a)所述組成物,其進而含有光學活性化合物、抗氧化劑、紫外線吸收劑、色素、消泡劑、聚合性化合物、聚合起始劑、聚合抑制劑、極性化合物般的添加物的至少一種。(b)一種AM元件,其含有所述組成物。(c)一種聚合物穩定配向(PSA)型的AM元件,其含有所述組成物,所述組成物進而含有聚合性化合物。(d)一種聚合物穩定配向(PSA)型的AM元件,其含有所述組成物,且該組成物中的聚合性化合物進行聚合。(e)一種元件,其含有所述組成物,而且具有PC、TN、STN、ECB、OCB、IPS、VA、FFS、或FPA的模式。(f)一種透過型的元件,其含有所述組成物。(g)將所述組成物作為具有向列相的組成物的用途。(h)藉由在所述組成物中添加光學活性化合物而作為光學活性組成物的用途。The present invention also includes the following items. (A) The composition further contains at least one of an optically active compound, an antioxidant, an ultraviolet absorber, a pigment, an antifoaming agent, a polymerizable compound, a polymerization initiator, a polymerization inhibitor, and an additive such as a polar compound . (B) An AM device containing the composition. (C) A polymer stabilized alignment (PSA) type AM device comprising the composition, and the composition further includes a polymerizable compound. (D) A polymer stabilized alignment (PSA) type AM device comprising the composition and polymerizing a polymerizable compound in the composition. (E) An element containing the composition and having a mode of PC, TN, STN, ECB, OCB, IPS, VA, FFS, or FPA. (F) A transmissive element containing the composition. (G) Use of the composition as a composition having a nematic phase. (H) Use as an optically active composition by adding an optically active compound to the composition.

本發明的液晶組成物含有具有至少兩個式(S)所表示的一價基的化合物。式(S)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基。四個基R獨立地為碳數1至12的烷基。The liquid crystal composition of the present invention contains a compound having at least two monovalent groups represented by formula (S). In formula (S), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons. The four radicals R are independently alkyl groups having 1 to 12 carbons.

本發明的化合物具有至少兩個式(S)所表示的一價基。該些一價基中,由R1 所表示的基與由其他R1 所表示的基不同。於該化合物具有兩個式(S)所表示的基時,R1 所表示的兩個基相互不同。即便於該化合物具有三個式(S)所表示的基的情況下,R1 所表示的兩個基亦相互不同。一例為三個基R1 為氫、氫、甲基的情況。另一例為氫、甲基、乙基的組合。即,R1 所表示的所有基並非相同。The compound of the present invention has at least two monovalent groups represented by formula (S). The plurality monovalent group, represented by R 1 group is represented by the other group represented by R 1 are different. When the compound has two groups represented by formula (S), the two groups represented by R 1 are different from each other. That is, when it is convenient for the compound to have three groups represented by formula (S), the two groups represented by R 1 are also different from each other. An example is a case where three groups R 1 are hydrogen, hydrogen, and methyl. Another example is a combination of hydrogen, methyl, and ethyl. That is, all the groups represented by R 1 are not the same.

可知,該化合物如比較例1、比較例2、比較例3所示般對於抑制元件的顯示不良而言有效。但是,顯示不良的原因複雜,無法充分闡明。進而,關於該化合物給顯示不良所帶來的效果,於現階段並不明確。雖然為此種情況,但可進行以下段落中所記載的說明。As shown in Comparative Example 1, Comparative Example 2, and Comparative Example 3, this compound is effective for suppressing display failure of an element. However, the cause of the poor display is complicated and cannot be fully elucidated. Furthermore, the effect of this compound on poor display is unknown at this stage. Although this is the case, the descriptions described in the following paragraphs can be made.

於長時間使用元件的情況下,有時亮度會部分性下降。一例為線殘像,且為藉由對相鄰的兩個電極反覆施加不同的電壓而電極間的亮度以條紋狀下降的現象。該現象起因於液晶組成物中所含的離子性雜質蓄積於電極附近的配向膜上。因而,為了抑制線殘像,有效的是防止離子性雜質局部存在於配向膜上。藉由該目的,利用極性化合物般的添加物被覆配向膜的表面,並使離子性雜質吸附於該添加物。為了獲得所期望的效果,對此種添加物而言重要的是相對於液晶組成物而具有高溶解性。When the device is used for a long time, the brightness may be partially reduced. One example is a line afterimage, and a phenomenon in which the brightness between electrodes decreases in a striped manner by repeatedly applying different voltages to two adjacent electrodes. This phenomenon is caused by the accumulation of ionic impurities contained in the liquid crystal composition on the alignment film near the electrode. Therefore, in order to suppress the line afterimage, it is effective to prevent the ionic impurities from locally existing on the alignment film. For this purpose, the surface of the alignment film is covered with an additive such as a polar compound, and ionic impurities are adsorbed to the additive. In order to obtain a desired effect, it is important for these additives to have high solubility with respect to the liquid crystal composition.

液晶組成物是於減壓下自注入口而注入至元件中。通常,將組成物於不使其成分的比例變化的情況下填充至元件中。但是,極性化合物般的添加物有時被吸附於配向膜上。於吸附速度大時,有時添加物無法到達元件的內部。添加物殘留是因為吸附速度大於注入速度。為了防止該現象,較佳為相對於配向膜具有適當的吸附性的添加物。因而,亦重要的是選擇具有適當的極性的添加物。項1中記載的化合物、特別是化合物(1)適合於該目的。化合物(1)具有至少兩個基R1 。由於至少兩個基R1 所表示的基相互不同,因此化合物(1)為非對稱。該非對稱有可能有助於適當的極性。請參照比較例。本發明的組成物含有化合物(1)作為第一添加物。The liquid crystal composition is injected into the device from the injection port under reduced pressure. Generally, a composition is filled in a device without changing the ratio of its components. However, additives like polar compounds are sometimes adsorbed on the alignment film. When the adsorption speed is high, the additive may not reach the inside of the device. Additives remain because the adsorption rate is greater than the injection rate. In order to prevent this phenomenon, an additive having an appropriate adsorption property with respect to the alignment film is preferred. Therefore, it is also important to select an additive having an appropriate polarity. The compound described in item 1, especially compound (1) is suitable for this purpose. The compound (1) has at least two groups R 1 . Since the groups represented by at least two groups R 1 are different from each other, the compound (1) is asymmetric. This asymmetry may contribute to proper polarity. Please refer to the comparative example. The composition of the present invention contains the compound (1) as a first additive.

以如下順序對本發明的組成物進行說明。第一,對組成物的構成進行說明。第二,對成分化合物的主要特性、以及該化合物給組成物或元件帶來的主要效果進行說明。第三,對組成物中的成分的組合、成分的較佳比例以及其根據進行說明。第四,對成分化合物的較佳形態進行說明。第五,示出較佳的成分化合物。第六,對可添加於組成物中的添加物進行說明。第七,對成分化合物的合成法進行說明。最後,對組成物的用途進行說明。The composition of the present invention will be described in the following order. First, the composition of the composition will be described. Second, the main characteristics of the component compounds and the main effects of the compounds on the composition or device will be described. Third, the combination of components in the composition, the preferred ratio of the components, and the basis thereof will be described. Fourth, preferred embodiments of the component compounds will be described. Fifth, preferred component compounds are shown. Sixth, additives that can be added to the composition will be described. Seventh, a method for synthesizing the component compounds will be described. Finally, the use of the composition will be described.

第一,對組成物的構成進行說明。該組成物含有多種液晶性化合物。該組成物亦可含有添加物。添加物為光學活性化合物、抗氧化劑、紫外線吸收劑、色素、消泡劑、聚合性化合物、聚合起始劑、聚合抑制劑、極性化合物等。就液晶性化合物的觀點而言,該組成物被分類為組成物A與組成物B。組成物A除了含有選自化合物(2)及化合物(3)中的液晶性化合物以外,亦可進而含有其他液晶性化合物、添加物等。「其他液晶性化合物」是與化合物(2)及化合物(3)不同的液晶性化合物。此種化合物是出於進一步調整特性的目的而混合於組成物中。First, the composition of the composition will be described. This composition contains a plurality of liquid crystal compounds. This composition may contain additives. The additives are optically active compounds, antioxidants, ultraviolet absorbers, pigments, defoamers, polymerizable compounds, polymerization initiators, polymerization inhibitors, polar compounds, and the like. From the viewpoint of a liquid crystal compound, the composition is classified into a composition A and a composition B. The composition A may contain a liquid crystal compound selected from the compound (2) and the compound (3), and may further contain other liquid crystal compounds, additives, and the like. The "other liquid crystal compound" is a liquid crystal compound different from the compound (2) and the compound (3). Such a compound is mixed in the composition for the purpose of further adjusting the characteristics.

組成物B實質上僅包含選自化合物(2)及化合物(3)中的液晶性化合物。「實質上」是指組成物B雖可含有添加物,但不含其他液晶性化合物。與組成物A比較,組成物B的成分的數量少。就降低成本的觀點而言,組成物B優於組成物A。就可藉由混合其他液晶性化合物來進一步調整特性的觀點而言,組成物A優於組成物B。The composition B contains substantially only a liquid crystal compound selected from the compound (2) and the compound (3). "Substantially" means that although the composition B may contain additives, it does not contain other liquid crystal compounds. Compared with the composition A, the number of components of the composition B is small. From the viewpoint of cost reduction, the composition B is superior to the composition A. From the viewpoint that the characteristics can be further adjusted by mixing other liquid crystal compounds, the composition A is superior to the composition B.

第二,對成分化合物的主要特性、以及該化合物給組成物或元件帶來的主要效果進行說明。基於本發明的效果,將成分化合物的主要特性歸納於表2中。表2的記號中,L是指大或高,M是指中等程度,S是指小或低。記號L、M、S是基於成分化合物之間的定性比較的分類,0(零)是指極小。Second, the main characteristics of the component compounds and the main effects of the compounds on the composition or device will be described. Based on the effects of the present invention, the main characteristics of the component compounds are summarized in Table 2. In the symbols in Table 2, L is large or high, M is medium, and S is small or low. Symbols L, M, and S are classifications based on a qualitative comparison between component compounds, and 0 (zero) means extremely small.

成分化合物的主要效果如下所述。化合物(1)有助於抑制顯示不良。化合物(1)的添加量為極少量,因此於大多情況下對上限溫度、光學各向異性、及介電各向異性般的特性無影響。化合物(2)提高介電各向異性,而且降低下限溫度。化合物(3)降低黏度,或者提高上限溫度。化合物(4)為聚合性,因此藉由聚合而形成聚合物。該聚合物由於使液晶分子的配向穩定化,故縮短元件的響應時間,而且改善圖像的殘像。The main effects of the component compounds are as follows. The compound (1) helps suppress poor display. Since the amount of the compound (1) to be added is extremely small, it has no effect on characteristics such as the upper limit temperature, optical anisotropy, and dielectric anisotropy in many cases. Compound (2) increases the dielectric anisotropy and lowers the lower limit temperature. Compound (3) reduces the viscosity or raises the upper limit temperature. Since the compound (4) is polymerizable, a polymer is formed by polymerization. Since this polymer stabilizes the alignment of liquid crystal molecules, it shortens the response time of the device and improves the afterimage of the image.

第三,對組成物中的成分的組合、成分化合物的較佳比例及其根據進行說明。組成物中的成分的較佳組合為化合物(1)+化合物(2)、化合物(1)+化合物(3)、化合物(1)+化合物(2)+化合物(3)、化合物(1)+化合物(2)+化合物(4)、化合物(1)+化合物(3)+化合物(4)、或化合物(1)+化合物(2)+化合物(3)+化合物(4)。尤佳組合為化合物(1)+化合物(2)+化合物(3)或化合物(1)+化合物(2)+化合物(3)+化合物(4)。Third, the combination of components in the composition, the preferred ratio of the component compounds, and the basis thereof will be described. A preferred combination of the components in the composition is compound (1) + compound (2), compound (1) + compound (3), compound (1) + compound (2) + compound (3), compound (1) + Compound (2) + compound (4), compound (1) + compound (3) + compound (4), or compound (1) + compound (2) + compound (3) + compound (4). A particularly preferred combination is compound (1) + compound (2) + compound (3) or compound (1) + compound (2) + compound (3) + compound (4).

為了抑制顯示不良,化合物(1)的較佳比例為約0.005重量%以上,為了降低下限溫度,化合物(1)的較佳比例為約1重量%以下。尤佳比例為約0.02重量%至約0.5重量%的範圍。特佳比例為約0.1重量%至約0.3重量%的範圍。In order to suppress display defects, a preferred ratio of the compound (1) is about 0.005% by weight or more. In order to lower the lower limit temperature, a preferred ratio of the compound (1) is about 1% by weight or less. A particularly preferred ratio is in the range of about 0.02% by weight to about 0.5% by weight. A particularly preferred ratio is in the range of about 0.1% by weight to about 0.3% by weight.

為了提高介電各向異性,化合物(2)的較佳比例為約10重量%以上,為了降低下限溫度,化合物(2)的較佳比例為約90重量%以下。尤佳比例為約20重量%至約85重量%的範圍。特佳比例為約30重量%至約85重量%的範圍。In order to improve the dielectric anisotropy, the preferred ratio of the compound (2) is about 10% by weight or more, and to lower the lower limit temperature, the preferred ratio of the compound (2) is about 90% by weight or less. A particularly preferred ratio is in the range of about 20% by weight to about 85% by weight. A particularly preferred ratio is in the range of about 30% by weight to about 85% by weight.

為了提高上限溫度或為了降低黏度,化合物(3)的較佳比例為約10重量%以上,為了提高介電各向異性,化合物(3)的較佳比例為約90重量%以下。尤佳比例為約20重量%至約80重量%的範圍。特佳比例為約30重量%至約70重量%的範圍。In order to increase the upper limit temperature or to reduce the viscosity, the preferred ratio of the compound (3) is about 10% by weight or more. In order to improve the dielectric anisotropy, the preferred ratio of the compound (3) is about 90% by weight or less. A particularly preferred ratio is in the range of about 20% by weight to about 80% by weight. A particularly preferred ratio is in the range of about 30% by weight to about 70% by weight.

化合物(4)是出於適合於聚合物穩定配向型的元件的目的而添加至組成物中。為了使液晶分子進行配向,化合物(4)的較佳比例為約0.03重量%以上,為了防止元件的顯示不良,化合物(4)的較佳比例為約10重量%以下。尤佳比例為約0.1重量%至約2重量%的範圍。特佳比例為約0.2重量%至約1.0重量%的範圍。The compound (4) is added to the composition for the purpose of being suitable for a polymer-stable alignment device. In order to align the liquid crystal molecules, the preferred ratio of the compound (4) is about 0.03% by weight or more. In order to prevent display failure of the device, the preferred ratio of the compound (4) is about 10% by weight or less. A particularly preferred ratio is in the range of about 0.1% by weight to about 2% by weight. A particularly preferred ratio is in the range of about 0.2% by weight to about 1.0% by weight.

第四,對成分化合物的較佳形態進行說明。式(S)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基,此處,由R1 所表示的基與由其他R1 所表示的基不同。R為碳數1至12的烷基。Fourth, preferred embodiments of the component compounds will be described. In the formula (S), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons. Here, a group represented by R 1 and a group represented by another R 1 different. R is an alkyl group having 1 to 12 carbons.

式(1)及式(S-1)中,Z1 及Z2 獨立地為單鍵或碳數1至20的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟、氯、或式(S-1)所表示的基取代。較佳的Z1 或Z2 為單鍵或者至少一個-CH2 -經-COO-或-OCO-取代的碳數1至20的伸烷基。Z3 為單鍵或碳數1至20的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟或氯取代。較佳的Z3 為單鍵或者至少一個-CH2 -經-COO-或-OCO-取代的碳數1至20的伸烷基。In formula (1) and formula (S-1), Z 1 and Z 2 are independently a single bond or an alkylene group having 1 to 20 carbon atoms. At least one of the alkylene groups may be -CH 2 -via -O. -, -COO-, -OCO-, or -OCOO-. At least one of these groups may be substituted with fluorine, chlorine, or a group represented by formula (S-1). Preferred Z 1 or Z 2 are single bonds or at least one alkylene group having 1 to 20 carbon atoms substituted with -CH 2 -by -COO- or -OCO-. Z 3 is a single bond or an alkylene group having 1 to 20 carbon atoms. At least one -CH 2 -in the alkylene group may be substituted with -O-, -COO-, -OCO-, or -OCOO-. These In the radical, at least one hydrogen may be substituted with fluorine or chlorine. Preferred Z 3 is a single bond or at least one -CH 2 -alkylene having 1 to 20 carbon atoms substituted with -COO- or -OCO-.

環A為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、或吡啶-2,5-二基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者式(S-1)所表示的基取代。較佳的環A為1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、或萘-2,7-二基。Ring A is 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1 , 4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl Naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2, 5-diyl, or pyridine-2,5-diyl, in these rings, at least one hydrogen may be passed through fluorine, chlorine, alkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons, at least one Hydrogen is substituted by a C1-C12 alkyl group substituted by fluorine or chlorine, or a group represented by formula (S-1). Preferred ring A is 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, Naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, or naphthalene-2, 7-diyl.

a為0、1、2、或3。較佳的a為0或1。尤佳的a為0。a is 0, 1, 2, or 3. The preferred a is 0 or 1. A particularly preferred a is 0.

式(1-1)至式(1-9)中,R2 為碳數1至12的烷基或碳數1至12的烷氧基。較佳的R2 為碳數1至12的烷基。In the formulae (1-1) to (1-9), R 2 is an alkyl group having 1 to 12 carbons or an alkoxy group having 1 to 12 carbons. Preferred R 2 is an alkyl group having 1 to 12 carbons.

Z4 為碳數1至15的伸烷基。較佳的Z4 為碳數6至10的伸烷基。尤佳的Z4 為碳數8的伸烷基。Z5 及Z6 獨立地為碳數1至5的伸烷基。Z7 及Z8 獨立地為單鍵或碳數1至20的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟或氯取代。較佳的Z7 或Z8 為單鍵。Z 4 is an alkylene group having 1 to 15 carbon atoms. Preferred Z 4 is an alkylene group having 6 to 10 carbon atoms. Particularly preferred Z 4 is an alkylene group having 8 carbon atoms. Z 5 and Z 6 are independently an alkylene group having 1 to 5 carbon atoms. Z 7 and Z 8 are independently a single bond or an alkylene group having 1 to 20 carbon atoms, at least one of -CH 2 -may pass through -O-, -COO-, -OCO-, or -OCOO -Substitution, in which at least one hydrogen may be substituted with fluorine or chlorine. The preferred Z 7 or Z 8 is a single bond.

X1 為氫或氟。較佳的X1 為氫。X 1 is hydrogen or fluorine. A preferred X 1 is hydrogen.

式(2)及式(3)中,R3 及R4 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、或碳數2至12的烯氧基。為了提高對紫外線或熱的穩定性,較佳的R3 或R4 為碳數1至12的烷基,為了提高介電各向異性,較佳的R3 或R4 為碳數1至12的烷氧基。R5 及R6 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數2至12的烯基。為了降低黏度,較佳的R5 或R6 為碳數2至12的烯基,為了提高對紫外線或熱的穩定性,較佳的R5 或R6 為碳數1至12的烷基。In formulas (2) and (3), R 3 and R 4 are independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, an alkenyl group having 2 to 12 carbon atoms, or a carbon number 2 to 12 alkenyloxy. For increasing the stability to ultraviolet light or heat, preferably R 3 or R 4 is alkyl having 1 to 12, for increasing the dielectric anisotropy, preferred R 3 or R 4 is from 1 to 12 carbon atoms, Alkoxy. R 5 and R 6 are independently an alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, an alkenyl group having 2 to 12 carbons, and at least one hydrogen having 1 to 12 carbon atoms substituted with fluorine or chlorine Alkyl, or at least one hydrogen alkenyl having 2 to 12 carbons substituted with fluorine or chlorine. In order to reduce the viscosity, preferred R 5 or R 6 is an alkenyl group having 2 to 12 carbons. In order to improve the stability to ultraviolet rays or heat, preferred R 5 or R 6 is an alkyl group having 1 to 12 carbon numbers.

較佳的烷基為甲基、乙基、丙基、丁基、戊基、己基、庚基、或辛基。為了降低黏度,尤佳的烷基為甲基、乙基、丙基、丁基、或戊基。Preferred alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, or octyl. To reduce viscosity, particularly preferred alkyl groups are methyl, ethyl, propyl, butyl, or pentyl.

較佳的烷氧基為甲氧基、乙氧基、丙氧基、丁氧基、戊氧基、己氧基、或庚氧基。為了降低黏度,尤佳的烷氧基為甲氧基或乙氧基。Preferred alkoxy is methoxy, ethoxy, propoxy, butoxy, pentoxy, hexyloxy, or heptyloxy. To reduce viscosity, a particularly preferred alkoxy group is methoxy or ethoxy.

較佳的烯基為乙烯基、1-丙烯基、2-丙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、3-戊烯基、4-戊烯基、1-己烯基、2-己烯基、3-己烯基、4-己烯基、或5-己烯基。為了降低黏度,尤佳的烯基為乙烯基、1-丙烯基、3-丁烯基、或3-戊烯基。該些烯基中的-CH=CH-的較佳立體構型依存於雙鍵的位置。為了降低黏度等原因,於1-丙烯基、1-丁烯基、1-戊烯基、1-己烯基、3-戊烯基、3-己烯基般的烯基中較佳為反式構型。於2-丁烯基、2-戊烯基、2-己烯基般的烯基中較佳為順式構型。Preferred alkenyl groups are vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3 -Pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, or 5-hexenyl. To reduce viscosity, particularly preferred alkenyl is vinyl, 1-propenyl, 3-butenyl, or 3-pentenyl. The preferred stereo configuration of -CH = CH- in these alkenyl groups depends on the position of the double bond. In order to reduce viscosity, etc., among 1-propenyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 3-pentenyl, and 3-hexenyl-like alkenyl groups are preferred. Style configuration. Among 2-butenyl, 2-pentenyl, and 2-hexenyl-like alkenyl groups, the cis configuration is preferred.

較佳的烯氧基為乙烯氧基、烯丙氧基、3-丁烯氧基、3-戊烯氧基、或4-戊烯氧基。為了降低黏度,尤佳的烯氧基為烯丙氧基或3-丁烯氧基。The preferred alkenyloxy group is vinyloxy, allyloxy, 3-butenyloxy, 3-pentenyloxy, or 4-pentenyloxy. In order to reduce viscosity, particularly preferred allyloxy is allyloxy or 3-butenyloxy.

至少一個氫經氟或氯取代的烷基的較佳例為氟甲基、2-氟乙基、3-氟丙基、4-氟丁基、5-氟戊基、6-氟己基、7-氟庚基、或8-氟辛基。為了提高介電各向異性,尤佳例為2-氟乙基、3-氟丙基、4-氟丁基、或5-氟戊基。Preferred examples of the alkyl group in which at least one hydrogen is substituted by fluorine or chlorine are fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluorobutyl, 5-fluoropentyl, 6-fluorohexyl, 7 -Fluoroheptyl, or 8-fluorooctyl. In order to increase the dielectric anisotropy, particularly preferred examples are 2-fluoroethyl, 3-fluoropropyl, 4-fluorobutyl, or 5-fluoropentyl.

至少一個氫經氟取代的烯基的較佳例為2,2-二氟乙烯基、3,3-二氟-2-丙烯基、4,4-二氟-3-丁烯基、5,5-二氟-4-戊烯基、或6,6-二氟-5-己烯基。為了降低黏度,尤佳例為2,2-二氟乙烯基或4,4-二氟-3-丁烯基。Preferred examples of the alkenyl group in which at least one hydrogen is substituted with fluorine are 2,2-difluorovinyl, 3,3-difluoro-2-propenyl, 4,4-difluoro-3-butenyl, 5, 5-difluoro-4-pentenyl, or 6,6-difluoro-5-hexenyl. In order to reduce the viscosity, a particularly preferred example is 2,2-difluorovinyl or 4,4-difluoro-3-butenyl.

環B及環D獨立地為1,4-伸環己基、1,4-伸環己烯基、四氫吡喃-2,5-二基、1,4-伸苯基、至少一個氫經氟或氯取代的1,4-伸苯基、萘-2,6-二基、至少一個氫經氟或氯取代的萘-2,6-二基、色原烷-2,6-二基、或者至少一個氫經氟或氯取代的色原烷-2,6-二基。為了降低黏度,較佳的環B或環D為1,4-伸環己基,為了提高介電各向異性,較佳的環B或環D為四氫吡喃-2,5-二基,為了提高光學各向異性,較佳的環B或環D為1,4-伸苯基。環C為2,3-二氟-1,4-伸苯基、2-氯-3-氟-1,4-伸苯基、2,3-二氟-5-甲基-1,4-伸苯基、3,4,5-三氟萘-2,6-二基、或7,8-二氟色原烷-2,6-二基。為了降低黏度,較佳的環C為2,3-二氟-1,4-伸苯基,為了降低光學各向異性,較佳的環C為2-氯-3-氟-1,4-伸苯基,為了提高介電各向異性,較佳的環C為7,8-二氟色原烷-2,6-二基。四氫吡喃-2,5-二基為, 較佳為Ring B and Ring D are independently 1,4-cyclohexyl, 1,4-cyclohexenyl, tetrahydropyran-2,5-diyl, 1,4-phenylene, at least one hydrogen atom Fluorine or chlorine substituted 1,4-phenylene, naphthalene-2,6-diyl, at least one hydrogen substituted with fluorine or chlorine naphthalene-2,6-diyl, chromogen-2,6-diyl , Or at least one chromogen-2,6-diyl substituted with fluorine or chlorine. In order to reduce the viscosity, the preferred ring B or ring D is 1,4-cyclohexyl. In order to improve the dielectric anisotropy, the preferred ring B or ring D is tetrahydropyran-2,5-diyl. In order to improve optical anisotropy, the preferred ring B or ring D is 1,4-phenylene. Ring C is 2,3-difluoro-1,4-phenylene, 2-chloro-3-fluoro-1,4-phenylene, 2,3-difluoro-5-methyl-1,4- Phenylene, 3,4,5-trifluoronaphthalene-2,6-diyl, or 7,8-difluorochromogen-2,6-diyl. To reduce viscosity, the preferred ring C is 2,3-difluoro-1,4-phenylene. To reduce the optical anisotropy, the preferred ring C is 2-chloro-3-fluoro-1,4- In order to increase the dielectric anisotropy of phenylene, the preferred ring C is 7,8-difluorochroman-2,6-diyl. Tetrahydropyran-2,5-diyl is or , Preferably .

環E及環F獨立地為1,4-伸環己基、1,4-伸苯基、2-氟-1,4-伸苯基、或2,5-二氟-1,4-伸苯基。為了降低黏度,或者為了提高上限溫度,較佳的環E或環F為1,4-伸環己基,為了降低下限溫度,較佳的環E或環F為1,4-伸苯基。Ring E and Ring F are independently 1,4-cyclohexyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, or 2,5-difluoro-1,4-phenylene base. In order to reduce the viscosity or to increase the upper limit temperature, the preferred ring E or ring F is 1,4-cyclohexyl, and in order to lower the lower limit temperature, the preferred ring E or ring F is 1,4-phenylene.

Z9 及Z10 獨立地為單鍵、伸乙基、羰氧基、或亞甲氧基。為了降低黏度,較佳的Z9 或Z10 為單鍵,為了降低下限溫度,較佳的Z9 或Z10 為伸乙基,為了提高介電各向異性,較佳的Z9 或Z10 為亞甲氧基。Z11 為單鍵、伸乙基、羰氧基、或亞甲氧基。為了提高對紫外線或熱的穩定性,較佳的Z11 為單鍵。Z 9 and Z 10 are independently a single bond, ethylene, carbonyloxy, or methyleneoxy. In order to reduce the viscosity, the preferred Z 9 or Z 10 is a single bond, in order to reduce the lower limit temperature, the preferred Z 9 or Z 10 is ethylene, and to improve the dielectric anisotropy, the preferred Z 9 or Z 10 Is methyleneoxy. Z 11 is a single bond, ethylene, carbonyloxy, or methyleneoxy. In order to improve the stability to ultraviolet rays or heat, the preferred Z 11 is a single bond.

b為1、2、或3,c為0或1,而且b與c之和為3以下。為了降低黏度,較佳的b為1,為了提高上限溫度,較佳的b為2或3。為了降低黏度,較佳的c為0,為了降低下限溫度,較佳的c為1。d為1、2、或3。為了降低黏度,較佳的d為1,為了提高上限溫度,較佳的d為2或3。b is 1, 2, or 3, c is 0 or 1, and the sum of b and c is 3 or less. In order to reduce the viscosity, the preferred b is 1, and in order to increase the upper limit temperature, the preferred b is 2 or 3. In order to reduce the viscosity, the preferred c is 0, and to lower the lower limit temperature, the preferred c is 1. d is 1, 2, or 3. In order to reduce the viscosity, the preferred d is 1, and in order to increase the upper limit temperature, the preferred d is 2 or 3.

式(4)中,P1 、P2 、及P3 獨立地為聚合性基。較佳的P1 、P2 、或P3 為選自式(P-1)至式(P-5)所表示的基的群組中的聚合性基。尤佳的P1 、P2 、或P3 為基(P-1)或基(P-2)。特佳的基(P-1)為-OCO-CH=CH2 或-OCO-C(CH3 )=CH2 。基(P-1)至基(P-5)的波浪線表示鍵結的部位。 In formula (4), P 1 , P 2 , and P 3 are independently a polymerizable group. Preferably, P 1 , P 2 , or P 3 is a polymerizable group selected from the group of groups represented by formula (P-1) to formula (P-5). Particularly preferred P 1 , P 2 , or P 3 is a radical (P-1) or a radical (P-2). A particularly preferred group (P-1) is -OCO-CH = CH 2 or -OCO-C (CH 3 ) = CH 2 . The wavy lines from the base (P-1) to the base (P-5) indicate the bonding sites.

基(P-1)至基(P-5)中,M1 、M2 、及M3 獨立地為氫、氟、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。為了提高反應性,較佳的M1 、M2 、或M3 為氫或甲基。尤佳的M1 為甲基,且尤佳的M2 或M3 為氫。In the groups (P-1) to (P-5), M 1 , M 2 , and M 3 are independently hydrogen, fluorine, an alkyl group having 1 to 5 carbon atoms, or at least one hydrogen is substituted with fluorine or chlorine. Alkyl having 1 to 5 carbons. In order to improve reactivity, preferred M 1 , M 2 , or M 3 is hydrogen or methyl. Particularly preferred M 1 is methyl, and particularly preferred M 2 or M 3 is hydrogen.

式(4-1)至式(4-27)中,P4 、P5 、及P6 獨立地為式(P-1)至式(P-3)所表示的基。較佳的P4 、P5 、或P6 為基(P-1)或基(P-2)。尤佳的基(P-1)為-OCO-CH=CH2 或-OCO-C(CH3 )=CH2 。基(P-1)至基(P-3)的波浪線表示鍵結的部位。 In the formulae (4-1) to (4-27), P 4 , P 5 , and P 6 are independently the groups represented by the formulae (P-1) to (P-3). Preferably, P 4 , P 5 , or P 6 is a radical (P-1) or a radical (P-2). A particularly preferred group (P-1) is -OCO-CH = CH 2 or -OCO-C (CH 3 ) = CH 2 . The wavy lines from the base (P-1) to the base (P-3) indicate the bonding sites.

式(4)中,Sp1 、Sp2 、及Sp3 獨立地為單鍵或碳數1至10的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,至少一個-CH2 CH2 -可經-CH=CH-或-C≡C-取代,該些基中,至少一個氫可經氟或氯取代。較佳的Sp1 、Sp2 、或Sp3 為單鍵、-CH2 CH2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-CO-CH=CH-、或-CH=CH-CO-。尤佳的Sp1 、Sp2 、或Sp3 為單鍵。In formula (4), Sp 1 , Sp 2 , and Sp 3 are independently a single bond or an alkylene group having 1 to 10 carbon atoms. At least one of the alkylene groups may be -CH 2 -via -O-,- COO-, -OCO-, or -OCOO- substitution, at least one -CH 2 CH 2 -may be substituted by -CH = CH- or -C≡C-, and among these groups, at least one hydrogen may be substituted by fluorine or chlorine . Preferably, Sp 1 , Sp 2 , or Sp 3 is a single bond, -CH 2 CH 2- , -CH 2 O-, -OCH 2- , -COO-, -OCO-, -CO-CH = CH-, Or -CH = CH-CO-. Particularly preferred Sp 1 , Sp 2 , or Sp 3 are single bonds.

環G及環J獨立地為環己基、環己烯基、苯基、1-萘基、2-萘基、四氫吡喃-2-基、1,3-二噁烷-2-基、嘧啶-2-基、或吡啶-2-基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代。較佳的環G或環J為苯基。環I為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、或吡啶-2,5-二基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代。較佳的環I為1,4-伸苯基或2-氟-1,4-伸苯基。Ring G and ring J are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxan-2-yl, Pyrimidin-2-yl, or pyridin-2-yl, in these rings, at least one hydrogen may be passed through fluorine, chlorine, alkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons, or at least one hydrogen C1-C12 alkyl substituted with fluorine or chlorine. Preferred ring G or ring J is phenyl. Ring I is 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1 , 4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl Naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2, 5-diyl, or pyridine-2,5-diyl, in these rings, at least one hydrogen may be passed through fluorine, chlorine, alkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons, or at least One hydrogen is substituted by a C1-C12 alkyl group substituted by fluorine or chlorine. Preferred ring I is 1,4-phenylene or 2-fluoro-1,4-phenylene.

Z12 及Z13 獨立地為單鍵或碳數1至10的伸烷基,該伸烷基中,至少一個-CH2 -可經-O-、-CO-、-COO-、或-OCO-取代,至少一個-CH2 CH2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-、或-C(CH3 )=C(CH3 )-取代,該些基中,至少一個氫可經氟或氯取代。較佳的Z12 或Z13 為單鍵、-CH2 CH2 -、-CH2 O-、-OCH2 -、-COO-、或-OCO-。尤佳的Z12 或Z13 為單鍵。Z 12 and Z 13 are independently a single bond or an alkylene group having 1 to 10 carbon atoms. In this alkylene group, at least one -CH 2 -can pass through -O-, -CO-, -COO-, or -OCO. -Substitution, at least one -CH 2 CH 2 -may be via -CH = CH-, -C (CH 3 ) = CH-, -CH = C (CH 3 )-, or -C (CH 3 ) = C (CH 3 ) -Substituting, in these groups, at least one hydrogen may be substituted with fluorine or chlorine. Preferably, Z 12 or Z 13 is a single bond, -CH 2 CH 2- , -CH 2 O-, -OCH 2- , -COO-, or -OCO-. A particularly preferred Z 12 or Z 13 is a single bond.

e為0、1、或2。較佳的e為0或1。f、g、及h獨立地為0、1、2、3、或4,而且f、g、及h之和為1以上。較佳的f、g、或h為1或2。e is 0, 1, or 2. The preferred e is 0 or 1. f, g, and h are independently 0, 1, 2, 3, or 4, and the sum of f, g, and h is 1 or more. Preferably, f, g, or h is 1 or 2.

第五,示出較佳的成分化合物。較佳的化合物(1)為項4所述的化合物(1-1)至化合物(1-9)。尤佳的化合物(1)為化合物(1-1)至化合物(1-3)。特佳的化合物(1)為化合物(1-1)。Fifth, preferred component compounds are shown. Preferred compound (1) is the compound (1-1) to compound (1-9) according to item 4. Particularly preferred compound (1) is compound (1-1) to compound (1-3). Particularly preferred compound (1) is compound (1-1).

較佳的化合物(2)為項8所述的化合物(2-1)至化合物(2-22)。該些化合物中,較佳為第一成分的至少一種為化合物(2-1)、化合物(2-3)、化合物(2-4)、化合物(2-6)、化合物(2-8)、或化合物(2-10)。較佳為第一成分的至少兩種為化合物(2-1)及化合物(2-6)、化合物(2-1)及化合物(2-10)、化合物(2-3)及化合物(2-6)、化合物(2-3)及化合物(2-10)、化合物(2-4)及化合物(2-6)、或化合物(2-4)及化合物(2-8)的組合。Preferred compound (2) is the compound (2-1) to compound (2-22) according to item 8. Among these compounds, it is preferred that at least one of the first components is compound (2-1), compound (2-3), compound (2-4), compound (2-6), compound (2-8), Or compound (2-10). It is preferable that at least two of the first components are compound (2-1) and compound (2-6), compound (2-1) and compound (2-10), compound (2-3) and compound (2- 6) Compound (2-3) and compound (2-10), compound (2-4) and compound (2-6), or a combination of compound (2-4) and compound (2-8).

較佳的化合物(3)為項11所述的化合物(3-1)至化合物(3-13)。該些化合物中,較佳為第二成分的至少一種為化合物(3-1)、化合物(3-3)、化合物(3-5)、化合物(3-6)、化合物(3-8)、或化合物(3-9)。較佳為第二成分的至少兩種為化合物(3-1)及化合物(3-3)、化合物(3-1)及化合物(3-5)、或化合物(3-1)及化合物(3-6)的組合。Preferred compound (3) is the compound (3-1) to compound (3-13) according to item 11. Among these compounds, it is preferred that at least one of the second components is compound (3-1), compound (3-3), compound (3-5), compound (3-6), compound (3-8), Or compound (3-9). It is preferable that at least two of the second component are the compound (3-1) and the compound (3-3), the compound (3-1) and the compound (3-5), or the compound (3-1) and the compound (3 -6).

較佳的化合物(4)為項15所述的化合物(4-1)至化合物(4-27)。該些化合物中,較佳為第二添加物的至少一種為化合物(4-1)、化合物(4-2)、化合物(4-24)、化合物(4-25)、化合物(4-26)、或化合物(4-27)。較佳為第二添加物的至少兩種為化合物(4-1)及化合物(4-2)、化合物(4-1)及化合物(4-18)、化合物(4-2)及化合物(4-24)、化合物(4-2)及化合物(4-25)、化合物(4-2)及化合物(4-26)、化合物(4-25)及化合物(4-26)、或化合物(4-18)及化合物(4-24)的組合。基(P-1)至基(P-3)中,較佳的M1 、M2 、或M3 為氫或甲基。較佳的Sp1 、Sp2 、或Sp3 為單鍵、-CH2 CH2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-CO-CH=CH-、或-CH=CH-CO-。Preferred compound (4) is the compound (4-1) to compound (4-27) according to item 15. Among these compounds, it is preferred that at least one of the second additives is compound (4-1), compound (4-2), compound (4-24), compound (4-25), compound (4-26) , Or compound (4-27). It is preferred that at least two of the second additives are compound (4-1) and compound (4-2), compound (4-1) and compound (4-18), compound (4-2) and compound (4 -24), compound (4-2) and compound (4-25), compound (4-2) and compound (4-26), compound (4-25) and compound (4-26), or compound (4 -18) and compound (4-24). Among the groups (P-1) to (P-3), preferred M 1 , M 2 , or M 3 is hydrogen or methyl. Preferably, Sp 1 , Sp 2 , or Sp 3 is a single bond, -CH 2 CH 2- , -CH 2 O-, -OCH 2- , -COO-, -OCO-, -CO-CH = CH-, Or -CH = CH-CO-.

第六,對可添加於組成物中的添加物進行說明。此種添加物為光學活性化合物、抗氧化劑、紫外線吸收劑、色素、消泡劑、聚合性化合物、聚合起始劑、聚合抑制劑、極性化合物等。出於引起液晶的螺旋結構來賦予扭轉角(torsion angle)的目的,而將光學活性化合物添加於組成物中。此種化合物的例子為化合物(5-1)至化合物(5-5)。光學活性化合物的較佳比例為約5重量%以下。尤佳比例為約0.01重量%至約2重量%的範圍。Sixth, additives that can be added to the composition will be described. Such additives are optically active compounds, antioxidants, ultraviolet absorbers, pigments, defoamers, polymerizable compounds, polymerization initiators, polymerization inhibitors, polar compounds, and the like. An optically active compound is added to the composition for the purpose of giving a torsion angle to the helical structure of the liquid crystal. Examples of such compounds are compound (5-1) to compound (5-5). A preferred ratio of the optically active compound is about 5 wt% or less. A particularly preferred ratio is in the range of about 0.01% by weight to about 2% by weight.

為了防止由大氣中的加熱所引起的比電阻的降低,或者為了在將元件長時間使用後,不僅於室溫下,而且於接近於上限溫度的溫度下亦維持大的電壓保持率,而將抗氧化劑添加於組成物中。抗氧化劑的較佳例是n為1至9的整數的化合物(6)等。 In order to prevent the decrease in specific resistance caused by heating in the atmosphere, or to maintain a large voltage holding ratio not only at room temperature but also at a temperature close to the upper limit temperature after using the element for a long time, An antioxidant is added to the composition. Preferable examples of the antioxidant are a compound (6) in which n is an integer of 1 to 9, and the like.

化合物(6)中,較佳的n為1、3、5、7、或9。尤佳的n為7。n為7的化合物(6)由於揮發性小,故對於在將元件長時間使用後,不僅於室溫下,而且於接近於上限溫度的溫度下亦維持大的電壓保持率而言有效。為了獲得所述效果,抗氧化劑的較佳比例為約50 ppm以上,為了不降低上限溫度,或者為了不提高下限溫度,抗氧化劑的較佳比例為約600 ppm以下。尤佳比例為約100 ppm至約300 ppm的範圍。In the compound (6), preferred n is 1, 3, 5, 7, or 9. A particularly preferred n is 7. The compound (6) in which n is 7 is small in volatility, and is effective for maintaining a large voltage holding ratio not only at room temperature but also at a temperature close to the upper limit temperature after a long-term use of the device. In order to obtain the effect, a preferred ratio of the antioxidant is about 50 ppm or more, and in order not to lower the upper limit temperature, or not to raise the lower limit temperature, the preferred ratio of the antioxidant is about 600 ppm or less. A particularly preferred ratio is in the range of about 100 ppm to about 300 ppm.

紫外線吸收劑的較佳例為二苯甲酮衍生物、苯甲酸酯衍生物、三唑衍生物等。另外,具有立體阻礙的胺般的光穩定劑亦較佳。為了獲得所述效果,該些吸收劑或穩定劑的較佳比例為約50 ppm以上,為了不降低上限溫度,或者為了不提高下限溫度,該些吸收劑或穩定劑的較佳比例為約10000 ppm以下。尤佳比例為約100 ppm至約10000 ppm的範圍。Preferred examples of the ultraviolet absorber include benzophenone derivatives, benzoate derivatives, and triazole derivatives. In addition, an amine-like light stabilizer having a steric hindrance is also preferred. In order to obtain the effect, the preferred ratio of these absorbers or stabilizers is about 50 ppm or more. In order not to lower the upper limit temperature, or to not raise the lower limit temperature, the preferred ratio of these absorbers or stabilizers is about 10,000 ppm or less. A particularly preferred ratio is in the range of about 100 ppm to about 10,000 ppm.

為了適合於賓主(guest host,GH)模式的元件,而將偶氮系色素、蒽醌系色素等般的二色性色素(dichroic dye)添加於組成物中。色素的較佳比例為約0.01重量%至約10重量%的範圍。為了防止起泡,而將二甲基矽酮油、甲基苯基矽酮油等消泡劑添加於組成物中。為了獲得所述效果,消泡劑的較佳比例為約1 ppm以上,為了防止顯示不良,消泡劑的較佳比例為約1000 ppm以下。尤佳比例為約1 ppm至約500 ppm的範圍。A dichroic dye such as an azo-based pigment, an anthraquinone-based pigment, or the like is added to the composition in order to be suitable for an element in a guest host (GH) mode. A preferred ratio of the pigment is in the range of about 0.01% by weight to about 10% by weight. To prevent foaming, antifoaming agents such as dimethyl silicone oil and methylphenyl silicone oil are added to the composition. In order to obtain the effect, the preferred ratio of the defoaming agent is about 1 ppm or more, and in order to prevent poor display, the preferred ratio of the defoaming agent is about 1000 ppm or less. A particularly preferred ratio is in the range of about 1 ppm to about 500 ppm.

為了適合於聚合物穩定配向(PSA)型的元件,而使用聚合性化合物。化合物(4)適合於該目的。亦可將化合物(4)以及與化合物(4)不同的聚合性化合物一起添加於組成物中。亦可代替化合物(4)而將與化合物(4)不同的聚合性化合物添加於組成物中。此種聚合性化合物的較佳例為丙烯酸酯、甲基丙烯酸酯、乙烯基化合物、乙烯氧基化合物、丙烯基醚、環氧化合物(氧雜環丙烷、氧雜環丁烷)、乙烯基酮等化合物。尤佳例為丙烯酸酯或甲基丙烯酸酯的衍生物。藉由改變化合物(4)的種類,或者藉由以適當的比使與化合物(4)不同的聚合性化合物與化合物(4)組合,可調整聚合的反應性或液晶分子的預傾角。藉由將預傾角最佳化,可達成元件的短的響應時間。液晶分子的配向穩定化,故可達成大的對比度或長壽命。In order to be suitable for a polymer stabilized alignment (PSA) type device, a polymerizable compound is used. Compound (4) is suitable for this purpose. The compound (4) and a polymerizable compound different from the compound (4) may be added to the composition together. Instead of the compound (4), a polymerizable compound different from the compound (4) may be added to the composition. Preferred examples of such polymerizable compounds are acrylates, methacrylates, vinyl compounds, vinyloxy compounds, propenyl ethers, epoxy compounds (oxetane, oxetane), and vinyl ketones. And other compounds. A particularly preferred example is a derivative of acrylate or methacrylate. By changing the type of the compound (4), or by combining a polymerizable compound different from the compound (4) with the compound (4) at an appropriate ratio, the reactivity of polymerization or the pretilt angle of the liquid crystal molecules can be adjusted. By optimizing the pretilt angle, a short response time of the element can be achieved. Since the alignment of the liquid crystal molecules is stabilized, a large contrast ratio or a long life can be achieved.

聚合性化合物藉由紫外線照射而聚合。亦可於光聚合起始劑等起始劑存在下進行聚合。用於進行聚合的適當條件、或起始劑的適當類型以及量已為本領域技術人員所知,並記載於文獻中。例如作為光聚合起始劑的豔佳固(Irgacure)651(註冊商標;巴斯夫(BASF))、豔佳固(Irgacure)184(註冊商標;巴斯夫(BASF))、或達羅卡(Darocur)1173(註冊商標;巴斯夫(BASF))適合於自由基聚合。基於聚合性化合物的重量,光聚合起始劑的較佳比例為約0.1重量%至約5重量%的範圍。尤佳比例為約1重量%至約3重量%的範圍。The polymerizable compound is polymerized by irradiation with ultraviolet rays. Polymerization can also be performed in the presence of an initiator such as a photopolymerization initiator. Suitable conditions for carrying out the polymerization, or suitable types and amounts of initiators are known to those skilled in the art and are described in the literature. Examples include photopolymerization initiators Irgacure 651 (registered trademark; BASF), Irgacure 184 (registered trademark; BASF), or Darocur 1173 (Registered trademark; BASF) is suitable for free radical polymerization. The preferred ratio of the photopolymerization initiator is in the range of about 0.1% by weight to about 5% by weight based on the weight of the polymerizable compound. A particularly preferred ratio is in the range of about 1% to about 3% by weight.

於保管聚合性化合物時,為了防止聚合,亦可添加聚合抑制劑。聚合性化合物通常是以未去除聚合抑制劑的狀態添加於組成物中。聚合抑制劑的例子為對苯二酚、甲基對苯二酚般的對苯二酚衍生物、4-第三丁基鄰苯二酚、4-甲氧基苯酚、啡噻嗪等。When storing a polymerizable compound, a polymerization inhibitor may be added to prevent polymerization. The polymerizable compound is usually added to the composition without removing the polymerization inhibitor. Examples of polymerization inhibitors are hydroquinone, methylhydroquinone-like hydroquinone derivatives, 4-tert-butylcatechol, 4-methoxyphenol, phenothiazine, and the like.

極性化合物為具有極性的有機化合物。此處,不含具有離子鍵的化合物。氧、硫、及氮般的原子的電性偏陰性且存在具有部分負電荷的傾向。碳及氫為中性或存在具有部分正電荷的傾向。極性是因部分電荷在化合物中的不同種的原子間不均等地分佈而產生。例如,極性化合物具有-OH、-COOH、-SH、-NH2 、>NH、>N-般的部分結構的至少一種。A polar compound is a polar organic compound. Here, a compound having an ionic bond is not included. Oxygen, sulfur, and nitrogen-like atoms are electrically negative and tend to have a partial negative charge. Carbon and hydrogen are neutral or tend to have a partially positive charge. Polarity is caused by the uneven distribution of partial charges among different kinds of atoms in a compound. For example, the polar compound has at least one of -OH, -COOH, -SH, -NH 2 ,> NH, and> N-like partial structures.

第七,對成分化合物的合成法進行說明。該些化合物可利用已知的方法來合成。例示合成法。化合物(1-1-1)及化合物(1-1-2)的合成法是記載於實施例的項中。亦可參照日本專利特開2016-037605號公報中所記載的合成法。化合物(2-6)是利用日本專利特開2000-53602號公報中所記載的方法來合成。化合物(3-1)是利用日本專利特開昭59-176221號公報中所記載的方法來合成。化合物(4-18)是利用日本專利特開平7-101900號公報中所記載的方法來合成。式(6)的n為1的化合物可自西格瑪奧德里奇公司(Sigma-Aldrich Corporation)獲取。n為7的化合物(6)等是利用美國專利第3660505號說明書中所記載的方法來合成。Seventh, a method for synthesizing the component compounds will be described. These compounds can be synthesized by known methods. Illustrative synthesis methods. The synthesis method of the compound (1-1-1) and the compound (1-1-2) is described in the item of an Example. Reference may also be made to the synthesis method described in Japanese Patent Laid-Open No. 2016-037605. The compound (2-6) is synthesized by a method described in Japanese Patent Laid-Open No. 2000-53602. Compound (3-1) is synthesized by the method described in Japanese Patent Laid-Open No. 59-176221. Compound (4-18) is synthesized by a method described in Japanese Patent Laid-Open No. 7-101900. The compound of formula (6) where n is 1 is available from Sigma-Aldrich Corporation. Compound (6) and the like in which n is 7 are synthesized by a method described in US Pat. No. 3,660,505.

未記載合成法的化合物可利用以下成書中所記載的方法來合成:「有機合成」(Organic Syntheses,約翰威立父子出版公司(John Wiley & Sons, Inc.))、「有機反應」(Organic Reactions,約翰威立父子出版公司)、「綜合有機合成」(Comprehensive Organic Synthesis,培格曼出版公司(Pergamon Press))、新實驗化學講座(丸善)等。組成物是利用公知的方法,由以所述方式獲得的化合物來製備。例如,將成分化合物混合,然後藉由加熱而使其相互溶解。Compounds without a synthetic method can be synthesized by the methods described in the following books: "Organic Syntheses" (John Wiley & Sons, Inc.), "Organic Reactions" Reactions, John Willie & Sons Publishing Company), Comprehensive Organic Synthesis (Pergamon Press), New Experimental Chemistry Lecture (Maruzen), etc. The composition is prepared from a compound obtained in the above-mentioned manner by a known method. For example, the component compounds are mixed and then dissolved in each other by heating.

最後,對組成物的用途進行說明。大部分的組成物具有約-10℃以下的下限溫度、約70℃以上的上限溫度、以及約0.07至約0.20的範圍的光學各向異性。可藉由控制成分化合物的比例或者藉由混合其他液晶性化合物,來製備具有約0.08至約0.25的範圍的光學各向異性的組成物。進而亦可藉由嘗試錯誤,來製備具有約0.10至約0.30的範圍的光學各向異性的組成物。含有該組成物的元件具有大的電壓保持率。該組成物適合於AM元件。該組成物特別適合於透過型的AM元件。該組成物可用作具有向列相的組成物,或可藉由添加光學活性化合物而用作光學活性組成物。Finally, the use of the composition will be described. Most compositions have a lower limit temperature of about -10 ° C or lower, an upper limit temperature of about 70 ° C or higher, and optical anisotropy in a range of about 0.07 to about 0.20. A composition having an optical anisotropy in a range of about 0.08 to about 0.25 can be prepared by controlling the ratio of the component compounds or by mixing other liquid crystal compounds. Furthermore, a composition having an optical anisotropy in a range of about 0.10 to about 0.30 can be prepared by trial and error. The device containing this composition has a large voltage holding ratio. This composition is suitable for an AM device. This composition is particularly suitable for a transmissive AM device. This composition can be used as a composition having a nematic phase, or can be used as an optically active composition by adding an optically active compound.

該組成物可用於AM元件。進而亦可用於PM元件。該組成物可用於具有PC、TN、STN、ECB、OCB、IPS、FFS、VA、FPA等模式的AM元件及PM元件。特佳為用於具有VA、OCB、IPS模式或FFS模式的AM元件。具有IPS模式或FFS模式的AM元件中,於不施加電壓時,液晶分子的排列可與玻璃基板平行,或者亦可為垂直。該些元件可為反射型、透過型或半透過型。較佳為用於透過型的元件。亦可用於非晶矽-TFT元件或多晶矽-TFT元件。亦可將該組成物用於進行微膠囊化(microencapsulation)而製作的向列曲線排列相(nematic curvilinear aligned phase,NCAP)型的元件或於組成物中形成三維網狀高分子而成的聚合物分散(polymer dispersed,PD)型的元件。This composition can be used for an AM device. It can also be used for PM devices. This composition can be used for AM devices and PM devices with PC, TN, STN, ECB, OCB, IPS, FFS, VA, FPA and other modes. Particularly preferred is for AM devices with VA, OCB, IPS mode or FFS mode. In an AM device having an IPS mode or an FFS mode, when no voltage is applied, the arrangement of the liquid crystal molecules may be parallel to the glass substrate, or may be vertical. These elements can be reflective, transmissive, or transflective. It is preferably used for a transmissive element. It can also be used for amorphous silicon-TFT elements or polycrystalline silicon-TFT elements. The composition can also be used in a nematic curvilinear aligned phase (NCAP) device made by microencapsulation or a polymer formed by forming a three-dimensional network polymer in the composition. A polymer dispersed (PD) type device.

製造聚合物穩定配向型的元件的方法的一例如下所述。組裝包括兩塊基板的元件,該兩塊基板被稱為陣列基板與彩色濾光片基板。該基板具有配向膜。該基板的至少一塊具有電極層。將液晶性化合物混合來製備液晶組成物。於該組成物中添加聚合性化合物。視需要可進而添加添加物。將該組成物注入至元件中。在對該元件施加電壓的狀態下進行光照射。較佳為紫外線。藉由光照射而使聚合性化合物進行聚合。藉由該聚合而生成含有聚合物的組成物。聚合物穩定配向型的元件是以如上所述的順序來製造。An example of a method of manufacturing a polymer-stabilized alignment element is described below. Assemble an element that includes two substrates, which are called an array substrate and a color filter substrate. The substrate has an alignment film. At least one of the substrates has an electrode layer. A liquid crystal compound is mixed to prepare a liquid crystal composition. A polymerizable compound is added to this composition. Additives can be added if necessary. This composition is injected into a device. Light irradiation is performed in a state where a voltage is applied to the element. Preferred is ultraviolet light. The polymerizable compound is polymerized by light irradiation. A polymer-containing composition is produced by this polymerization. The polymer stabilized alignment type element is manufactured in the order described above.

該順序中,於施加電壓時,液晶分子藉由配向膜及電場的作用而配向。依據該配向,聚合性化合物的分子亦進行配向。由於聚合性化合物是在該狀態下藉由紫外線來進行聚合,故生成維持該配向的聚合物。藉由該聚合物的效果,元件的響應時間縮短。由於圖像的殘像為液晶分子的運作不良,故藉由該聚合物的效果,殘像亦同時得到改善。此外,亦可使組成物中的聚合性化合物預先進行聚合,將該組成物配置於液晶顯示元件的基板之間。 [實施例]In this sequence, when a voltage is applied, the liquid crystal molecules are aligned by the action of an alignment film and an electric field. According to this alignment, the molecules of the polymerizable compound are also aligned. Since the polymerizable compound is polymerized by ultraviolet rays in this state, a polymer that maintains the alignment is produced. The effect of this polymer shortens the response time of the device. Since the residual image of the image is a poor operation of the liquid crystal molecules, the effect of the polymer also improves the residual image. In addition, the polymerizable compound in the composition may be polymerized in advance, and the composition may be disposed between the substrates of the liquid crystal display element. [Example]

藉由實施例來對本發明進一步進行詳細說明。本發明不受該些實施例的限制。本發明包含實施例1的組成物與實施例2的組成物的混合物。本發明亦包含將組成例的組成物的至少兩種混合而成的混合物。所合成的化合物是藉由核磁共振(nuclear magnetic resonance,NMR)分析等方法來鑑定。化合物、組成物及元件的特性是利用下述所記載的方法來測定。The present invention will be further described in detail through examples. The invention is not limited by these examples. The present invention includes a mixture of the composition of Example 1 and the composition of Example 2. The present invention also includes a mixture obtained by mixing at least two of the compositions of the composition examples. The synthesized compounds were identified by methods such as nuclear magnetic resonance (NMR) analysis. The properties of compounds, compositions, and devices were measured by the methods described below.

NMR分析:測定時使用布魯克拜厄斯賓(Bruker BioSpin)公司製造的DRX-500。1 H-NMR的測定中,使試樣溶解於CDCl3 等氘化溶媒中,於室溫下以500 MHz、累計次數為16次的條件進行測定。使用四甲基矽烷作為內部標準。19 F-NMR的測定中,使用CFCl3 作為內部標準,以累計次數24次來進行。核磁共振波譜的說明中,s是指單峰(singlet),d是指雙重峰(doublet),t是指三重峰(triplet),q是指四重峰(quartet),quin是指五重峰(quintet),sex是指六重峰(sextet),m是指多重峰(multiplet),br是指寬峰(broad)。NMR analysis: DRX-500 manufactured by Bruker BioSpin was used for measurement. In the measurement of 1 H-NMR, the sample was dissolved in a deuterated solvent such as CDCl 3, and the measurement was performed at room temperature under the conditions of 500 MHz and a cumulative number of 16 times. Tetramethylsilane was used as the internal standard. In the 19 F-NMR measurement, CFCl 3 was used as an internal standard, and the total number of measurements was performed 24 times. In the description of nuclear magnetic resonance spectrum, s refers to singlet, d refers to doublet, t refers to triplet, q refers to quartet, and quin refers to quintet. (Quintet), sex means sixt (sextet), m means multiplet, and br means broad.

氣相層析分析:測定時使用島津製作所製造的GC-14B型氣相層析儀。載體氣體為氦氣(2 mL/min)。將試樣氣化室設定為280℃,將檢測器(火焰離子化檢測器(flame ionization detector,FID))設定為300℃。進行成分化合物的分離時使用安捷倫科技有限公司(Agilent Technologies Inc.)製造的毛細管柱DB-1(長度30 m、內徑0.32 mm、膜厚0.25 μm;固定液相為二甲基聚矽氧烷;無極性)。該管柱於200℃下保持2分鐘後,以5℃/min的比例昇溫至280℃。將試樣製備成丙酮溶液(0.1重量%)後,將其1 μL注入至試樣氣化室中。記錄計為島津製作所製造的C-R5A型層析儀組件(Chromatopac)或其同等品。所獲得的氣相層析圖顯示出與成分化合物對應的峰值的保持時間以及峰值的面積。Gas chromatographic analysis: The GC-14B gas chromatograph manufactured by Shimadzu Corporation was used for the measurement. The carrier gas was helium (2 mL / min). The sample gasification chamber was set to 280 ° C, and the detector (flame ionization detector (FID)) was set to 300 ° C. For separation of constituent compounds, a capillary column DB-1 (30 m in length, 0.32 mm in inner diameter, and 0.25 μm in thickness) manufactured by Agilent Technologies Inc. was used; the fixed liquid phase was dimethylpolysiloxane ; Non-polar). After the column was held at 200 ° C for 2 minutes, the temperature was raised to 280 ° C at a rate of 5 ° C / min. After the sample was prepared as an acetone solution (0.1% by weight), 1 μL of the sample was injected into the sample gasification chamber. The recorder is a C-R5A Chromatopac manufactured by Shimadzu Corporation or its equivalent. The obtained gas chromatogram showed the retention time of the peak corresponding to the component compounds and the area of the peak.

用於稀釋試樣的溶媒可使用氯仿、己烷等。為了將成分化合物分離,可使用如下的毛細管柱。安捷倫科技有限公司製造的HP-1(長度30 m、內徑0.32 mm、膜厚0.25 μm)、瑞斯泰克公司(Restek Corporation)製造的Rtx-1(長度30 m、內徑0.32 mm、膜厚0.25 μm)、澳大利亞SGE國際公司(SGE International Pty. Ltd)製造的BP-1(長度30 m、內徑0.32 mm、膜厚0.25 μm)。出於防止化合物峰值的重疊的目的,可使用島津製作所製造的毛細管柱CBP1-M50-025(長度50 m、內徑0.25 mm、膜厚0.25 μm)。As a solvent for diluting the sample, chloroform, hexane, or the like can be used. To separate the component compounds, the following capillary columns can be used. HP-1 (30 m in length, 0.32 mm ID, film thickness of 0.25 μm) manufactured by Agilent Technologies, Rtx-1 (30 m in length, 0.32 mm ID, film thickness) manufactured by Restek Corporation 0.25 μm), BP-1 manufactured by Australia SGE International Pty. Ltd (length 30 m, inner diameter 0.32 mm, film thickness 0.25 μm). To prevent compound peaks from overlapping, a capillary column CBP1-M50-025 (length 50 m, inner diameter 0.25 mm, and film thickness 0.25 μm) manufactured by Shimadzu Corporation can be used.

組成物中所含有的液晶性化合物的比例可利用如下所述的方法來算出。利用氣相層析法(FID)來對液晶性化合物的混合物進行分析。氣相層析圖中的峰值的面積比相當於液晶性化合物的比例(重量比)。於使用上文記載的毛細管柱時,可將各種液晶性化合物的修正係數視為1。因而,液晶性化合物的比例(重量%)可根據峰值的面積比來算出。The ratio of the liquid crystal compound contained in the composition can be calculated by the method described below. Gas chromatography (FID) was used to analyze a mixture of liquid crystal compounds. The area ratio of the peaks in the gas chromatogram corresponds to the ratio (weight ratio) of the liquid crystal compound. When the capillary column described above is used, the correction coefficient of various liquid crystal compounds can be regarded as one. Therefore, the ratio (% by weight) of the liquid crystalline compound can be calculated from the peak area ratio.

測定試樣:於測定組成物或元件的特性時,將組成物直接用作試樣。於測定化合物的特性時,藉由將該化合物(15重量%)混合於母液晶(85重量%)中來製備測定用試樣。根據藉由測定而獲得的值,利用外推法來算出化合物的特性值。(外推值)={(試樣的測定值)-0.85×(母液晶的測定值)}/0.15。當於該比例下,層列相(或結晶)於25℃下析出時,將化合物與母液晶的比例以10重量%:90重量%、5重量%:95重量%、1重量%:99重量%的順序變更。利用該外推法來求出與化合物相關的上限溫度、光學各向異性、黏度、以及介電各向異性的值。Measurement sample: When measuring the characteristics of a composition or an element, the composition is directly used as a sample. When measuring the characteristics of a compound, a sample for measurement was prepared by mixing the compound (15% by weight) with a mother liquid crystal (85% by weight). From the values obtained by the measurement, the characteristic values of the compounds were calculated by extrapolation. (Extrapolated value) = {(measured value of the sample)-0.85 × (measured value of the mother liquid crystal)} /0.15. When the smectic phase (or crystal) is precipitated at 25 ° C at this ratio, the ratio of the compound to the mother liquid crystal is 10% by weight: 90% by weight, 5% by weight: 95% by weight, and 1% by weight: 99% % Order change. This extrapolation method was used to determine the values of the compound-dependent upper temperature, optical anisotropy, viscosity, and dielectric anisotropy.

使用下述母液晶。成分化合物的比例是以重量%表示。 The following mother liquid crystals were used. The proportion of the component compounds is expressed in% by weight.

測定方法:利用下述方法來進行特性的測定。該些方法大多是日本電子資訊技術產業協會(Japan Electronics and Information Technology Industries Association;稱為JEITA)審議製定的JEITA規格(JEITA·ED-2521B)中所記載的方法或將其修飾而成的方法。用於測定的TN元件上未安裝薄膜電晶體(TFT)。Measurement method: The characteristics were measured by the following method. Most of these methods are methods described or modified from the JEITA standard (JEITA · ED-2521B) reviewed and formulated by the Japan Electronics and Information Technology Industries Association (referred to as JEITA). The thin-film transistor (TFT) was not mounted on the TN element used for the measurement.

(1)向列相的上限溫度(NI;℃):於具備偏光顯微鏡的熔點測定裝置的加熱板上放置試樣,以1℃/min的速度進行加熱。測定試樣的一部分由向列相變化為各向同性液體時的溫度。有時將向列相的上限溫度簡稱為「上限溫度」。(1) Upper limit temperature of the nematic phase (NI; ° C): A sample is placed on a hot plate of a melting point measuring device equipped with a polarizing microscope, and heated at a rate of 1 ° C / min. The temperature at which a part of the sample changed from a nematic phase to an isotropic liquid was measured. The upper limit temperature of the nematic phase may be simply referred to as the "upper limit temperature".

(2)向列相的下限溫度(TC ;℃):將具有向列相的試樣放入玻璃瓶中,於0℃、-10℃、-20℃、-30℃、及-40℃的冷凍器中保管10天後,觀察液晶相。例如,當試樣於-20℃下保持向列相的狀態,而於-30℃下變化為結晶或層列相時,將TC 記載為<-20℃。有時將向列相的下限溫度簡稱為「下限溫度」。(2) Lower limit temperature (T C ; ℃) of nematic phase: Put the sample with nematic phase into the glass bottle at 0 ℃, -10 ℃, -20 ℃, -30 ℃, and -40 ℃ After storing in a freezer for 10 days, the liquid crystal phase was observed. For example, when the sample maintains a nematic phase state at -20 ° C and changes to a crystal or a smectic phase at -30 ° C, the T C is described as <-20 ° C. The lower limit temperature of the nematic phase may be simply referred to as "lower limit temperature".

(3)黏度(體積黏度;η;於20℃下測定;mPa·s):測定時使用東京計器股份有限公司製造的E型旋轉黏度計。(3) Viscosity (volume viscosity; η; measured at 20 ° C; mPa · s): For measurement, an E-type rotary viscometer manufactured by Tokyo Keiki Co., Ltd. was used.

(4)黏度(旋轉黏度;γ1;於25℃下測定;mPa·s):依據M.今井(M. Imai)等人的「分子晶體與液晶」(Molecular Crystals and Liquid Crystals)第259卷第37頁(1995)中所記載的方法來進行測定。於兩片玻璃基板的間隔(單元間隙)為20 μm的VA元件中放入試樣。對該元件於39伏特至50伏特的範圍內,以1伏特為單位階段性地施加電壓。不施加電壓0.2秒後,以僅施加1個矩形波(矩形脈衝;0.2秒)與不施加(2秒)的條件重複施加電壓。測定藉由該施加而產生的暫態電流(transient current)的峰值電流(peak current)及峰值時間(peak time)。由該些測定值與M. Imai等人的論文第40頁的計算式(8)來獲得旋轉黏度的值。該計算所需要的介電各向異性是藉由(6)項進行測定。(4) Viscosity (rotational viscosity; γ1; measured at 25 ° C; mPa · s): According to "Molecular Crystals and Liquid Crystals" by M. Imai et al. The measurement is described in the method described on page 37 (1995). A sample was placed in a VA device with a gap (cell gap) between two glass substrates of 20 μm. A voltage is applied to the device in a range of 39 volts to 50 volts in steps of 1 volt. After 0.2 seconds without applying voltage, the voltage was repeatedly applied under the conditions of applying only 1 rectangular wave (rectangular pulse; 0.2 seconds) and not applying (2 seconds). The peak current and peak time of the transient current generated by the application were measured. From these measured values and the calculation formula (8) on page 40 of the paper by M. Imai et al., The value of the rotational viscosity is obtained. The dielectric anisotropy required for this calculation is measured by the item (6).

(5)光學各向異性(折射率各向異性;Δn;於25℃下測定):使用波長為589 nm的光,利用在接目鏡上安裝有偏光板的阿貝折射計來進行測定。將主稜鏡的表面向一個方向摩擦後,將試樣滴加至主稜鏡上。折射率n∥是於偏光的方向與摩擦的方向平行時進行測定。折射率n⊥是於偏光的方向與摩擦的方向垂直時進行測定。光學各向異性的值是根據Δn=n∥-n⊥的式子來計算。(5) Optical anisotropy (refractive index anisotropy; Δn; measured at 25 ° C): The light was measured at 589 nm using an Abbe refractometer with a polarizing plate mounted on the eyepiece. After rubbing the surface of the main shaft in one direction, the sample was dropped onto the main shaft. The refractive index n∥ is measured when the direction of polarized light is parallel to the direction of rubbing. The refractive index n⊥ is measured when the direction of polarized light is perpendicular to the direction of rubbing. The value of optical anisotropy is calculated from the formula of Δn = n∥-n⊥.

(6)介電各向異性(Δε;於25℃下測定):根據Δε=ε∥-ε⊥的式子來計算出介電各向異性的值。以如下方式測定介電常數(ε∥及ε⊥)。 1)介電常數(ε∥)的測定:於經充分清洗的玻璃基板上塗佈十八烷基三乙氧基矽烷(0.16 mL)的乙醇(20 mL)溶液。利用旋轉器使玻璃基板旋轉後,於150℃下加熱1小時。於兩片玻璃基板的間隔(單元間隙)為4 μm的VA元件中放入試樣,利用以紫外線進行硬化的黏接劑將該元件密封。對該元件施加正弦波(0.5 V,1 kHz),2秒後測定液晶分子的長軸方向上的介電常數ε(∥)。(6) Dielectric anisotropy (Δε; measured at 25 ° C): The value of the dielectric anisotropy is calculated according to the formula of Δε = ε∥-ε⊥. The dielectric constants (ε∥ and ε⊥) were measured as follows. 1) Measurement of dielectric constant (ε∥): Apply a solution of octadecyltriethoxysilane (0.16 mL) in ethanol (20 mL) on a sufficiently cleaned glass substrate. After the glass substrate was rotated by a spinner, it was heated at 150 ° C for 1 hour. A sample was placed in a VA device having a distance (cell gap) between two glass substrates of 4 μm, and the device was sealed with an adhesive hardened with ultraviolet rays. A sine wave (0.5 V, 1 kHz) was applied to the device, and the dielectric constant ε (∥) in the major axis direction of the liquid crystal molecules was measured after 2 seconds.

2)介電常數(ε⊥)的測定:於經充分清洗的玻璃基板上塗佈聚醯亞胺溶液。將該玻璃基板煅燒後,對所獲得的配向膜進行摩擦處理。於兩片玻璃基板的間隔(單元間隙)為9 μm、扭轉角為80度的TN元件中放入試樣。對該元件施加正弦波(0.5 V,1 kHz),2秒後測定液晶分子的短軸方向上的介電常數(ε⊥)。2) Measurement of dielectric constant (ε⊥): A polyimide solution is coated on a sufficiently cleaned glass substrate. After the glass substrate is fired, the obtained alignment film is subjected to a rubbing treatment. A sample was placed in a TN device having a distance (cell gap) between two glass substrates of 9 μm and a twist angle of 80 degrees. A sine wave (0.5 V, 1 kHz) was applied to the device, and the dielectric constant (ε⊥) in the minor axis direction of the liquid crystal molecules was measured after 2 seconds.

(7)臨限電壓(Vth;於25℃下測定;V):測定時使用大塚電子股份有限公司製造的LCD5100型亮度計。光源為鹵素燈。於兩片玻璃基板的間隔(單元間隙)為4 μm、摩擦方向為反平行的正常顯黑模式(normally black mode)的VA元件中放入試樣,使用以紫外線進行硬化的黏接劑將該元件密封。對該元件施加的電壓(60 Hz,矩形波)是以0.02 V為單位自0 V階段性地增加至20 V。此時,自垂直方向對元件照射光,測定透過元件的光量。製成於該光量達到最大時透過率為100%,且於該光量為最小時透過率為0%的電壓-透過率曲線。臨限電壓是以透過率達到10%時的電壓來表示。(7) Threshold voltage (Vth; measured at 25 ° C; V): The LCD5100 brightness meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source is a halogen lamp. A sample was placed in a normally black mode VA device with a gap (cell gap) of two glass substrates of 4 μm and a rubbing direction in antiparallel, and the adhesive was cured with an ultraviolet curing adhesive. Component sealed. The voltage (60 Hz, rectangular wave) applied to the device was increased stepwise from 0 V to 20 V in units of 0.02 V. At this time, the device was irradiated with light from the vertical direction, and the amount of light transmitted through the device was measured. A voltage-transmittance curve having a transmittance of 100% when the amount of light reaches the maximum and a transmittance of 0% when the amount of light reaches the minimum is made. The threshold voltage is expressed as a voltage when the transmittance reaches 10%.

(8)電壓保持率(VHR-1;於25℃下測定;%):用於測定的TN元件具有聚醯亞胺配向膜,而且兩片玻璃基板的間隔(單元間隙)為5 μm。該元件在放入試樣後,利用以紫外線進行硬化的黏接劑來密封。對該TN元件施加脈衝電壓(5 V、60微秒)進行充電。利用高速電壓計於16.7毫秒的期間內測定衰減的電壓,求出單位週期的電壓曲線與橫軸之間的面積A。面積B為電壓未衰減時的面積。電壓保持率是以面積A相對於面積B的百分率來表示。(8) Voltage holding ratio (VHR-1; measured at 25 ° C;%): The TN device used for the measurement has a polyimide alignment film, and the distance (cell gap) between two glass substrates is 5 μm. This device was sealed with an adhesive hardened with ultraviolet rays after the sample was put in the sample. A pulse voltage (5 V, 60 microseconds) was applied to the TN device to charge it. The decaying voltage was measured with a high-speed voltmeter over a period of 16.7 milliseconds, and the area A between the voltage curve per unit cycle and the horizontal axis was obtained. Area B is the area when the voltage is not attenuated. The voltage holding ratio is expressed as a percentage of the area A to the area B.

(9)電壓保持率(VHR-2;於80℃下測定;%):除了代替25℃而於80℃下測定以外,以與所述相同的順序測定電壓保持率。將所獲得的值以VHR-2表示。(9) Voltage holding ratio (VHR-2; measured at 80 ° C;%): The voltage holding ratio was measured in the same procedure as described above, except that the measurement was performed at 80 ° C instead of 25 ° C. The obtained value is represented by VHR-2.

(10)電壓保持率(VHR-3;於25℃下測定;%):照射紫外線後,測定電壓保持率,評價對紫外線的穩定性。用於測定的TN元件具有聚醯亞胺配向膜,而且單元間隙為5 μm。於該元件中注入試樣,照射光20分鐘。光源為超高壓水銀燈USH-500D(牛尾(Ushio)電機製造),元件與光源的間隔為20 cm。VHR-3的測定中,於16.7毫秒的期間內測定所衰減的電壓。具有大的VHR-3的組成物對紫外線具有大的穩定性。VHR-3較佳為90%以上,尤佳為95%以上。(10) Voltage holding ratio (VHR-3; measured at 25 ° C;%): After irradiation with ultraviolet rays, the voltage holding ratio was measured to evaluate the stability to ultraviolet rays. The TN device used for the measurement has a polyimide alignment film, and the cell gap is 5 μm. A sample was injected into the device, and the device was irradiated with light for 20 minutes. The light source is an ultra-high-pressure mercury lamp USH-500D (made by Ushio Motor), and the distance between the component and the light source is 20 cm. In the measurement of VHR-3, the attenuated voltage was measured over a period of 16.7 milliseconds. A composition having a large VHR-3 has a large stability to ultraviolet rays. VHR-3 is preferably 90% or more, particularly preferably 95% or more.

(11)電壓保持率(VHR-4;於25℃下測定;%):將注入有試樣的TN元件於80℃的恆溫槽內加熱500小時後,測定電壓保持率,評價對熱的穩定性。VHR-4的測定中,於16.7毫秒的期間內測定所衰減的電壓。具有大的VHR-4的組成物對熱具有大的穩定性。(11) Voltage holding ratio (VHR-4; measured at 25 ° C;%): After heating the TN element filled with the sample in a constant temperature bath at 80 ° C for 500 hours, measure the voltage holding ratio and evaluate the stability against heat Sex. In the measurement of VHR-4, the attenuated voltage was measured over a period of 16.7 milliseconds. A composition having a large VHR-4 has a large stability to heat.

(12)響應時間(τ;於25℃下測定;ms):測定時使用大塚電子股份有限公司製造的LCD5100型亮度計。光源為鹵素燈。低通濾波器(Low-pass filter)設定為5 kHz。於兩片玻璃基板的間隔(單元間隙)為4 μm、摩擦方向為反平行的正常顯黑模式(normally black mode)的VA元件中放入試樣。使用以紫外線進行硬化的黏接劑將該元件密封。對該元件施加矩形波(60 Hz,10 V,0.5秒)。此時,自垂直方向對元件照射光,測定透過元件的光量。於該光量達到最大時視為透過率100%,於該光量為最小時視為透過率0%。響應時間是以透過率自90%變化至10%所需要的時間(下降時間;fall time;毫秒)表示。(12) Response time (τ; measured at 25 ° C; ms): LCD5100 type brightness meter manufactured by Otsuka Electronics Co., Ltd. was used for measurement. The light source is a halogen lamp. The low-pass filter is set to 5 kHz. A sample was placed in a normally black mode VA device in which the distance (cell gap) between two glass substrates was 4 μm and the rubbing direction was antiparallel. This element was sealed with an adhesive hardened with ultraviolet rays. A rectangular wave (60 Hz, 10 V, 0.5 seconds) was applied to the device. At this time, the device was irradiated with light from the vertical direction, and the amount of light transmitted through the device was measured. When the amount of light reaches the maximum, the transmittance is considered to be 100%, and when the amount of light is the smallest, the transmittance is considered to be 0%. Response time is expressed as the time (fall time; milliseconds) required for the transmittance to change from 90% to 10%.

(13)比電阻(ρ;於25℃下測定;Ωcm):於具備電極的容器中注入試樣1.0 mL。對該容器施加直流電壓(10 V),測定10秒後的直流電流。比電阻是根據以下的式子而算出。(比電阻)={(電壓)×(容器的電容)}/{(直流電流)×(真空的介電常數)}。(13) Specific resistance (ρ; measured at 25 ° C; Ωcm): Inject 1.0 mL of a sample into a container provided with an electrode. A DC voltage (10 V) was applied to the container, and a DC current after 10 seconds was measured. The specific resistance is calculated based on the following formula. (Specific resistance) = {(voltage) × (capacitance of the container)} / {(DC current) × (dielectric constant of the vacuum)}.

(14)線殘像(Line Image Sticking Parameter;LISP;%):藉由對液晶顯示元件施加電氣應力而產生線殘像。測定存在線殘像的區域的亮度與其餘區域的亮度。算出因線殘像而導致亮度下降的比例,藉由該比例表示線殘像的大小。(14) Line image sticking parameter (LISP;%): A line afterimage is generated by applying electrical stress to a liquid crystal display element. The brightness of the area where the line afterimage is present and the brightness of the remaining areas are measured. Calculate the ratio of the brightness reduction caused by the line afterimage, and use this ratio to indicate the size of the line afterimage.

14a)亮度的測定:使用成像色彩亮度計(瑞澱曦脈(Radiant Zemax)公司製造,PM-1433F-0)來拍攝元件的圖像。藉由使用軟體(Prometric 9.1,Radiant Imaging公司製造)對該圖像進行解析而算出元件的各區域的亮度。14a) Measurement of brightness: An imaging color brightness meter (manufactured by Radiant Zemax, manufactured by PM-1433F-0) was used to take an image of the element. The brightness of each region of the element was calculated by analyzing the image using software (Prometric 9.1, manufactured by Radiant Imaging).

14b)應力電壓的設定:於單元間隙為3.5 μm、具有矩陣結構的FFS元件(縱4單元×橫4單元的16單元)中放入試樣,使用以紫外線進行硬化的黏接劑將該元件密封。以偏光軸正交的方式分別於該元件的上面與下面配置偏光板。對該元件照射光並施加電壓(矩形波,60 Hz)。電壓是於0 V至7.5 V的範圍內,以0.1 V為單位階段性地增加,測定各電壓下的透過光的亮度。將亮度達到最大時的電壓簡稱為V255。將亮度達到V255的21.6%時(即,127灰階)的電壓簡稱為V127。14b) Setting of stress voltage: Put a sample in an FFS device with a cell gap of 3.5 μm and a matrix structure (16 cells in 4 cells x 4 cells in 4 cells), and use an adhesive hardened with ultraviolet rays to make the device seal. A polarizing plate is arranged above and below the element so that the polarization axes are orthogonal to each other. This element was irradiated with light and a voltage was applied (rectangular wave, 60 Hz). The voltage was gradually increased in the range of 0 V to 7.5 V in units of 0.1 V, and the brightness of transmitted light at each voltage was measured. The voltage when the brightness reaches the maximum is referred to as V255. The voltage when the brightness reaches 21.6% of V255 (ie, 127 gray levels) is referred to as V127 for short.

14c)應力的條件:於60℃、23小時的條件下對元件施加V255(矩形波,30 Hz)與0.5 V(矩形波,30 Hz),並顯示棋盤格圖案。其次,施加V127(矩形波,0.25 Hz),於曝光時間4000毫秒的條件下測定亮度。14c) Stress conditions: V255 (rectangular wave, 30 Hz) and 0.5 V (rectangular wave, 30 Hz) are applied to the element at 60 ° C for 23 hours, and a checkerboard pattern is displayed. Next, V127 (rectangular wave, 0.25 Hz) was applied, and the brightness was measured under an exposure time of 4000 milliseconds.

14d)線殘像的算出:於算出時使用16單元中的中央部的4單元(縱2單元×橫2單元)。將該4單元分割為25個區域(縱5單元×橫5單元)。將位於四角落的四個區域(縱2單元×橫2單元)的平均亮度簡稱為亮度A。自25個區域去除四角落的區域而成的區域為十字形。於自該十字形的區域去除中央的交叉區域而成的四個區域中,將亮度的最小值簡稱為亮度B。線殘像是根據以下的式子而算出。(線殘像)=(亮度A-亮度B)/亮度A×100。14d) Calculation of line residual image: In the calculation, 4 units (2 units vertically × 2 units horizontally) of the central portion of the 16 units are used. The 4 cells are divided into 25 regions (5 cells in a vertical direction and 5 cells in a horizontal direction). The average brightness of four areas (2 units by 2 units) at the four corners is referred to as brightness A for short. The area formed by excluding the four corner areas from the 25 areas is cross-shaped. Of the four areas obtained by excluding the central intersection area from the cross-shaped area, the minimum value of the brightness is simply referred to as the brightness B. The line residual image is calculated based on the following formula. (Line afterimage) = (Brightness A-Brightness B) / Brightness A × 100.

(15)擴展性:添加物的擴展性是藉由對元件施加電壓並測定亮度而定性地進行評價。亮度的測定是與所述項14a同樣地進行。電壓(V127)的設定是與所述項14b同樣地進行。其中,使用VA元件代替FFS元件。以如下方式測定亮度。首先,對元件施加2分鐘的直流電壓(2 V)。其次,施加V127(矩形波,0.05 Hz),於曝光時間4000毫秒的條件下測定亮度。根據該結果來評價擴展性。(15) Expandability: The expandability of the additive is qualitatively evaluated by applying a voltage to the element and measuring the brightness. The measurement of the brightness is performed in the same manner as in the item 14a. The setting of the voltage (V127) is performed in the same manner as in the item 14b. Among them, a VA element is used instead of the FFS element. The brightness was measured as follows. First, a DC voltage (2 V) was applied to the element for 2 minutes. Next, V127 (rectangular wave, 0.05 Hz) was applied, and the brightness was measured under an exposure time of 4000 milliseconds. Based on the results, scalability was evaluated.

圖1至圖3為元件的照片,表示亮度的狀態。於圖1與圖2中,亮度的大小互不相同,但亮度整體均勻。該些表示擴展性良好。於圖3中在上方觀察到凸的曲線。這表示液晶組成物自位於照片下側的注入口注入至元件整體中,但組成物中所含的添加物未到達元件的上端。Figures 1 to 3 are photos of the elements, showing the state of brightness. In FIG. 1 and FIG. 2, the brightness is different from each other, but the brightness is uniform as a whole. These indicate good scalability. A convex curve is observed above in FIG. 3. This means that the liquid crystal composition was injected into the entire device from the injection port located on the lower side of the photograph, but the additives contained in the composition did not reach the upper end of the device.

合成例1 化合物(1-1-1)是藉由下述路徑來合成。 Synthesis Example 1 Compound (1-1-1) was synthesized by the following route.

第1步驟: 於氮氣環境下,將癸二醯氯(532.0 g,2.225 mol)、以及二乙醚(1500 ml)放入至反應器中,並冷卻至-70℃。花費1.5小時向其中滴加苄基醇(158.8 g,1.468 mol),繼而花費1小時滴加三乙胺(225.1 g,2.225 mol)。昇溫至室溫並攪拌18小時。將反應混合物冷卻至0℃,滴加1 N鹽酸(500 ml)。將有機層分離,利用二乙醚對水層進行萃取。以飽和食鹽水對一起產生的有機層進行清洗,並利用無水硫酸鎂加以乾燥。於減壓下對該溶液進行濃縮,藉由矽膠管柱層析法對殘渣進行純化。於展開溶媒中首先使用甲苯,其次使用甲苯/乙酸乙酯=9/1(體積比)的混合溶媒。自庚烷/甲苯=1/1(體積比)的混合溶媒進行再結晶,從而獲得化合物(T-1)(206.5 g,產率31.7%)。Step 1: Under a nitrogen environment, place sebacin chloride (532.0 g, 2.225 mol) and diethyl ether (1500 ml) into the reactor, and cool to -70 ° C. Over 1.5 hours, benzyl alcohol (158.8 g, 1.468 mol) was added dropwise thereto, and then triethylamine (225.1 g, 2.225 mol) was added dropwise over 1 hour. Warm to room temperature and stir for 18 hours. The reaction mixture was cooled to 0 ° C, and 1 N hydrochloric acid (500 ml) was added dropwise. The organic layer was separated, and the aqueous layer was extracted with diethyl ether. The organic layers generated together were washed with saturated saline and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography. In the developing solvent, toluene was used first, and a mixed solvent of toluene / ethyl acetate = 9/1 (volume ratio) was used next. Recrystallization was performed from a mixed solvent of heptane / toluene = 1/1 (volume ratio) to obtain compound (T-1) (206.5 g, yield 31.7%).

第2步驟: 於氮氣環境下,將化合物(T-1)(60.00 g,204.8 mmol)、4-羥基-1,2,2,6,6-五甲基哌啶(36.83 g,215.1 mmol)、以及二氯甲烷(600 ml)放入至反應器中,並冷卻至0℃。向其中加入4-二甲基胺基吡啶(DMAP)(7.51 g,61.44 mmol),繼而加入N,N'-二環己基碳二醯亞胺(DCC)(46.48 g,225.3 mmol)。昇溫至室溫並攪拌24小時。將所析出的無色固體去除,以飽和碳酸氫鈉水溶液、水依序清洗濾液,並利用無水硫酸鎂加以乾燥。於減壓下對該溶液進行濃縮,藉由矽膠管柱層析法(甲苯/乙酸乙酯=8/2至0/10(體積比))對殘渣進行純化,從而獲得化合物(T-2)(69.44 g,產率75.9%)。Step 2: Under a nitrogen atmosphere, compound (T-1) (60.00 g, 204.8 mmol), 4-hydroxy-1,2,2,6,6-pentamethylpiperidine (36.83 g, 215.1 mmol) And dichloromethane (600 ml) were put into the reactor and cooled to 0 ° C. To this was added 4-dimethylaminopyridine (DMAP) (7.51 g, 61.44 mmol), followed by N, N'-dicyclohexylcarbodiimide (DCC) (46.48 g, 225.3 mmol). Warm to room temperature and stir for 24 hours. The precipitated colorless solid was removed, and the filtrate was sequentially washed with a saturated sodium bicarbonate aqueous solution and water, and then dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (toluene / ethyl acetate = 8/2 to 0/10 (volume ratio)) to obtain a compound (T-2) (69.44 g, yield 75.9%).

第3步驟: 將化合物(T-2)(69.44 g,155.5 mmol)、20%氫氧化鈀碳(3.47 g)、2-丙醇(IPA)(700 ml)放入至反應器中,並於氫環境下、室溫下攪拌18小時。將20%氫氧化鈀碳去除,對濾液進行濃縮,並藉由矽膠管柱層析法(丙酮)對殘渣進行純化,從而獲得化合物(T-3)(55.01 g,產率99.5%)。Step 3: Put compound (T-2) (69.44 g, 155.5 mmol), 20% palladium hydroxide carbon (3.47 g), 2-propanol (IPA) (700 ml) into the reactor, and Stir under a hydrogen atmosphere at room temperature for 18 hours. The 20% palladium hydroxide carbon was removed, the filtrate was concentrated, and the residue was purified by silica gel column chromatography (acetone) to obtain compound (T-3) (55.01 g, yield 99.5%).

第4步驟: 於氮氣環境下,將化合物(T-3)(56.43 g,158.7 mmol)、4-羥基-2,2,6,6-四甲基哌啶(26.21 g,166.7 mmol)、以及二氯甲烷(600 ml)放入至反應器中,並冷卻至0℃。向其中加入DMAP(5.82 g,47.62 mmol),繼而加入DCC(36.03 g,174.6 mmol)。昇溫至室溫並攪拌16小時。將所析出的無色固體去除,以飽和碳酸氫鈉水溶液、水依序清洗濾液,並利用無水硫酸鎂加以乾燥。於減壓下對該溶液進行濃縮,藉由矽膠管柱層析法(丙酮)對殘渣進行純化。自庚烷進行再結晶,從而獲得化合物(1-1-1)(25.51 g,產率32.4%)。Step 4: Under a nitrogen atmosphere, compound (T-3) (56.43 g, 158.7 mmol), 4-hydroxy-2,2,6,6-tetramethylpiperidine (26.21 g, 166.7 mmol), and Dichloromethane (600 ml) was placed in the reactor and cooled to 0 ° C. To this was added DMAP (5.82 g, 47.62 mmol), followed by DCC (36.03 g, 174.6 mmol). Warm to room temperature and stir for 16 hours. The precipitated colorless solid was removed, and the filtrate was sequentially washed with a saturated sodium bicarbonate aqueous solution and water, and then dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (acetone). Recrystallization was performed from heptane to obtain compound (1-1-1) (25.51 g, yield 32.4%).

1 H-NMR (ppm;CDCl3 ):δ5.19 (tt, J=11.5 Hz, J=4.2 Hz, 1H), 5.09 (tt, J=11.7 Hz, J=4.2 Hz, 1H), 2.27 (t, J=7.5 Hz, 2H), 2.26 (t, J=7.4 Hz, 2H), 2.24 (s, 3H), 1.91 (ddd, J=10.9 Hz, J=4.2 Hz, J=1.4 Hz, 2H), 1.83 (ddd, J=11.0 Hz, J=4.2 Hz, J=1.4 Hz, 2H), 1.59 (quin, J=6.9 Hz, 4H), 1.47 (dd, J=11.6 Hz, J=11.6 Hz, 2H), 1.36-1.28 (m, 8H), 1.24 (s, 6H), 1.16 (s, 6H), 1.15 (s, 6H), 1.13 (dd, J=11.7 Hz, J=11.7 Hz, 2H), 1.07 (s, 6H), 0.88-0.50 (br, 1H). 1 H-NMR (ppm; CDCl 3 ): δ5.19 (tt, J = 11.5 Hz, J = 4.2 Hz, 1H), 5.09 (tt, J = 11.7 Hz, J = 4.2 Hz, 1H), 2.27 (t , J = 7.5 Hz, 2H), 2.26 (t, J = 7.4 Hz, 2H), 2.24 (s, 3H), 1.91 (ddd, J = 10.9 Hz, J = 4.2 Hz, J = 1.4 Hz, 2H), 1.83 (ddd, J = 11.0 Hz, J = 4.2 Hz, J = 1.4 Hz, 2H), 1.59 (quin, J = 6.9 Hz, 4H), 1.47 (dd, J = 11.6 Hz, J = 11.6 Hz, 2H) , 1.36-1.28 (m, 8H), 1.24 (s, 6H), 1.16 (s, 6H), 1.15 (s, 6H), 1.13 (dd, J = 11.7 Hz, J = 11.7 Hz, 2H), 1.07 ( s, 6H), 0.88-0.50 (br, 1H).

合成例2 化合物(1-1-2)是藉由下述路徑來合成。 Synthesis Example 2 Compound (1-1-2) was synthesized by the following route.

第1步驟: 將4-羥基-2,2,6,6-四甲基哌啶1-氧自由基(25.00 g,145.1 mmol)、以及第三丁醇(50 ml)/水(25 ml)放入至反應器中,向其中加入壬醛(72.26 g,508.0 mmol)、及氯化銅(I)(0.36 g,3.63 mmol)。進而,花費1.5小時滴加過氧化氫(30%水溶液;49.37 g,435.4 mmol)後,於室溫下攪拌18小時。利用庚烷對反應混合物進行萃取,以10%抗壞血酸水溶液、10%亞硫酸氫鈉水溶液、1 N氫氧化鈉水溶液、水、飽和食鹽水依序清洗萃取液,並利用無水硫酸鎂加以乾燥。於減壓下對該溶液進行濃縮,藉由矽膠管柱層析法(庚烷/丙酮=8/1(體積比))對殘渣進行純化,從而獲得化合物(T-4)(25.00 g,產率60.3%)。Step 1: Add 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl radical (25.00 g, 145.1 mmol) and tertiary butanol (50 ml) / water (25 ml) Put into the reactor, and add nonanal (72.26 g, 508.0 mmol) and copper (I) chloride (0.36 g, 3.63 mmol) to the reactor. Furthermore, hydrogen peroxide (30% aqueous solution; 49.37 g, 435.4 mmol) was added dropwise over 1.5 hours, followed by stirring at room temperature for 18 hours. The reaction mixture was extracted with heptane, and the extract was sequentially washed with 10% ascorbic acid aqueous solution, 10% sodium bisulfite aqueous solution, 1 N sodium hydroxide aqueous solution, water, and saturated brine, and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (heptane / acetone = 8/1 (volume ratio)) to obtain compound (T-4) (25.00 g, product Rate 60.3%).

第2步驟: 於氮氣環境下,將化合物(T-4)(2.56 g,8.98 mmol)、合成例1中獲得的化合物(T-1)(2.63 g,8.98 mmol)、以及二氯甲烷(250 ml)放入至反應器中,並冷卻至0℃。向其中加入DMAP(0.33 g,2.69 mmol),繼而加入DCC(2.04 g,9.88 mmol)。昇溫至室溫並攪拌22小時。將所析出的無色固體去除,以飽和碳酸氫鈉水溶液、水依序清洗濾液,並利用無水硫酸鎂加以乾燥。於減壓下對該溶液進行濃縮,藉由矽膠管柱層析法(庚烷/乙酸乙酯=4/1(體積比))對殘渣進行純化,從而獲得化合物(T-5)(3.64 g,產率72.4%)。Step 2: Under a nitrogen atmosphere, compound (T-4) (2.56 g, 8.98 mmol), compound (T-1) obtained in Synthesis Example 1 (2.63 g, 8.98 mmol), and dichloromethane (250 ml) into the reactor and cooled to 0 ° C. To this was added DMAP (0.33 g, 2.69 mmol), followed by DCC (2.04 g, 9.88 mmol). Warm to room temperature and stir for 22 hours. The precipitated colorless solid was removed, and the filtrate was sequentially washed with a saturated sodium bicarbonate aqueous solution and water, and then dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (heptane / ethyl acetate = 4/1 (volume ratio)) to obtain compound (T-5) (3.64 g , Yield 72.4%).

第3步驟: 將化合物(T-5)(3.64 g,6.50 mmol)、20%氫氧化鈀碳(0.18 g)、以及甲苯(35 ml)/IPA(35 ml)放入至反應器中,並於氫環境下、室溫下攪拌18小時。將20%氫氧化鈀碳去除,對濾液進行濃縮,並藉由矽膠管柱層析法(庚烷/乙酸乙酯=4/1(體積比))對殘渣進行純化,從而獲得化合物(T-6)(2.40 g,產率78.6%)。Step 3: Put compound (T-5) (3.64 g, 6.50 mmol), 20% palladium hydroxide carbon (0.18 g), and toluene (35 ml) / IPA (35 ml) into the reactor, and Stir under a hydrogen atmosphere at room temperature for 18 hours. The 20% palladium hydroxide carbon was removed, the filtrate was concentrated, and the residue was purified by silica gel column chromatography (heptane / ethyl acetate = 4/1 (volume ratio)) to obtain a compound (T- 6) (2.40 g, 78.6% yield).

第4步驟: 於氮氣環境下,將化合物(T-6)(2.83 g,6.03 mmol)、4-羥基-2,2,6,6-四甲基哌啶(0.99 g,6.33 mmol)、以及二氯甲烷(50 ml)放入至反應器中,並冷卻至0℃。向其中加入DMAP(0.22 g,1.81 mmol),繼而加入DCC(1.37 g,6.63 mmol)。昇溫至室溫並攪拌24小時。將所析出的無色固體去除,以飽和碳酸氫鈉水溶液、水依序清洗濾液,並利用無水硫酸鎂加以乾燥。於減壓下對該溶液進行濃縮,藉由矽膠管柱層析法(乙酸乙酯)對殘渣進行純化,從而獲得化合物(1-1-2)(1.62 g,產率44.2%)。Step 4: Under a nitrogen atmosphere, compound (T-6) (2.83 g, 6.03 mmol), 4-hydroxy-2,2,6,6-tetramethylpiperidine (0.99 g, 6.33 mmol), and Dichloromethane (50 ml) was placed in the reactor and cooled to 0 ° C. To this was added DMAP (0.22 g, 1.81 mmol), followed by DCC (1.37 g, 6.63 mmol). Warm to room temperature and stir for 24 hours. The precipitated colorless solid was removed, and the filtrate was sequentially washed with a saturated sodium bicarbonate aqueous solution and water, and then dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate) to obtain compound (1-1-2) (1.62 g, yield 44.2%).

1 H-NMR (ppm;CDCl3 ):δ5.19 (tt, J=11.4 Hz, J=4.2 Hz, 1H), 5.01 (tt, J=11.5 Hz, J=4.4 Hz, 1H), 3.72 (t, J=6.7 Hz, 2H), 2.27 (t, J=7.5 Hz, 2H), 2.25 (t, J=7.7 Hz, 2H), 1.91 (dd, J=12.5 Hz, J=4.2 Hz, 2H), 1.80 (dd, J=11.1 Hz, J=3.7 Hz, 2H), 1.61 (quin, J=7.2 Hz, 4H), 1.56-1.48 (m, 4H), 1.37-1.28 (m, 18H), 1.24 (s, 6H), 1.18 (s, 12H), 1.15 (s, 6H), 1.14 (dd, J=11.9 Hz, J=11.9 Hz, 2H), 0.88 (t, J=6.9 Hz, 3H), 0.85-0.65 (br, 1H). 1 H-NMR (ppm; CDCl 3 ): δ5.19 (tt, J = 11.4 Hz, J = 4.2 Hz, 1H), 5.01 (tt, J = 11.5 Hz, J = 4.4 Hz, 1H), 3.72 (t , J = 6.7 Hz, 2H), 2.27 (t, J = 7.5 Hz, 2H), 2.25 (t, J = 7.7 Hz, 2H), 1.91 (dd, J = 12.5 Hz, J = 4.2 Hz, 2H), 1.80 (dd, J = 11.1 Hz, J = 3.7 Hz, 2H), 1.61 (quin, J = 7.2 Hz, 4H), 1.56-1.48 (m, 4H), 1.37-1.28 (m, 18H), 1.24 (s , 6H), 1.18 (s, 12H), 1.15 (s, 6H), 1.14 (dd, J = 11.9 Hz, J = 11.9 Hz, 2H), 0.88 (t, J = 6.9 Hz, 3H), 0.85-0.65 (br, 1H).

以下表示組成物的實施例。成分化合物基於下述表3的定義而以記號表示。表3中,與1,4-伸環己基相關的立體構型為反式構型。位於經記號化的化合物後的括弧內的編號表示化合物所屬的化學式。記號(-)是指其他液晶性化合物。液晶性化合物的比例(百分率)是基於不含添加物的液晶組成物的重量的重量百分率(重量%)。最後歸納組成物的特性值。Examples of the composition are shown below. The component compounds are represented by symbols based on the definitions in Table 3 below. In Table 3, the stereo configuration related to 1,4-cyclohexyl is a trans configuration. The number in parentheses after the marked compound indicates the chemical formula to which the compound belongs. The symbol (-) means another liquid crystal compound. The ratio (percentage) of the liquid crystalline compound is a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additives. Finally, the characteristic values of the composition are summarized.

[實施例1] V-HB(2F,3F)-O2 (2-1) 7% V2-BB(2F,3F)-O2 (2-4) 10% V-HHB(2F,3F)-O1 (2-6) 7% V-HHB(2F,3F)-O2 (2-6) 9% V2-HHB(2F,3F)-O2 (2-6) 8% 3-HH2B(2F,3F)-O2 (2-7) 9% V-HBB(2F,3F)-O2 (2-10) 8% V-HBB(2F,3F)-O4 (2-10) 6% 3-HH-V (3-1) 15% 3-HH-V1 (3-1) 6% 2-HH-3 (3-1) 9% 3-HH-5 (3-1) 3% 1V2-HH-3 (3-1) 3% 製備所述組成物(1)。以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。依據測定(14)中記載的方法來測定線殘像(LISP),結果為2.2%。 NI=87.5℃;Tc<-20℃;Δn=0.100;Δε=-3.4;Vth=2.02 V;η=18.9 mPa・s. [Example 1] V-HB (2F, 3F) -O2 (2-1) 7% V2-BB (2F, 3F) -O2 (2-4) 10% V-HHB (2F, 3F) -O1 ( 2-6) 7% V-HHB (2F, 3F) -O2 (2-6) 9% V2-HHB (2F, 3F) -O2 (2-6) 8% 3-HH2B (2F, 3F) -O2 (2-7) 9% V-HBB (2F, 3F) -O2 (2-10) 8% V-HBB (2F, 3F) -O4 (2-10) 6% 3-HH-V (3-1 ) 15% 3-HH-V1 (3-1) 6% 2-HH-3 (3-1) 9% 3-HH-5 (3-1) 3% 1V2-HH-3 (3-1) 3 % The composition (1) was prepared. Compound (1-1-1) was added to the composition in a proportion of 0.15% by weight. The linear afterimage (LISP) was measured according to the method described in Measurement (14), and it was 2.2%. NI = 87.5 ℃; Tc <-20 ℃; Δn = 0.100; Δε = -3.4; Vth = 2.02 V; η = 18.9 mPa ・ s.

[比較例1] 以0.15重量%的比例將比較化合物(A-1)添加於實施例1中記載的組成物(1)中。線殘像(LISP)為4.4%。與實施例1的結果一起歸納於表4中。根據表4可知,相較於比較化合物,化合物(1-1-1)更優異。 [Comparative Example 1] A comparative compound (A-1) was added to the composition (1) described in Example 1 at a ratio of 0.15% by weight. The linear afterimage (LISP) was 4.4%. It is summarized in Table 4 together with the results of Example 1. As can be seen from Table 4, the compound (1-1-1) is more excellent than the comparative compound.

[實施例2] 以0.15重量%的比例將化合物(1-1-2)添加於實施例1中記載的組成物(1)中。下限溫度(Tc)為<-20℃。該結果與實施例1的情況相同。 [Example 2] The compound (1-1-2) was added to the composition (1) described in Example 1 at a ratio of 0.15% by weight. The lower limit temperature (Tc) is <-20 ° C. This result is the same as in the case of Example 1.

[比較例2] 以0.15重量%的比例將下述的比較化合物(A-2)添加於實施例1中記載的組成物(1)中。下限溫度(Tc)為<0℃。與實施例1、實施例2的結果一起歸納於表5中。於添加物相對於組成物的溶解性佳的情況下,容易維持向列相。於溶解性差的情況下,容易轉移至結晶(或層列相)。可藉由該方法來對低溫下的溶解性進行比較。根據表5可知,與比較化合物相比,化合物(1)於溶解性方面優異。 [Comparative Example 2] The following comparative compound (A-2) was added to the composition (1) described in Example 1 at a ratio of 0.15% by weight. The lower limit temperature (Tc) is <0 ° C. The results of Example 1 and Example 2 are summarized in Table 5. When the solubility of the additive with respect to the composition is good, it is easy to maintain the nematic phase. In the case of poor solubility, it is easy to transfer to crystals (or smectic phases). This method can be used to compare solubility at low temperatures. From Table 5, it turns out that the compound (1) is excellent in solubility compared with a comparative compound.

[實施例3] 3-HB(2F,3F)-O2 (2-1) 7% 5-HB(2F,3F)-O2 (2-1) 7% 3-BB(2F,3F)-O2 (2-4) 8% 3-HHB(2F,3F)-O2 (2-6) 4% 5-HHB(2F,3F)-O2 (2-6) 5% 3-HH1OB(2F,3F)-O2 (2-8) 5% 2-BB(2F,3F)B-3 (2-9) 4% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 5% 5-HBB(2F,3F)-O2 (2-10) 8% 3-HH-V (3-1) 33% V-HHB-1 (3-5) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=76.4℃;Tc<-20℃;Δn=0.104;Δε=-3.2;Vth=2.06 V;η=15.6 mPa・s;LISP=2.4%. [Example 3] 3-HB (2F, 3F) -O2 (2-1) 7% 5-HB (2F, 3F) -O2 (2-1) 7% 3-BB (2F, 3F) -O2 ( 2-4) 8% 3-HHB (2F, 3F) -O2 (2-6) 4% 5-HHB (2F, 3F) -O2 (2-6) 5% 3-HH1OB (2F, 3F) -O2 (2-8) 5% 2-BB (2F, 3F) B-3 (2-9) 4% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 (2-10) 5% 5-HBB (2F, 3F) -O2 (2-10) 8% 3-HH-V (3 -1) 33% V-HHB-1 (3-5) 3% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 76.4 ℃; Tc <-20 ℃; Δn = 0.104; Δε = -3.2; Vth = 2.06 V; η = 15.6 mPa ・ s; LISP = 2.4%.

[實施例4] 2-H1OB(2F,3F)-O2 (2-3) 6% 3-H1OB(2F,3F)-O2 (2-3) 4% 3-BB(2F,3F)-O2 (2-4) 3% 2-HH1OB(2F,3F)-O2 (2-8) 14% 2-HBB(2F,3F)-O2 (2-10) 7% 3-HBB(2F,3F)-O2 (2-10) 11% 5-HBB(2F,3F)-O2 (2-10) 9% 2-HH-3 (3-1) 5% 3-HH-VFF (3-1) 30% 1-BB-3 (3-3) 5% 3-HHB-1 (3-5) 3% 3-HBB-2 (3-6) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=78.3℃;Tc<-20℃;Δn=0.103;Δε=-3.2;Vth=2.17 V;η=17.7 mPa・s;LISP=2.2%. [Example 4] 2-H1OB (2F, 3F) -O2 (2-3) 6% 3-H1OB (2F, 3F) -O2 (2-3) 4% 3-BB (2F, 3F) -O2 ( 2-4) 3% 2-HH1OB (2F, 3F) -O2 (2-8) 14% 2-HBB (2F, 3F) -O2 (2-10) 7% 3-HBB (2F, 3F) -O2 (2-10) 11% 5-HBB (2F, 3F) -O2 (2-10) 9% 2-HH-3 (3-1) 5% 3-HH-VFF (3-1) 30% 1- BB-3 (3-3) 5% 3-HHB-1 (3-5) 3% 3-HBB-2 (3-6) 3% Compound (1-1-1) is added in a proportion of 0.10% by weight In the composition. NI = 78.3 ℃; Tc <-20 ℃; Δn = 0.103; Δε = -3.2; Vth = 2.17 V; η = 17.7 mPa ・ s; LISP = 2.2%.

[實施例5] 3-HB(2F,3F)-O2 (2-1) 5% 5-HB(2F,3F)-O2 (2-1) 7% 3-BB(2F,3F)-O2 (2-4) 8% 3-HHB(2F,3F)-O2 (2-6) 5% 5-HHB(2F,3F)-O2 (2-6) 4% 3-HH1OB(2F,3F)-O2 (2-8) 5% 2-BB(2F,3F)B-3 (2-9) 4% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 9% 4-HBB(2F,3F)-O2 (2-10) 4% 5-HBB(2F,3F)-O2 (2-10) 8% 3-HH-V (3-1) 27% 3-HH-V1 (3-1) 6% V-HHB-1 (3-5) 5% 以0.10重量%的比例將化合物(1-1-2)添加於該組成物中。 NI=81.2℃;Tc<-20℃;Δn=0.107;Δε=-3.2;Vth=2.11 V;η=15.5 mPa・s. [Example 5] 3-HB (2F, 3F) -O2 (2-1) 5% 5-HB (2F, 3F) -O2 (2-1) 7% 3-BB (2F, 3F) -O2 ( 2-4) 8% 3-HHB (2F, 3F) -O2 (2-6) 5% 5-HHB (2F, 3F) -O2 (2-6) 4% 3-HH1OB (2F, 3F) -O2 (2-8) 5% 2-BB (2F, 3F) B-3 (2-9) 4% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 9% 4-HBB (2F, 3F) -O2 (2-10) 4% 5-HBB (2F, 3F) -O2 (2-10) 8% 3-HH-V (3 -1) 27% 3-HH-V1 (3-1) 6% V-HHB-1 (3-5) 5% Compound (1-1-2) is added to the composition at a ratio of 0.10% by weight . NI = 81.2 ℃; Tc <-20 ℃; Δn = 0.107; Δε = -3.2; Vth = 2.11 V; η = 15.5 mPa ・ s.

[實施例6] 3-H2B(2F,3F)-O2 (2-2) 7% 3-HHB(2F,3F)-O2 (2-6) 8% 3-HH1OB(2F,3F)-O2 (2-8) 5% 2-BB(2F,3F)B-3 (2-9) 7% 2-BB(2F,3F)B-4 (2-9) 7% 3-HDhB(2F,3F)-O2 (2-16) 3% 5-HDhB(2F,3F)-O2 (2-16) 4% 2-HchB(2F,3F)-O2 (2-19) 8% 4-HH-V (3-1) 15% 3-HH-V1 (3-1) 6% 1-HH-2V1 (3-1) 6% 3-HH-2V1 (3-1) 4% V2-BB-1 (3-3) 5% 1V2-BB-1 (3-3) 5% 3-HHB-1 (3-5) 6% 3-HB(F)BH-3 (3-12) 4% 以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=88.7℃;Tc<-20℃;Δn=0.115;Δε=-1.9;Vth=2.82 V;η=17.3 mPa・s;LISP=2.1%. [Example 6] 3-H2B (2F, 3F) -O2 (2-2) 7% 3-HHB (2F, 3F) -O2 (2-6) 8% 3-HH1OB (2F, 3F) -O2 ( 2-8) 5% 2-BB (2F, 3F) B-3 (2-9) 7% 2-BB (2F, 3F) B-4 (2-9) 7% 3-HDhB (2F, 3F) -O2 (2-16) 3% 5-HDhB (2F, 3F) -O2 (2-16) 4% 2-HchB (2F, 3F) -O2 (2-19) 8% 4-HH-V (3 -1) 15% 3-HH-V1 (3-1) 6% 1-HH-2V1 (3-1) 6% 3-HH-2V1 (3-1) 4% V2-BB-1 (3-3 ) 5% 1V2-BB-1 (3-3) 5% 3-HHB-1 (3-5) 6% 3-HB (F) BH-3 (3-12) 4% Compound (1-1-1) is added to the composition. NI = 88.7 ℃; Tc <-20 ℃; Δn = 0.115; Δε = -1.9; Vth = 2.82 V; η = 17.3 mPa ・ s; LISP = 2.1%.

[實施例7] V2-H2B(2F,3F)-O2 (2-2) 8% V2-H1OB(2F,3F)-O4 (2-3) 4% 3-BB(2F,3F)-O2 (2-4) 7% 2-HHB(2F,3F)-O2 (2-6) 7% 3-HHB(2F,3F)-O2 (2-6) 7% 3-HH2B(2F,3F)-O2 (2-7) 7% 5-HH2B(2F,3F)-O2 (2-7) 4% V-HH2B(2F,3F)-O2 (2-7) 6% V2-HBB(2F,3F)-O2 (2-10) 5% V-HBB(2F,3F)-O2 (2-10) 5% V-HBB(2F,3F)-O4 (2-10) 6% 2-HH-3 (3-1) 12% 1-BB-5 (3-3) 12% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 3% 3-HBB-2 (3-6) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=89.9℃;Tc<-20℃;Δn=0.122;Δε=-4.2;Vth=2.16 V;η=23.4 mPa・s;LISP=2.3%. [Example 7] V2-H2B (2F, 3F) -O2 (2-2) 8% V2-H1OB (2F, 3F) -O4 (2-3) 4% 3-BB (2F, 3F) -O2 ( 2-4) 7% 2-HHB (2F, 3F) -O2 (2-6) 7% 3-HHB (2F, 3F) -O2 (2-6) 7% 3-HH2B (2F, 3F) -O2 (2-7) 7% 5-HH2B (2F, 3F) -O2 (2-7) 4% V-HH2B (2F, 3F) -O2 (2-7) 6% V2-HBB (2F, 3F)- O2 (2-10) 5% V-HBB (2F, 3F) -O2 (2-10) 5% V-HBB (2F, 3F) -O4 (2-10) 6% 2-HH-3 (3- 1) 12% 1-BB-5 (3-3) 12% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 3% 3-HBB-2 (3-6) 3% Compound (1-1-1) was added to the composition at a ratio of 0.10% by weight. NI = 89.9 ℃; Tc <-20 ℃; Δn = 0.122; Δε = -4.2; Vth = 2.16 V; η = 23.4 mPa ・ s; LISP = 2.3%.

[實施例8] 3-HB(2F,3F)-O2 (2-1) 3% V-HB(2F,3F)-O2 (2-1) 3% V2-HB(2F,3F)-O2 (2-1) 5% 5-H2B(2F,3F)-O2 (2-2) 5% V2-BB(2F,3F)-O2 (2-4) 3% 1V2-BB(2F,3F)-O2 (2-4) 3% 3-HHB(2F,3F)-O2 (2-6) 6% V-HHB(2F,3F)-O2 (2-6) 6% V-HHB(2F,3F)-O4 (2-6) 5% V2-HHB(2F,3F)-O2 (2-6) 4% V2-BB(2F,3F)B-1 (2-9) 4% V2-HBB(2F,3F)-O2 (2-10) 5% V-HBB(2F,3F)-O2 (2-10) 4% V-HBB(2F,3F)-O4 (2-10) 5% V-HHB(2F,3Cl)-O2 (2-12) 3% 3-HH-V (3-1) 27% 3-HH-V1 (3-1) 6% V-HHB-1 (3-5) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=77.1℃;Tc<-20℃;Δn=0.101;Δε=-3.0;Vth=2.04 V;η=13.9 mPa・s;LISP=2.2%. [Example 8] 3-HB (2F, 3F) -O2 (2-1) 3% V-HB (2F, 3F) -O2 (2-1) 3% V2-HB (2F, 3F) -O2 ( 2-1) 5% 5-H2B (2F, 3F) -O2 (2-2) 5% V2-BB (2F, 3F) -O2 (2-4) 3% 1V2-BB (2F, 3F) -O2 (2-4) 3% 3-HHB (2F, 3F) -O2 (2-6) 6% V-HHB (2F, 3F) -O2 (2-6) 6% V-HHB (2F, 3F)- O4 (2-6) 5% V2-HHB (2F, 3F) -O2 (2-6) 4% V2-BB (2F, 3F) B-1 (2-9) 4% V2-HBB (2F, 3F ) -O2 (2-10) 5% V-HBB (2F, 3F) -O2 (2-10) 4% V-HBB (2F, 3F) -O4 (2-10) 5% V-HHB (2F, 3Cl) -O2 (2-12) 3% 3-HH-V (3-1) 27% 3-HH-V1 (3-1) 6% V-HHB-1 (3-5) 3% by weight of 0.10 Compound (1-1-1) is added to the composition at a ratio of%. NI = 77.1 ℃; Tc <-20 ℃; Δn = 0.101; Δε = -3.0; Vth = 2.04 V; η = 13.9 mPa ・ s; LISP = 2.2%.

[實施例9] V-HB(2F,3F)-O2 (2-1) 10% V2-HB(2F,3F)-O2 (2-1) 10% 2-H1OB(2F,3F)-O2 (2-3) 3% 3-H1OB(2F,3F)-O2 (2-3) 3% 2O-BB(2F,3F)-O2 (2-4) 3% V2-BB(2F,3F)-O2 (2-4) 8% V2-HHB(2F,3F)-O2 (2-6) 5% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 3% V-HBB(2F,3F)-O2 (2-10) 6% V-HBB(2F,3F)-O4 (2-10) 8% V-HHB(2F,3Cl)-O2 (2-12) 7% 3-HH-4 (3-1) 14% V-HHB-1 (3-5) 10% 3-HBB-2 (3-6) 7% 以0.10重量%的比例將化合物(1-1-2)添加於該組成物中。 NI=75.9℃;Tc<-20℃;Δn=0.114;Δε=-3.9;Vth=2.20 V;η=24.7 mPa・s. [Example 9] V-HB (2F, 3F) -O2 (2-1) 10% V2-HB (2F, 3F) -O2 (2-1) 10% 2-H1OB (2F, 3F) -O2 ( 2-3) 3% 3-H1OB (2F, 3F) -O2 (2-3) 3% 2O-BB (2F, 3F) -O2 (2-4) 3% V2-BB (2F, 3F) -O2 (2-4) 8% V2-HHB (2F, 3F) -O2 (2-6) 5% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F)- O2 (2-10) 3% V-HBB (2F, 3F) -O2 (2-10) 6% V-HBB (2F, 3F) -O4 (2-10) 8% V-HHB (2F, 3Cl) -O2 (2-12) 7% 3-HH-4 (3-1) 14% V-HHB-1 (3-5) 10% 3-HBB-2 (3-6) 7% to 0.10% by weight Compound (1-1-2) is added to this composition in proportion. NI = 75.9 ℃; Tc <-20 ℃; Δn = 0.114; Δε = -3.9; Vth = 2.20 V; η = 24.7 mPa ・ s.

[實施例10] 3-HB(2F,3F)-O2 (2-1) 10% 5-HB(2F,3F)-O2 (2-1) 7% 2-BB(2F,3F)-O2 (2-4) 7% 3-BB(2F,3F)-O2 (2-4) 7% 3-B(2F,3F)B(2F,3F)-O2 (2-5) 3% 2-HHB(2F,3F)-O2 (2-6) 5% 3-HHB(2F,3F)-O2 (2-6) 10% 2-HBB(2F,3F)-O2 (2-10) 8% 3-HBB(2F,3F)-O2 (2-10) 10% 2-HH-3 (3-1) 14% 3-HB-O1 (3-2) 5% 3-HHB-1 (3-5) 3% 3-HHB-O1 (3-5) 3% 3-HHB-3 (3-5) 4% 2-BB(F)B-3 (3-8) 4% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=73.2℃;Tc<-20℃;Δn=0.113;Δε=-4.0;Vth=2.18 V;η=22.6 mPa・s;LISP=2.1%. [Example 10] 3-HB (2F, 3F) -O2 (2-1) 10% 5-HB (2F, 3F) -O2 (2-1) 7% 2-BB (2F, 3F) -O2 ( 2-4) 7% 3-BB (2F, 3F) -O2 (2-4) 7% 3-B (2F, 3F) B (2F, 3F) -O2 (2-5) 3% 2-HHB ( 2F, 3F) -O2 (2-6) 5% 3-HHB (2F, 3F) -O2 (2-6) 10% 2-HBB (2F, 3F) -O2 (2-10) 8% 3-HBB (2F, 3F) -O2 (2-10) 10% 2-HH-3 (3-1) 14% 3-HB-O1 (3-2) 5% 3-HHB-1 (3-5) 3% 3-HHB-O1 (3-5) 3% 3-HHB-3 (3-5) 4% 2-BB (F) B-3 (3-8) 4% The compound (1 -1-1) is added to the composition. NI = 73.2 ℃; Tc <-20 ℃; Δn = 0.113; Δε = -4.0; Vth = 2.18 V; η = 22.6 mPa ・ s; LISP = 2.1%.

[實施例11] 3-HB(2F,3F)-O4 (2-1) 6% 3-H2B(2F,3F)-O2 (2-2) 8% 3-H1OB(2F,3F)-O2 (2-3) 4% 3-BB(2F,3F)-O2 (2-4) 7% 2-HHB(2F,3F)-O2 (2-6) 7% 3-HHB(2F,3F)-O2 (2-6) 7% 3-HH2B(2F,3F)-O2 (2-7) 7% 5-HH2B(2F,3F)-O2 (2-7) 4% 2-HBB(2F,3F)-O2 (2-10) 5% 3-HBB(2F,3F)-O2 (2-10) 5% 4-HBB(2F,3F)-O2 (2-10) 6% 2-HH-3 (3-1) 12% 1-BB-5 (3-3) 12% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 3% 3-HBB-2 (3-6) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=82.8℃;Tc<-20℃;Δn=0.118;Δε=-4.4;Vth=2.13 V;η=22.5 mPa・s;LISP=2.0%. [Example 11] 3-HB (2F, 3F) -O4 (2-1) 6% 3-H2B (2F, 3F) -O2 (2-2) 8% 3-H1OB (2F, 3F) -O2 ( 2-3) 4% 3-BB (2F, 3F) -O2 (2-4) 7% 2-HHB (2F, 3F) -O2 (2-6) 7% 3-HHB (2F, 3F) -O2 (2-6) 7% 3-HH2B (2F, 3F) -O2 (2-7) 7% 5-HH2B (2F, 3F) -O2 (2-7) 4% 2-HBB (2F, 3F)- O2 (2-10) 5% 3-HBB (2F, 3F) -O2 (2-10) 5% 4-HBB (2F, 3F) -O2 (2-10) 6% 2-HH-3 (3- 1) 12% 1-BB-5 (3-3) 12% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 3% 3-HBB-2 (3-6) 3% Compound (1-1-1) was added to the composition at a ratio of 0.10% by weight. NI = 82.8 ℃; Tc <-20 ℃; Δn = 0.118; Δε = -4.4; Vth = 2.13 V; η = 22.5 mPa ・ s; LISP = 2.0%.

[實施例12] 3-HB(2F,3F)-O2 (2-1) 7% 5-HB(2F,3F)-O2 (2-1) 7% 3-BB(2F,3F)-O2 (2-4) 8% 3-HHB(2F,3F)-O2 (2-6) 5% 5-HHB(2F,3F)-O2 (2-6) 4% 3-HH1OB(2F,3F)-O2 (2-8) 4% 2-BB(2F,3F)B-3 (2-9) 5% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 5% 5-HBB(2F,3F)-O2 (2-10) 8% 3-HH-V (3-1) 27% 3-HH-V1 (3-1) 6% V-HHB-1 (3-5) 3% 以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=78.1℃;Tc<-20℃;Δn=0.107;Δε=-3.2;Vth=2.02 V;η=15.9 mPa・s;LISP=2.2%. [Example 12] 3-HB (2F, 3F) -O2 (2-1) 7% 5-HB (2F, 3F) -O2 (2-1) 7% 3-BB (2F, 3F) -O2 ( 2-4) 8% 3-HHB (2F, 3F) -O2 (2-6) 5% 5-HHB (2F, 3F) -O2 (2-6) 4% 3-HH1OB (2F, 3F) -O2 (2-8) 4% 2-BB (2F, 3F) B-3 (2-9) 5% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 (2-10) 5% 5-HBB (2F, 3F) -O2 (2-10) 8% 3-HH-V (3 -1) 27% 3-HH-V1 (3-1) 6% V-HHB-1 (3-5) 3% Compound (1-1-1) is added to the composition in a proportion of 0.15% by weight . NI = 78.1 ℃; Tc <-20 ℃; Δn = 0.107; Δε = -3.2; Vth = 2.02 V; η = 15.9 mPa ・ s; LISP = 2.2%.

[實施例13] 3-HB(2F,3F)-O2 (2-1) 10% 5-HB(2F,3F)-O2 (2-1) 10% 3-H2B(2F,3F)-O2 (2-2) 8% 5-H2B(2F,3F)-O2 (2-2) 8% 2-HBB(2F,3F)-O2 (2-10) 6% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 7% 5-HBB(2F,3F)-O2 (2-10) 7% 3-HDhB(2F,3F)-O2 (2-16) 5% 3-HH-4 (3-1) 14% V-HHB-1 (3-5) 10% 3-HBB-2 (3-6) 7% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=88.5℃;Tc<-20℃;Δn=0.108;Δε=-3.8;Vth=2.25 V;η=24.6 mPa・s;LISP=2.1%. [Example 13] 3-HB (2F, 3F) -O2 (2-1) 10% 5-HB (2F, 3F) -O2 (2-1) 10% 3-H2B (2F, 3F) -O2 ( 2-2) 8% 5-H2B (2F, 3F) -O2 (2-2) 8% 2-HBB (2F, 3F) -O2 (2-10) 6% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 (2-10) 7% 5-HBB (2F, 3F) -O2 (2-10) 7% 3-HDhB (2F, 3F)- O2 (2-16) 5% 3-HH-4 (3-1) 14% V-HHB-1 (3-5) 10% 3-HBB-2 (3-6) 7% at a ratio of 0.10% by weight Compound (1-1-1) is added to the composition. NI = 88.5 ℃; Tc <-20 ℃; Δn = 0.108; Δε = -3.8; Vth = 2.25 V; η = 24.6 mPa ・ s; LISP = 2.1%.

[實施例14] 3-HB(2F,3F)-O2 (2-1) 7% 3-HB(2F,3F)-O4 (2-1) 8% 3-H2B(2F,3F)-O2 (2-2) 8% 3-BB(2F,3F)-O2 (2-4) 10% 2-HHB(2F,3F)-O2 (2-6) 4% 3-HHB(2F,3F)-O2 (2-6) 7% 3-HHB(2F,3F)-1 (2-6) 6% 2-HBB(2F,3F)-O2 (2-10) 6% 3-HBB(2F,3F)-O2 (2-10) 6% 4-HBB(2F,3F)-O2 (2-10) 5% 5-HBB(2F,3F)-O2 (2-10) 4% 3-HEB(2F,3F)B(2F,3F)-O2 (2-11) 3% 3-H1OCro(7F,8F)-5 (2-14) 3% 3-HDhB(2F,3F)-O2 (2-16) 5% 3-HH-O1 (3-1) 5% 1-BB-5 (3-3) 4% V-HHB-1 (3-5) 4% 5-HB(F)BH-3 (3-12) 5% 以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=81.1℃;Tc<-20℃;Δn=0.119;Δε=-4.5;Vth=1.69 V;η=31.4 mPa・s;LISP=2.4%. [Example 14] 3-HB (2F, 3F) -O2 (2-1) 7% 3-HB (2F, 3F) -O4 (2-1) 8% 3-H2B (2F, 3F) -O2 ( 2-2) 8% 3-BB (2F, 3F) -O2 (2-4) 10% 2-HHB (2F, 3F) -O2 (2-6) 4% 3-HHB (2F, 3F) -O2 (2-6) 7% 3-HHB (2F, 3F) -1 (2-6) 6% 2-HBB (2F, 3F) -O2 (2-10) 6% 3-HBB (2F, 3F)- O2 (2-10) 6% 4-HBB (2F, 3F) -O2 (2-10) 5% 5-HBB (2F, 3F) -O2 (2-10) 4% 3-HEB (2F, 3F) B (2F, 3F) -O2 (2-11) 3% 3-H1OCro (7F, 8F) -5 (2-14) 3% 3-HDhB (2F, 3F) -O2 (2-16) 5% 3 -HH-O1 (3-1) 5% 1-BB-5 (3-3) 4% V-HHB-1 (3-5) 4% 5-HB (F) BH-3 (3-12) 5 % Compound (1-1-1) is added to the composition in a proportion of 0.15% by weight. NI = 81.1 ℃; Tc <-20 ℃; Δn = 0.119; Δε = -4.5; Vth = 1.69 V; η = 31.4 mPa ・ s; LISP = 2.4%.

[實施例15] 3-HB(2F,3F)-O4 (2-1) 15% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 5% 5-HBB(2F,3F)-O2 (2-10) 7% 3-dhBB(2F,3F)-O2 (2-17) 5% 3-chB(2F,3F)-O2 (2-18) 7% 2-HchB(2F,3F)-O2 (2-19) 8% 5-HH-V (3-1) 18% 7-HB-1 (3-2) 5% V-HHB-1 (3-5) 7% V2-HHB-1 (3-5) 7% 3-HBB(F)B-3 (3-13) 8% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=98.8℃;Tc<-20℃;Δn=0.111;Δε=-3.2;Vth=2.47 V;η=23.9 mPa・s;LISP=2.1%. [Example 15] 3-HB (2F, 3F) -O4 (2-1) 15% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 ( 2-10) 5% 5-HBB (2F, 3F) -O2 (2-10) 7% 3-dhBB (2F, 3F) -O2 (2-17) 5% 3-chB (2F, 3F) -O2 (2-18) 7% 2-HchB (2F, 3F) -O2 (2-19) 8% 5-HH-V (3-1) 18% 7-HB-1 (3-2) 5% V- HHB-1 (3-5) 7% V2-HHB-1 (3-5) 7% 3-HBB (F) B-3 (3-13) 8% Compound (1-1 -1) Added to this composition. NI = 98.8 ℃; Tc <-20 ℃; Δn = 0.111; Δε = -3.2; Vth = 2.47 V; η = 23.9 mPa ・ s; LISP = 2.1%.

[實施例16] 3-H2B(2F,3F)-O2 (2-2) 18% 5-H2B(2F,3F)-O2 (2-2) 17% 3-HHB(2F,3Cl)-O2 (2-12) 5% 3-HBB(2F,3Cl)-O2 (2-13) 8% 5-HBB(2F,3Cl)-O2 (2-13) 7% 3-HDhB(2F,3F)-O2 (2-16) 5% 3-HH-V (3-1) 11% 3-HH-VFF (3-1) 7% F3-HH-V (3-1) 10% 3-HHEH-3 (3-4) 4% 3-HB(F)HH-2 (3-10) 4% 3-HHEBH-3 (3-11) 4% 以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=77.5℃;Tc<-20℃;Δn=0.084;Δε=-2.6;Vth=2.43 V;η=22.8 mPa・s;LISP=2.5%. [Example 16] 3-H2B (2F, 3F) -O2 (2-2) 18% 5-H2B (2F, 3F) -O2 (2-2) 17% 3-HHB (2F, 3Cl) -O2 ( 2-12) 5% 3-HBB (2F, 3Cl) -O2 (2-13) 8% 5-HBB (2F, 3Cl) -O2 (2-13) 7% 3-HDhB (2F, 3F) -O2 (2-16) 5% 3-HH-V (3-1) 11% 3-HH-VFF (3-1) 7% F3-HH-V (3-1) 10% 3-HHEH-3 (3 -4) 4% 3-HB (F) HH-2 (3-10) 4% 3-HHEBH-3 (3-11) 4% Compound (1-1-1) is added to 0.15 wt% This composition. NI = 77.5 ℃; Tc <-20 ℃; Δn = 0.084; Δε = -2.6; Vth = 2.43 V; η = 22.8 mPa ・ s; LISP = 2.5%.

[實施例17] 3-HB(2F,3F)-O2 (2-1) 8% 3-H2B(2F,3F)-O2 (2-2) 10% 3-BB(2F,3F)-O2 (2-4) 10% 2O-BB(2F,3F)-O2 (2-4) 3% 2-HHB(2F,3F)-O2 (2-6) 4% 3-HHB(2F,3F)-O2 (2-6) 7% 2-HHB(2F,3F)-1 (2-6) 5% 2-BB(2F,3F)B-3 (2-9) 6% 2-BB(2F,3F)B-4 (2-9) 6% 2-HBB(2F,3F)-O2 (2-10) 4% 3-HBB(2F,3F)-O2 (2-10) 7% 3-HH1OCro(7F,8F)-5 (2-15) 4% 3-HDhB(2F,3F)-O2 (2-16) 6% 3-dhBB(2F,3F)-O2 (2-17) 4% 3-HH-V (3-1) 11% 1-BB-5 (3-3) 5% 以0.10重量%的比例將化合物(1-1-2)添加於該組成物中。 NI=70.6℃;Tc<-20℃;Δn=0.129;Δε=-4.3;Vth=1.69 V;η=27.0 mPa・s. [Example 17] 3-HB (2F, 3F) -O2 (2-1) 8% 3-H2B (2F, 3F) -O2 (2-2) 10% 3-BB (2F, 3F) -O2 ( 2-4) 10% 2O-BB (2F, 3F) -O2 (2-4) 3% 2-HHB (2F, 3F) -O2 (2-6) 4% 3-HHB (2F, 3F) -O2 (2-6) 7% 2-HHB (2F, 3F) -1 (2-6) 5% 2-BB (2F, 3F) B-3 (2-9) 6% 2-BB (2F, 3F) B-4 (2-9) 6% 2-HBB (2F, 3F) -O2 (2-10) 4% 3-HBB (2F, 3F) -O2 (2-10) 7% 3-HH1OCro (7F, 8F) -5 (2-15) 4% 3-HDhB (2F, 3F) -O2 (2-16) 6% 3-dhBB (2F, 3F) -O2 (2-17) 4% 3-HH-V (3-1) 11% 1-BB-5 (3-3) 5% Compound (1-1-2) is added to the composition at a ratio of 0.10% by weight. NI = 70.6 ℃; Tc <-20 ℃; Δn = 0.129; Δε = -4.3; Vth = 1.69 V; η = 27.0 mPa ・ s.

[實施例18] 3-HB(2F,3F)-O4 (2-1) 14% 3-H1OB(2F,3F)-O2 (2-3) 3% 3-BB(2F,3F)-O2 (2-4) 10% 2-HHB(2F,3F)-O2 (2-6) 7% 3-HHB(2F,3F)-O2 (2-6) 7% 3-HH1OB(2F,3F)-O2 (2-8) 6% 2-HBB(2F,3F)-O2 (2-10) 4% 3-HBB(2F,3F)-O2 (2-10) 6% 4-HBB(2F,3F)-O2 (2-10) 4% 3-HH-V (3-1) 14% 1-BB-3 (3-3) 3% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 4% V-HBB-2 (3-6) 4% 1-BB(F)B-2V (3-8) 6% 5-HBBH-1O1 (-) 4% 以0.12重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=93.0℃;Tc<-20℃;Δn=0.123;Δε=-4.0;Vth=2.27 V;η=29.6 mPa・s;LISP=2.2%. [Example 18] 3-HB (2F, 3F) -O4 (2-1) 14% 3-H1OB (2F, 3F) -O2 (2-3) 3% 3-BB (2F, 3F) -O2 ( 2-4) 10% 2-HHB (2F, 3F) -O2 (2-6) 7% 3-HHB (2F, 3F) -O2 (2-6) 7% 3-HH1OB (2F, 3F) -O2 (2-8) 6% 2-HBB (2F, 3F) -O2 (2-10) 4% 3-HBB (2F, 3F) -O2 (2-10) 6% 4-HBB (2F, 3F)- O2 (2-10) 4% 3-HH-V (3-1) 14% 1-BB-3 (3-3) 3% 3-HHB-1 (3-5) 4% 3-HHB-O1 ( 3-5) 4% V-HBB-2 (3-6) 4% 1-BB (F) B-2V (3-8) 6% 5-HBBH-1O1 (-) 4% at a ratio of 0.12% by weight Compound (1-1-1) is added to the composition. NI = 93.0 ℃; Tc <-20 ℃; Δn = 0.123; Δε = -4.0; Vth = 2.27 V; η = 29.6 mPa ・ s; LISP = 2.2%.

[實施例19] 3-HB(2F,3F)-O4 (2-1) 6% 3-H2B(2F,3F)-O2 (2-2) 8% 3-H1OB(2F,3F)-O2 (2-3) 5% 3-BB(2F,3F)-O2 (2-4) 10% 2-HHB(2F,3F)-O2 (2-6) 7% 3-HHB(2F,3F)-O2 (2-6) 7% 5-HHB(2F,3F)-O2 (2-6) 7% 2-HBB(2F,3F)-O2 (2-10) 4% 3-HBB(2F,3F)-O2 (2-10) 7% 5-HBB(2F,3F)-O2 (2-10) 6% 3-HH-V (3-1) 11% 1-BB-3 (3-3) 6% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 4% 3-B(F)BB-2 (3-7) 4% 以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=87.6℃;Tc<-20℃;Δn=0.126;Δε=-4.5;Vth=2.21 V;η=25.3 mPa・s;LISP=2.3%. [Example 19] 3-HB (2F, 3F) -O4 (2-1) 6% 3-H2B (2F, 3F) -O2 (2-2) 8% 3-H1OB (2F, 3F) -O2 ( 2-3) 5% 3-BB (2F, 3F) -O2 (2-4) 10% 2-HHB (2F, 3F) -O2 (2-6) 7% 3-HHB (2F, 3F) -O2 (2-6) 7% 5-HHB (2F, 3F) -O2 (2-6) 7% 2-HBB (2F, 3F) -O2 (2-10) 4% 3-HBB (2F, 3F)- O2 (2-10) 7% 5-HBB (2F, 3F) -O2 (2-10) 6% 3-HH-V (3-1) 11% 1-BB-3 (3-3) 6% 3 -HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 4% 3-B (F) BB-2 (3-7) 4 % Compound (1-1-1) is added to the composition in a proportion of 0.15% by weight. NI = 87.6 ℃; Tc <-20 ℃; Δn = 0.126; Δε = -4.5; Vth = 2.21 V; η = 25.3 mPa ・ s; LISP = 2.3%.

[實施例20] 3-HB(2F,3F)-O4 (2-1) 6% 3-H2B(2F,3F)-O2 (2-2) 8% 3-H1OB(2F,3F)-O2 (2-3) 4% 3-BB(2F,3F)-O2 (2-4) 7% 2-HHB(2F,3F)-O2 (2-6) 6% 3-HHB(2F,3F)-O2 (2-6) 10% 5-HHB(2F,3F)-O2 (2-6) 8% 2-HBB(2F,3F)-O2 (2-10) 5% 3-HBB(2F,3F)-O2 (2-10) 7% 5-HBB(2F,3F)-O2 (2-10) 5% 2-HH-3 (3-1) 12% 1-BB-3 (3-3) 6% 3-HHB-1 (3-5) 3% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 6% 3-B(F)BB-2 (3-7) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=93.0℃;Tc<-20℃;Δn=0.124;Δε=-4.5;Vth=2.22 V;η=25.0 mPa・s;LISP=2.2%. [Example 20] 3-HB (2F, 3F) -O4 (2-1) 6% 3-H2B (2F, 3F) -O2 (2-2) 8% 3-H1OB (2F, 3F) -O2 ( 2-3) 4% 3-BB (2F, 3F) -O2 (2-4) 7% 2-HHB (2F, 3F) -O2 (2-6) 6% 3-HHB (2F, 3F) -O2 (2-6) 10% 5-HHB (2F, 3F) -O2 (2-6) 8% 2-HBB (2F, 3F) -O2 (2-10) 5% 3-HBB (2F, 3F)- O2 (2-10) 7% 5-HBB (2F, 3F) -O2 (2-10) 5% 2-HH-3 (3-1) 12% 1-BB-3 (3-3) 6% 3 -HHB-1 (3-5) 3% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 6% 3-B (F) BB-2 (3-7) 3 % Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 93.0 ℃; Tc <-20 ℃; Δn = 0.124; Δε = -4.5; Vth = 2.22 V; η = 25.0 mPa ・ s; LISP = 2.2%.

[實施例21] 3-H2B(2F,3F)-O2 (2-2) 10% 3-BB(2F,3F)-O2 (2-4) 10% 5-BB(2F,3F)-O2 (2-4) 5% V-HHB(2F,3F)-O1 (2-6) 5% V-HHB(2F,3F)-O2 (2-6) 12% V-HHB(2F,3F)-O4 (2-6) 8% 3-HDhB(2F,3F)-O2 (2-16) 8% 3-HH-V (3-1) 23% 3-HH-4 (3-1) 11% 3-HHB-1 (3-5) 4% 3-HHB-3 (3-5) 2% 3-HHB-O1 (3-5) 2% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=74.7℃;Tc<-20℃;Δn=0.089;Δε=-3.3;Vth=2.14 V;η=16.3 mPa・s;LISP=2.4%. [Example 21] 3-H2B (2F, 3F) -O2 (2-2) 10% 3-BB (2F, 3F) -O2 (2-4) 10% 5-BB (2F, 3F) -O2 ( 2-4) 5% V-HHB (2F, 3F) -O1 (2-6) 5% V-HHB (2F, 3F) -O2 (2-6) 12% V-HHB (2F, 3F) -O4 (2-6) 8% 3-HDhB (2F, 3F) -O2 (2-16) 8% 3-HH-V (3-1) 23% 3-HH-4 (3-1) 11% 3- HHB-1 (3-5) 4% 3-HHB-3 (3-5) 2% 3-HHB-O1 (3-5) 2% Compound (1-1-1) is added in a proportion of 0.10% by weight In the composition. NI = 74.7 ℃; Tc <-20 ℃; Δn = 0.089; Δε = -3.3; Vth = 2.14 V; η = 16.3 mPa ・ s; LISP = 2.4%.

[實施例22] 3-BB(2F,3F)-O2 (2-4) 13% 5-BB(2F,3F)-O2 (2-4) 12% V-HHB(2F,3F)-O1 (2-6) 5% V-HHB(2F,3F)-O2 (2-6) 12% V-HHB(2F,3F)-O4 (2-6) 14% 3-HH-V (3-1) 16% 3-HH-4 (3-1) 11% 1-BB-3 (3-3) 4% 3-HHB-O1 (3-5) 2% 3-HHB-1 (3-5) 7% 3-HHB-3 (3-5) 4% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=76.3℃;Tc<-20℃;Δn=0.103;Δε=-2.9;Vth=2.24 V;η=16.4 mPa・s;LISP=2.1%. [Example 22] 3-BB (2F, 3F) -O2 (2-4) 13% 5-BB (2F, 3F) -O2 (2-4) 12% V-HHB (2F, 3F) -O1 ( 2-6) 5% V-HHB (2F, 3F) -O2 (2-6) 12% V-HHB (2F, 3F) -O4 (2-6) 14% 3-HH-V (3-1) 16% 3-HH-4 (3-1) 11% 1-BB-3 (3-3) 4% 3-HHB-O1 (3-5) 2% 3-HHB-1 (3-5) 7% 3-HHB-3 (3-5) 4% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 76.3 ℃; Tc <-20 ℃; Δn = 0.103; Δε = -2.9; Vth = 2.24 V; η = 16.4 mPa ・ s; LISP = 2.1%.

[實施例23] 3-H2B(2F,3F)-O2 (2-2) 13% 5-H2B(2F,3F)-O2 (2-2) 14% V-HHB(2F,3F)-O1 (2-6) 5% V-HHB(2F,3F)-O2 (2-6) 12% V-HHB(2F,3F)-O4 (2-6) 14% 3-HH2B(2F,3F)-O2 (2-7) 4% 3-HH-V (3-1) 16% 1-BB-3 (3-3) 4% 1-BB-5 (3-3) 4.5% 3-HHB-1 (3-5) 1.5% 3-HBB-2 (3-6) 12% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=75.6℃;Tc<-20℃;Δn=0.103;Δε=-3.1;Vth=2.30 V;η=18.1 mPa・s;LISP=2.0%. [Example 23] 3-H2B (2F, 3F) -O2 (2-2) 13% 5-H2B (2F, 3F) -O2 (2-2) 14% V-HHB (2F, 3F) -O1 ( 2-6) 5% V-HHB (2F, 3F) -O2 (2-6) 12% V-HHB (2F, 3F) -O4 (2-6) 14% 3-HH2B (2F, 3F) -O2 (2-7) 4% 3-HH-V (3-1) 16% 1-BB-3 (3-3) 4% 1-BB-5 (3-3) 4.5% 3-HHB-1 (3 -5) 1.5% 3-HBB-2 (3-6) 12% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 75.6 ℃; Tc <-20 ℃; Δn = 0.103; Δε = -3.1; Vth = 2.30 V; η = 18.1 mPa ・ s; LISP = 2.0%.

[實施例24] 3-HB(2F,3F)-O2 (2-1) 6% 3-H1OB(2F,3F)-O2 (2-3) 11% 2-HH1OB(2F,3F)-O2 (2-8) 13% 3-HH1OB(2F,3F)-O2 (2-8) 8% 3-HH-5 (3-1) 5% 2-HH-3 (3-1) 11% 3-HH-4 (3-1) 11% 3-HB-O2 (3-2) 3% 1-BB-3 (3-3) 4% 1-BB-5 (3-3) 4% 3-HHB-1 (3-5) 5.5% 3-HBB-2 (3-6) 6.5% 5-B(F)BB-2 (3-7) 12% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=75.3℃;Tc<-20℃;Δn=0.105;Δε=-2.4;Vth=2.43 V;η=16.7 mPa・s;LISP=2.3%. [Example 24] 3-HB (2F, 3F) -O2 (2-1) 6% 3-H1OB (2F, 3F) -O2 (2-3) 11% 2-HH1OB (2F, 3F) -O2 ( 2-8) 13% 3-HH1OB (2F, 3F) -O2 (2-8) 8% 3-HH-5 (3-1) 5% 2-HH-3 (3-1) 11% 3-HH -4 (3-1) 11% 3-HB-O2 (3-2) 3% 1-BB-3 (3-3) 4% 1-BB-5 (3-3) 4% 3-HHB-1 (3-5) 5.5% 3-HBB-2 (3-6) 6.5% 5-B (F) BB-2 (3-7) 12% Compound (1-1-1) at a ratio of 0.10% by weight Added to this composition. NI = 75.3 ℃; Tc <-20 ℃; Δn = 0.105; Δε = -2.4; Vth = 2.43 V; η = 16.7 mPa ・ s; LISP = 2.3%.

[實施例25] 2-H1OB(2F,3F)-O2 (2-3) 7% 3-H1OB(2F,3F)-O2 (2-3) 7% 2-HHB(2F,3F)-O2 (2-6) 3% 3-HHB(2F,3F)-O2 (2-6) 4% 5-HHB(2F,3F)-O2 (2-6) 4% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 3% 5-HBB(2F,3F)-O2 (2-10) 4% 3-HDhB(2F,3F)-O2 (2-16) 6% 2-HH-3 (3-1) 18% 2-HH-5 (3-1) 3% 3-HH-4 (3-1) 4% 3-HH-5 (3-1) 3% 3-HB-O2 (3-2) 17.5% 3-HHB-3 (3-5) 3.5% 3-HHB-O1 (3-5) 2% 以0.10重量%的比例將化合物(1-1-1)、並以0.43重量%的比例將化合物(4-25-1)添加於該組成物中。 NI=75.2℃;Δn=0.089;Δε=-3.0;Vth=2.24 V;LISP=2.2%. [Example 25] 2-H1OB (2F, 3F) -O2 (2-3) 7% 3-H1OB (2F, 3F) -O2 (2-3) 7% 2-HHB (2F, 3F) -O2 ( 2-6) 3% 3-HHB (2F, 3F) -O2 (2-6) 4% 5-HHB (2F, 3F) -O2 (2-6) 4% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 (2-10) 3% 5-HBB (2F, 3F)- O2 (2-10) 4% 3-HDhB (2F, 3F) -O2 (2-16) 6% 2-HH-3 (3-1) 18% 2-HH-5 (3-1) 3% 3 -HH-4 (3-1) 4% 3-HH-5 (3-1) 3% 3-HB-O2 (3-2) 17.5% 3-HHB-3 (3-5) 3.5% 3-HHB -O1 (3-5) 2% Compound (1-1-1) is added at a ratio of 0.10% by weight, and compound (4-25-1) is added at a ratio of 0.43% by weight. NI = 75.2 ℃; Δn = 0.089; Δε = -3.0; Vth = 2.24 V; LISP = 2.2%.

[實施例26] 2-H1OB(2F,3F)-O2 (2-3) 7% 3-H1OB(2F,3F)-O2 (2-3) 7% 2-HHB(2F,3F)-O2 (2-6) 3% 3-HHB(2F,3F)-O2 (2-6) 4% 5-HHB(2F,3F)-O2 (2-6) 4% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 3% 5-HBB(2F,3F)-O2 (2-10) 4% 3-HDhB(2F,3F)-O2 (2-16) 6% 2-HH-3 (3-1) 18% 2-HH-5 (3-1) 3% 3-HH-4 (3-1) 4% 3-HH-5 (3-1) 3% 3-HB-O2 (3-2) 17.5% 3-HHB-3 (3-5) 3.5% 3-HHB-O1 (3-5) 2% 以0.10重量%的比例將化合物(1-1-1)、並以0.80重量%的比例將化合物(4-25-1)添加於該組成物中。 NI=74.9℃;Δn=0.089;Δε=-3.3;Vth=2.24 V;LISP=2.1%. [Example 26] 2-H1OB (2F, 3F) -O2 (2-3) 7% 3-H1OB (2F, 3F) -O2 (2-3) 7% 2-HHB (2F, 3F) -O2 ( 2-6) 3% 3-HHB (2F, 3F) -O2 (2-6) 4% 5-HHB (2F, 3F) -O2 (2-6) 4% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 (2-10) 3% 5-HBB (2F, 3F)- O2 (2-10) 4% 3-HDhB (2F, 3F) -O2 (2-16) 6% 2-HH-3 (3-1) 18% 2-HH-5 (3-1) 3% 3 -HH-4 (3-1) 4% 3-HH-5 (3-1) 3% 3-HB-O2 (3-2) 17.5% 3-HHB-3 (3-5) 3.5% 3-HHB -O1 (3-5) 2% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight, and compound (4-25-1) is added at a ratio of 0.80% by weight. NI = 74.9 ℃; Δn = 0.089; Δε = -3.3; Vth = 2.24 V; LISP = 2.1%.

[實施例27] V-HB(2F,3F)-O2 (2-1) 7% V2-BB(2F,3F)-O2 (2-4) 10% V-HHB(2F,3F)-O1 (2-6) 7% V-HHB(2F,3F)-O2 (2-6) 9% V2-HHB(2F,3F)-O2 (2-6) 8% 3-HH2B(2F,3F)-O2 (2-7) 9% V-HBB(2F,3F)-O2 (2-10) 7% V-HBB(2F,3F)-O4 (2-10) 7% 3-HH-V (3-1) 15% 3-HH-V1 (3-1) 6% 2-HH-3 (3-1) 9% 3-HH-4 (3-1) 3% 1V2-HH-3 (3-1) 3% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=87.5℃;Δn=0.100;Δε=-3.4;Vth=2.25 V;LISP=2.2%. [Example 27] V-HB (2F, 3F) -O2 (2-1) 7% V2-BB (2F, 3F) -O2 (2-4) 10% V-HHB (2F, 3F) -O1 ( 2-6) 7% V-HHB (2F, 3F) -O2 (2-6) 9% V2-HHB (2F, 3F) -O2 (2-6) 8% 3-HH2B (2F, 3F) -O2 (2-7) 9% V-HBB (2F, 3F) -O2 (2-10) 7% V-HBB (2F, 3F) -O4 (2-10) 7% 3-HH-V (3-1 ) 15% 3-HH-V1 (3-1) 6% 2-HH-3 (3-1) 9% 3-HH-4 (3-1) 3% 1V2-HH-3 (3-1) 3 % Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 87.5 ℃; Δn = 0.100; Δε = -3.4; Vth = 2.25 V; LISP = 2.2%.

[實施例28] 3-H1OB(2F,3F)-O2 (2-3) 10% 2-BB(2F,3F)-O2 (2-4) 5% V2-BB(2F,3F)-O2 (2-4) 11% 2-HH1OB(2F,3F)-O2 (2-8) 6% 3-HH1OB(2F,3F)-O2 (2-8) 18% 3-HH-VFF (3-1) 30% 1-BB-3 (3-3) 2.5% 3-HHB-1 (3-5) 5% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 8.5% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=75.7℃;Δn=0.101;Δε=-3.3;Vth=2.22 V;η=15.8 mPa・s;LISP=2.4%. [Example 28] 3-H1OB (2F, 3F) -O2 (2-3) 10% 2-BB (2F, 3F) -O2 (2-4) 5% V2-BB (2F, 3F) -O2 ( 2-4) 11% 2-HH1OB (2F, 3F) -O2 (2-8) 6% 3-HH1OB (2F, 3F) -O2 (2-8) 18% 3-HH-VFF (3-1) 30% 1-BB-3 (3-3) 2.5% 3-HHB-1 (3-5) 5% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 8.5% Compound (1-1-1) was added to the composition at a ratio of 0.10% by weight. NI = 75.7 ℃; Δn = 0.101; Δε = -3.3; Vth = 2.22 V; η = 15.8 mPa ・ s; LISP = 2.4%.

[實施例29] 3-H1OB(2F,3F)-O2 (2-3) 11.5% 2-BB(2F,3F)-O2 (2-4) 5% V2-BB(2F,3F)-O2 (2-4) 11% V-HHB(2F,3F)-O1 (2-6) 6% V-HHB(2F,3F)-O2 (2-6) 10% 2-HH1OB(2F,3F)-O2 (2-8) 6% 3-HH1OB(2F,3F)-O2 (2-8) 3% 3-HH-VFF (3-1) 30% 3-HHB-1 (3-5) 5% 3-HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 8.5% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=76.4℃;Δn=0.101;Δε=-3.3;Vth=2.21 V;η=15.9 mPa・s;LISP=2.6%. [Example 29] 3-H1OB (2F, 3F) -O2 (2-3) 11.5% 2-BB (2F, 3F) -O2 (2-4) 5% V2-BB (2F, 3F) -O2 ( 2-4) 11% V-HHB (2F, 3F) -O1 (2-6) 6% V-HHB (2F, 3F) -O2 (2-6) 10% 2-HH1OB (2F, 3F) -O2 (2-8) 6% 3-HH1OB (2F, 3F) -O2 (2-8) 3% 3-HH-VFF (3-1) 30% 3-HHB-1 (3-5) 5% 3- HHB-O1 (3-5) 4% 3-HBB-2 (3-6) 8.5% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 76.4 ℃; Δn = 0.101; Δε = -3.3; Vth = 2.21 V; η = 15.9 mPa ・ s; LISP = 2.6%.

[實施例30] 3-H2B(2F,3F)-O2 (2-2) 13% 2-BB(2F,3F)-O2 (2-4) 3.5% 3-BB(2F,3F)-O2 (2-4) 4% 3-HH2B(2F,3F)-O2 (2-7) 11% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 9% 4-HBB(2F,3F)-O2 (2-10) 2% V-HBB(2F,3F)-O2 (2-10) 8% V-HBB(2F,3F)-O4 (2-10) 4% 2-HH-3 (3-1) 21% 3-HH-VFF (3-1) 9% 3-HB-O2 (3-2) 2.5% 3-HHB-1 (3-5) 5% 3-HHB-3 (3-5) 5% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=80.2℃;Tc<-20℃;Δn=0.102;Δε=-2.8;Vth=2.43 V;η=14.2 mPa・s;LISP=2.1%. [Example 30] 3-H2B (2F, 3F) -O2 (2-2) 13% 2-BB (2F, 3F) -O2 (2-4) 3.5% 3-BB (2F, 3F) -O2 ( 2-4) 4% 3-HH2B (2F, 3F) -O2 (2-7) 11% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 9% 4-HBB (2F, 3F) -O2 (2-10) 2% V-HBB (2F, 3F) -O2 (2-10) 8% V-HBB (2F, 3F)- O4 (2-10) 4% 2-HH-3 (3-1) 21% 3-HH-VFF (3-1) 9% 3-HB-O2 (3-2) 2.5% 3-HHB-1 ( 3-5) 5% 3-HHB-3 (3-5) 5% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 80.2 ℃; Tc <-20 ℃; Δn = 0.102; Δε = -2.8; Vth = 2.43 V; η = 14.2 mPa ・ s; LISP = 2.1%.

[實施例31] 2-H1OB(2F,3F)-O2 (2-3) 6% 3-H1OB(2F,3F)-O2 (2-3) 7% V2-BB(2F,3F)-O2 (2-4) 3% 2-BB(2F,3F)-O2 (2-4) 4% 3-BB(2F,3F)-O2 (2-4) 6% 3-HH2B(2F,3F)-O2 (2-7) 7% 3-HH1OB(2F,3F)-O2 (2-8) 5% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 7% 4-HBB(2F,3F)-O2 (2-10) 3% V-HBB(2F,3F)-O2 (2-10) 7% V-HBB(2F,3F)-O4 (2-10) 5% 2-HH-3 (3-1) 13% 3-HH-4 (3-1) 10% 3-HHB-1 (3-5) 4% 3-HHB-3 (3-5) 5% 3-HHB-O1 (3-5) 3% 3-HBB-2 (3-6) 2% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=85.7℃;Tc<-20℃;Δn=0.111;Δε=-4.0;Vth=2.08 V;η=21.8 mPa・s;LISP=2.2%. [Example 31] 2-H1OB (2F, 3F) -O2 (2-3) 6% 3-H1OB (2F, 3F) -O2 (2-3) 7% V2-BB (2F, 3F) -O2 ( 2-4) 3% 2-BB (2F, 3F) -O2 (2-4) 4% 3-BB (2F, 3F) -O2 (2-4) 6% 3-HH2B (2F, 3F) -O2 (2-7) 7% 3-HH1OB (2F, 3F) -O2 (2-8) 5% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F)- O2 (2-10) 7% 4-HBB (2F, 3F) -O2 (2-10) 3% V-HBB (2F, 3F) -O2 (2-10) 7% V-HBB (2F, 3F) -O4 (2-10) 5% 2-HH-3 (3-1) 13% 3-HH-4 (3-1) 10% 3-HHB-1 (3-5) 4% 3-HHB-3 (3-5) 5% 3-HHB-O1 (3-5) 3% 3-HBB-2 (3-6) 2% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. In. NI = 85.7 ℃; Tc <-20 ℃; Δn = 0.111; Δε = -4.0; Vth = 2.08 V; η = 21.8 mPa ・ s; LISP = 2.2%.

[實施例32] 3-H2B(2F,3F)-O2 (2-2) 17% 5-H2B(2F,3F)-O2 (2-2) 12% 3-H1OB(2F,3F)-O2 (2-3) 8% 3-HH1OB(2F,3F)-O2 (2-8) 3% 2-HBB(2F,3F)-O2 (2-10) 3% 3-HBB(2F,3F)-O2 (2-10) 7% 4-HBB(2F,3F)-O2 (2-10) 4% 5-HBB(2F,3F)-O2 (2-10) 8% V-HBB(2F,3F)-O2 (2-10) 4% V-HBB(2F,3F)-O4 (2-10) 5% 3-HDhB(2F,3F)-O2 (2-16) 8% 2-HH-3 (3-1) 6% 3-HH-4 (3-1) 3% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 2% 3-HBB-2 (3-6) 6% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=84.5℃;Tc<-20℃;Δn=0.114;Δε=-5.5;Vth=1.81 V;η=29.4 mPa・s;LISP=2.3%. [Example 32] 3-H2B (2F, 3F) -O2 (2-2) 17% 5-H2B (2F, 3F) -O2 (2-2) 12% 3-H1OB (2F, 3F) -O2 ( 2-3) 8% 3-HH1OB (2F, 3F) -O2 (2-8) 3% 2-HBB (2F, 3F) -O2 (2-10) 3% 3-HBB (2F, 3F) -O2 (2-10) 7% 4-HBB (2F, 3F) -O2 (2-10) 4% 5-HBB (2F, 3F) -O2 (2-10) 8% V-HBB (2F, 3F)- O2 (2-10) 4% V-HBB (2F, 3F) -O4 (2-10) 5% 3-HDhB (2F, 3F) -O2 (2-16) 8% 2-HH-3 (3- 1) 6% 3-HH-4 (3-1) 3% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 2% 3-HBB-2 (3-6) 6% Compound (1-1-1) was added to the composition at a ratio of 0.10% by weight. NI = 84.5 ℃; Tc <-20 ℃; Δn = 0.114; Δε = -5.5; Vth = 1.81 V; η = 29.4 mPa ・ s; LISP = 2.3%.

[實施例33] 3-BB(2F,3F)-O2 (2-4) 10% V2-BB(2F,3F)-O2 (2-4) 6% 2-HH1OB(2F,3F)-O2 (2-8) 13% 3-HH1OB(2F,3F)-O2 (2-8) 14% 2-HBB(2F,3F)-O2 (2-10) 2% 3-HBB(2F,3F)-O2 (2-10) 6% V-HBB(2F,3F)-O2 (2-10) 6% V-HBB(2F,3F)-O4 (2-10) 3% 2-HH-3 (3-1) 7% 3-HH-VFF (3-1) 25% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 2% 3-HBB-2 (3-6) 2% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=89.5℃;Tc<-20℃;Δn=0.108;Δε=-3.8;Vth=2.11 V;η=20.2 mPa・s;LISP=2.1%. [Example 33] 3-BB (2F, 3F) -O2 (2-4) 10% V2-BB (2F, 3F) -O2 (2-4) 6% 2-HH1OB (2F, 3F) -O2 ( 2-8) 13% 3-HH1OB (2F, 3F) -O2 (2-8) 14% 2-HBB (2F, 3F) -O2 (2-10) 2% 3-HBB (2F, 3F) -O2 (2-10) 6% V-HBB (2F, 3F) -O2 (2-10) 6% V-HBB (2F, 3F) -O4 (2-10) 3% 2-HH-3 (3-1 ) 7% 3-HH-VFF (3-1) 25% 3-HHB-1 (3-5) 4% 3-HHB-O1 (3-5) 2% 3-HBB-2 (3-6) 2 % Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 89.5 ℃; Tc <-20 ℃; Δn = 0.108; Δε = -3.8; Vth = 2.11 V; η = 20.2 mPa ・ s; LISP = 2.1%.

[實施例34] 3-H2B(2F,3F)-O2 (2-2) 9% 3-BB(2F,3F)-O2 (2-4) 9% V2-BB(2F,3F)-O2 (2-4) 8% 3-HH2B(2F,3F)-O2 (2-7) 15% 3-HDhB(2F,3F)-O2 (2-16) 18% 3-HH-V (3-1) 29% V-HHB-1 (3-5) 10% 3-HBB-2 (3-6) 2% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=74.6℃;Δn=0.095;Δε=-3.5;Vth=2.16 V;LISP=2.2%. [Example 34] 3-H2B (2F, 3F) -O2 (2-2) 9% 3-BB (2F, 3F) -O2 (2-4) 9% V2-BB (2F, 3F) -O2 ( 2-4) 8% 3-HH2B (2F, 3F) -O2 (2-7) 15% 3-HDhB (2F, 3F) -O2 (2-16) 18% 3-HH-V (3-1) 29% V-HHB-1 (3-5) 10% 3-HBB-2 (3-6) 2% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 74.6 ℃; Δn = 0.095; Δε = -3.5; Vth = 2.16 V; LISP = 2.2%.

[實施例35] 3-HB(2F,3F)-O2 (2-1) 8% 5-HB(2F,3F)-O2 (2-1) 3% 2-BB(2F,3F)-O2 (2-4) 8% V2-BB(2F,3F)-O2 (2-4) 7% 3-HHB(2F,3F)-O2 (2-6) 10% V-HHB(2F,3F)-O1 (2-6) 4% V-HHB(2F,3F)-O2 (2-6) 10% 3-HDhB(2F,3F)-O2 (2-16) 10% 3-HH-V (3-1) 29% V-HHB-1 (3-5) 11% 以0.10重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=75.4℃;Δn=0.094;Δε=-3.6;Vth=2.05 V;LISP=2.0%. [Example 35] 3-HB (2F, 3F) -O2 (2-1) 8% 5-HB (2F, 3F) -O2 (2-1) 3% 2-BB (2F, 3F) -O2 ( 2-4) 8% V2-BB (2F, 3F) -O2 (2-4) 7% 3-HHB (2F, 3F) -O2 (2-6) 10% V-HHB (2F, 3F) -O1 (2-6) 4% V-HHB (2F, 3F) -O2 (2-6) 10% 3-HDhB (2F, 3F) -O2 (2-16) 10% 3-HH-V (3-1 ) 29% V-HHB-1 (3-5) 11% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight. NI = 75.4 ℃; Δn = 0.094; Δε = -3.6; Vth = 2.05 V; LISP = 2.0%.

[實施例36] V-HB(2F,3F)-O2 (2-1) 5% 2-BB(2F,3F)-O2 (2-4) 6% 3-BB(2F,3F)-O2 (2-4) 11% V-HHB(2F,3F)-O1 (2-6) 6% V-HHB(2F,3F)-O2 (2-6) 12% V-HHB(2F,3F)-O4 (2-6) 6% V2-HHB(2F,3F)-O2 (2-6) 10% V-HBB(2F,3F)-O2 (2-10) 7% V-HBB(2F,3F)-O4 (2-10) 7% 3-HH-V (3-1) 27.5% 3-HH-V1 (3-1) 2.5% 以0.15重量%的比例將化合物(1-1-1)添加於該組成物中。 NI=79.6℃;Tc<-30℃;Δn=0.107;Δε=-4.1;Vth=1.94 V;LISP=2.5%. [Example 36] V-HB (2F, 3F) -O2 (2-1) 5% 2-BB (2F, 3F) -O2 (2-4) 6% 3-BB (2F, 3F) -O2 ( 2-4) 11% V-HHB (2F, 3F) -O1 (2-6) 6% V-HHB (2F, 3F) -O2 (2-6) 12% V-HHB (2F, 3F) -O4 (2-6) 6% V2-HHB (2F, 3F) -O2 (2-6) 10% V-HBB (2F, 3F) -O2 (2-10) 7% V-HBB (2F, 3F)- O4 (2-10) 7% 3-HH-V (3-1) 27.5% 3-HH-V1 (3-1) 2.5% Compound (1-1-1) is added to this in a proportion of 0.15% by weight组合 物。 Composition. NI = 79.6 ℃; Tc <-30 ℃; Δn = 0.107; Δε = -4.1; Vth = 1.94 V; LISP = 2.5%.

[實施例37] 2-H1OB(2F,3F)-O2 (2-3) 10% 3-H1OB(2F,3F)-O2 (2-3) 10% 2-HHB(2F,3F)-O2 (2-6) 4% 3-HHB(2F,3F)-O2 (2-6) 6% 5-HHB(2F,3F)-O2 (2-6) 2% 2-HBB(2F,3F)-O2 (2-10) 2% 3-HBB(2F,3F)-O2 (2-10) 8% 4-HBB(2F,3F)-O2 (2-10) 8% 5-HBB(2F,3F)-O2 (2-10) 3% 2-HH-3 (3-1) 22% 3-HH-4 (3-1) 4% 3-HB-O2 (3-2) 10% 3-HBB-2 (3-6) 11% 以0.10重量%的比例將化合物(1-1-1)、並以0.30重量%的比例將化合物(4-25-1)添加於該組成物中。 NI=75.9℃;Δn=0.098;Δε=-3.2;Vth=2.09 V;LISP=2.2%. [Example 37] 2-H1OB (2F, 3F) -O2 (2-3) 10% 3-H1OB (2F, 3F) -O2 (2-3) 10% 2-HHB (2F, 3F) -O2 ( 2-6) 4% 3-HHB (2F, 3F) -O2 (2-6) 6% 5-HHB (2F, 3F) -O2 (2-6) 2% 2-HBB (2F, 3F) -O2 (2-10) 2% 3-HBB (2F, 3F) -O2 (2-10) 8% 4-HBB (2F, 3F) -O2 (2-10) 8% 5-HBB (2F, 3F)- O2 (2-10) 3% 2-HH-3 (3-1) 22% 3-HH-4 (3-1) 4% 3-HB-O2 (3-2) 10% 3-HBB-2 ( 3-6) 11% Compound (1-1-1) is added to the composition at a ratio of 0.10% by weight, and compound (4-25-1) is added at a ratio of 0.30% by weight. NI = 75.9 ℃; Δn = 0.098; Δε = -3.2; Vth = 2.09 V; LISP = 2.2%.

[實施例38] 3-BB(2F,3F)-O2 (2-4) 13% 2-HH1OB(2F,3F)-O2 (2-8) 20% 3-HH1OB(2F,3F)-O2 (2-8) 14% 3-HH-V (3-1) 31% 1-BB-5 (3-3) 8% 3-HHB-1 (3-5) 4% 3-HHB-3 (3-5) 3% 5-B(F)BB-2 (3-7) 7% 最後,評價擴展性。製備所述組成物(38)。以0.01重量%的比例將化合物(1-1-1)添加於該組成物中。擴展性是利用測定(15)中記載的方法來測定,並根據圖1進行定性評價(表6)。 [Example 38] 3-BB (2F, 3F) -O2 (2-4) 13% 2-HH1OB (2F, 3F) -O2 (2-8) 20% 3-HH1OB (2F, 3F) -O2 ( 2-8) 14% 3-HH-V (3-1) 31% 1-BB-5 (3-3) 8% 3-HHB-1 (3-5) 4% 3-HHB-3 (3- 5) 3% 5-B (F) BB-2 (3-7) 7% Finally, evaluate scalability. The composition (38) is prepared. Compound (1-1-1) was added to the composition at a ratio of 0.01% by weight. Scalability was measured by the method described in Measurement (15), and qualitatively evaluated based on FIG. 1 (Table 6).

[實施例39] 以0.01重量%的比例將化合物(1-1-2)添加於實施例38中記載的組成物(38)中。根據圖2評價該化合物的擴展性(表6)。 [Example 39] The compound (1-1-2) was added to the composition (38) described in Example 38 at a ratio of 0.01% by weight. The extensibility of the compound was evaluated according to FIG. 2 (Table 6).

[比較例3] 以0.01重量%的比例將比較化合物(A-2)添加於實施例38中記載的組成物(38)中。根據圖3評價該化合物的擴展性。將該結果與實施例38、實施例39的結果一起歸納於表6中。 [Comparative Example 3] A comparative compound (A-2) was added to the composition (38) described in Example 38 at a ratio of 0.01% by weight. The extensibility of the compound was evaluated according to FIG. 3. The results are summarized in Table 6 together with the results of Examples 38 and 39.

圖1至圖3為元件的照片。注入口位於照片的下側,從此處注入含有添加物的組成物。於圖1與圖2中,亮度的大小互不相同,但亮度整體均勻。該些表示擴展性良好。於圖3中,在上方觀察到凸的曲線。這表示雖然元件被液晶組成物充滿,但組成物中所含的添加物未到達元件的上端。根據該些結果可知,於實施例38及實施例39中,擴展性良好。另一方面,於比較例3中,擴展性不良。Figures 1 to 3 are photos of the components. The injection port is located on the lower side of the photo, from which the composition containing additives is injected. In FIG. 1 and FIG. 2, the brightness is different from each other, but the brightness is uniform as a whole. These indicate good scalability. In FIG. 3, a convex curve is observed from above. This means that although the device was filled with the liquid crystal composition, the additives contained in the composition did not reach the upper end of the device. From these results, it can be seen that in Examples 38 and 39, the scalability was good. On the other hand, in Comparative Example 3, the scalability was poor.

進行線殘像、下限溫度(低溫下的溶解性)、擴展性的比較實驗,並將結果歸納於表4、表5、表6中。於任一情況下,化合物(1)與比較化合物相比,均實現優異的結果。因而,可得出本發明的組成物具有優異的特性的結論。 [產業上之可利用性]Comparative experiments on line afterimage, lower limit temperature (solubility at low temperature), and expandability were performed, and the results are summarized in Table 4, Table 5, and Table 6. In either case, the compound (1) achieved superior results compared to the comparative compound. Therefore, it can be concluded that the composition of the present invention has excellent characteristics. [Industrial availability]

本發明的液晶組成物可用於液晶監視器、液晶電視等。The liquid crystal composition of the present invention can be used in a liquid crystal monitor, a liquid crystal television, and the like.

no

圖1為表示擴展性良好的元件的照片。 圖2為表示擴展性良好的元件的照片。 圖3為表示擴展性不良的元件的照片。FIG. 1 is a photograph showing a device having good expandability. FIG. 2 is a photograph showing a device having good expandability. FIG. 3 is a photograph showing an element having poor scalability.

no

Claims (21)

一種化合物,其具有至少兩個式(S)所表示的一價基,該些一價基中,由R1 所表示的基與由其他R1 所表示的基不同,式(S)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基;R為碳數1至12的烷基。A compound having the (S) a divalent group represented by the formula is at least two, the plurality monovalent group, the other group with a group represented by R 1 is represented by R 1 by a different, In the formula (S), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons; R is an alkyl group having 1 to 12 carbons. 如申請專利範圍第1項所述的化合物,其中如申請專利範圍第1項所述的式(S)所表示的一價基中,R為甲基。The compound according to item 1 of the scope of patent application, wherein in the monovalent group represented by the formula (S) described in item 1 of the scope of patent application, R is methyl. 如申請專利範圍第1項或第2項所述的化合物,其是由式(1)所表示,式(1)及式(S-1)中,R1 為氫、碳數1至12的烷基、或碳數1至12的烷氧基,此處,由R1 所表示的基與由其他R1 所表示的基不同;環A為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、或吡啶-2,5-二基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者式(S-1)所表示的基取代;Z1 及Z2 獨立地為單鍵或碳數1至20的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟、氯、或式(S-1)所表示的基取代;Z3 為單鍵或碳數1至20的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟或氯取代;a為0、1、2、或3。The compound as described in claim 1 or 2, which is represented by formula (1), In Formula (1) and Formula (S-1), R 1 is hydrogen, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons. Here, the group represented by R 1 and Other R 1 groups are different; ring A is 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-phenyl, naphthalene-1,2-diyl, naphthalene-1 , 3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl Naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2, 5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings, at least one hydrogen may be passed through fluorine, chlorine, alkyl having 1 to 12 carbons, carbon 1 Alkoxy to 12, at least one hydrogen substituted with fluorine or chlorine, an alkyl group having 1 to 12 carbons, or a group represented by formula (S-1); Z 1 and Z 2 are independently a single bond or carbon 1 to 20 alkylene groups, at least one of which is -CH 2 -may be substituted with -O-, -COO-, -OCO-, or -OCOO-, and among these groups, at least one hydrogen group may be fluorine, chlorine, or formula (S-1) represented by substituent; Z 3 is a single bond or alkylene having a carbon number of 1 to 20, said alkylene, at least one -CH 2 - may be -O - -OCOO- substituted OCO-, or, the plurality of groups, at least one hydrogen may be replaced by fluorine or chlorine, - COO - -,; a is 0, 1, or 3. 如申請專利範圍第1項所述的化合物,其是由式(1-1)至式(1-9)的任一者所表示, 式(1-1)至式(1-9)中,R2 為碳數1至12的烷基或碳數1至12的烷氧基;Z4 為碳數1至15的伸烷基;Z5 及Z6 獨立地為碳數1至5的伸烷基;Z7 及Z8 獨立地為單鍵或碳數1至20的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,該些基中,至少一個氫可經氟或氯取代;X1 為氫或氟。The compound according to item 1 of the scope of patent application, which is represented by any one of formula (1-1) to formula (1-9), In formulas (1-1) to (1-9), R 2 is an alkyl group having 1 to 12 carbons or an alkoxy group having 1 to 12 carbons; Z 4 is an alkylene group having 1 to 15 carbons; Z 5 and Z 6 are independently an alkylene group having 1 to 5 carbon atoms; Z 7 and Z 8 are independently a single bond or an alkylene group having 1 to 20 carbon atoms, and at least one of the alkylene groups is -CH 2 -may be substituted with -O-, -COO-, -OCO-, or -OCOO-, in which at least one hydrogen may be substituted with fluorine or chlorine; X 1 is hydrogen or fluorine. 一種液晶組成物,其含有至少一種如申請專利範圍第1項至第4項中任一項所述的化合物作為第一添加物,且具有負的介電各向異性。A liquid crystal composition containing at least one compound as described in any one of claims 1 to 4 of the scope of patent application as a first additive, and having negative dielectric anisotropy. 如申請專利範圍第5項所述的液晶組成物,其中第一添加物的比例為0.005重量%至1重量%的範圍。The liquid crystal composition according to item 5 of the scope of patent application, wherein the proportion of the first additive is in the range of 0.005% by weight to 1% by weight. 如申請專利範圍第5項或第6項所述的液晶組成物,其含有選自式(2)所表示的化合物的群組中的至少一種化合物作為第一成分,式(2)中,R3 及R4 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、或碳數2至12的烯氧基;環B及環D獨立地為1,4-伸環己基、1,4-伸環己烯基、四氫吡喃-2,5-二基、1,4-伸苯基、至少一個氫經氟或氯取代的1,4-伸苯基、萘-2,6-二基、至少一個氫經氟或氯取代的萘-2,6-二基、色原烷-2,6-二基、或者至少一個氫經氟或氯取代的色原烷-2,6-二基;環C為2,3-二氟-1,4-伸苯基、2-氯-3-氟-1,4-伸苯基、2,3-二氟-5-甲基-1,4-伸苯基、3,4,5-三氟萘-2,6-二基、或7,8-二氟色原烷-2,6-二基;Z9 及Z10 獨立地為單鍵、伸乙基、羰氧基、或亞甲氧基;b為1、2、或3,c為0或1,而且b與c之和為3以下。The liquid crystal composition according to item 5 or item 6 of the patent application scope, which contains at least one compound selected from the group of compounds represented by formula (2) as a first component, In formula (2), R 3 and R 4 are independently an alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, an alkenyl group having 2 to 12 carbons, or an olefin having 2 to 12 carbons Oxygen; ring B and ring D are independently 1,4-cyclohexyl, 1,4-cyclohexenyl, tetrahydropyran-2,5-diyl, 1,4-phenylene, at least 1,4-phenylene substituted with fluorine or chlorine, naphthalene-2,6-diyl, at least one hydrogen substituted with fluorine or chlorine, naphthalene-2,6-diyl, chromogen-2,6 -Diyl, or chromogen-2,6-diyl in which at least one hydrogen is replaced by fluorine or chlorine; ring C is 2,3-difluoro-1,4-phenylene, 2-chloro-3-fluoro -1,4-phenylene, 2,3-difluoro-5-methyl-1,4-phenylene, 3,4,5-trifluoronaphthalene-2,6-diyl, or 7,8 -Difluorochroman-2,6-diyl; Z 9 and Z 10 are independently a single bond, ethylene, carbonyloxy, or methyleneoxy; b is 1, 2, or 3, and c is 0 or 1, and the sum of b and c is 3 or less. 如申請專利範圍第5項所述的液晶組成物,其含有選自式(2-1)至式(2-22)所表示的化合物的群組中的至少一種化合物作為第一成分, 式(2-1)至式(2-22)中,R3 及R4 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、或碳數2至12的烯氧基。The liquid crystal composition according to item 5 of the scope of patent application, which contains at least one compound selected from the group of compounds represented by formula (2-1) to formula (2-22) as a first component, In the formulae (2-1) to (2-22), R 3 and R 4 are independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, and an alkenyl group having 2 to 12 carbon atoms. Or an alkenyloxy group having 2 to 12 carbon atoms. 如申請專利範圍第7項所述的液晶組成物,其中第一成分的比例為10重量%至90重量%的範圍。The liquid crystal composition according to item 7 of the scope of patent application, wherein the ratio of the first component is in a range of 10% by weight to 90% by weight. 如申請專利範圍第5項所述的液晶組成物,其含有選自式(3)所表示的化合物的群組中的至少一種化合物作為第二成分,式(3)中,R5 及R6 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數2至12的烯基;環E及環F獨立地為1,4-伸環己基、1,4-伸苯基、2-氟-1,4-伸苯基、或2,5-二氟-1,4-伸苯基;Z11 為單鍵、伸乙基、羰氧基、或亞甲氧基;d為1、2、或3。The liquid crystal composition according to item 5 of the scope of patent application, which contains at least one compound selected from the group of compounds represented by formula (3) as a second component, In formula (3), R 5 and R 6 are independently an alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, an alkenyl group having 2 to 12 carbons, and at least one hydrogen is substituted with fluorine or chlorine Alkyl group having 1 to 12 carbon atoms, or alkenyl group having 2 to 12 carbon atoms in which at least one hydrogen is replaced by fluorine or chlorine; ring E and ring F are independently 1,4-cyclohexyl, 1,4-cyclohexyl Phenyl, 2-fluoro-1,4-phenylene, or 2,5-difluoro-1,4-phenylene; Z 11 is a single bond, ethylene, carbonyloxy, or methyleneoxy ; D is 1, 2, or 3. 如申請專利範圍第5項所述的液晶組成物,其含有選自式(3-1)至式(3-13)所表示的化合物的群組中的至少一種化合物作為第二成分, 式(3-1)至式(3-13)中,R5 及R6 獨立地為碳數1至12的烷基、碳數1至12的烷氧基、碳數2至12的烯基、至少一個氫經氟或氯取代的碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數2至12的烯基。The liquid crystal composition according to item 5 of the scope of patent application, which contains at least one compound selected from the group of compounds represented by formula (3-1) to formula (3-13) as a second component, In the formulae (3-1) to (3-13), R 5 and R 6 are independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, and an alkenyl group having 2 to 12 carbon atoms. , At least one hydrogen having 1 to 12 carbons substituted with fluorine or chlorine, or at least one hydrogen having 2 to 12 carbons substituted with fluorine or chlorine. 如申請專利範圍第10項所述的液晶組成物,其中第二成分的比例為10重量%至90重量%的範圍。The liquid crystal composition according to item 10 of the scope of patent application, wherein the proportion of the second component is in a range of 10% by weight to 90% by weight. 如申請專利範圍第5項所述的液晶組成物,其含有選自式(4)所表示的聚合性化合物的群組中的至少一種化合物作為第二添加物,式(4)中,環G及環J獨立地為環己基、環己烯基、苯基、1-萘基、2-萘基、四氫吡喃-2-基、1,3-二噁烷-2-基、嘧啶-2-基、或吡啶-2-基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代;環I為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、或吡啶-2,5-二基,該些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代;Z12 及Z13 獨立地為單鍵或碳數1至10的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-CO-、-COO-、或-OCO-取代,至少一個-CH2 CH2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-、或-C(CH3 )=C(CH3 )-取代,該些基中,至少一個氫可經氟或氯取代;P1 、P2 、及P3 獨立地為聚合性基;Sp1 、Sp2 、及Sp3 獨立地為單鍵或碳數1至10的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,至少一個-CH2 CH2 -可經-CH=CH-或-C≡C-取代,該些基中,至少一個氫可經氟或氯取代;e為0、1、或2;f、g、及h獨立地為0、1、2、3、或4,而且f、g、及h之和為1以上。The liquid crystal composition according to item 5 of the scope of patent application, which contains at least one compound selected from the group of polymerizable compounds represented by formula (4) as a second additive, In formula (4), ring G and ring J are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxane Alk-2-yl, pyrimidin-2-yl, or pyridin-2-yl, in which at least one hydrogen may pass through fluorine, chlorine, alkyl having 1 to 12 carbons, and alkoxy having 1 to 12 carbons Or at least one hydrogen substituted with fluorine or chlorine and 1 to 12 carbon alkyl groups; ring I is 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-phenylene Naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1, 7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5- Diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings, at least one hydrogen may be passed through fluorine, chlorine , An alkyl group having 1 to 12 carbons, an alkoxy group having 1 to 12 carbons, or an alkyl group having 1 to 12 carbons in which at least one hydrogen is replaced with fluorine or chlorine; Z 12 and Z 13 are independently a single bond Or an alkylene group having 1 to 10 carbon atoms, at least one -CH 2 -of which may be substituted with -O-, -CO-, -COO-, or -OCO- -CH 2 CH 2 -may be replaced by -CH = CH-, -C (CH 3 ) = CH-, -CH = C (CH 3 )-, or -C (CH 3 ) = C (CH 3 )-, Among these groups, at least one hydrogen may be substituted by fluorine or chlorine; P 1 , P 2 , and P 3 are independently polymerizable groups; Sp 1 , Sp 2 , and Sp 3 are independently a single bond or a carbon number of 1 to 10 alkylene groups, at least one -CH 2 -of which may be substituted by -O-, -COO-, -OCO-, or -OCOO-, and at least one -CH 2 CH 2 -may be- CH = CH- or -C≡C- substitution, in these groups, at least one hydrogen may be substituted by fluorine or chlorine; e is 0, 1, or 2; f, g, and h are independently 0, 1, 2 , 3, or 4, and the sum of f, g, and h is 1 or more. 如申請專利範圍第13項所述的液晶組成物,其中式(4)中,P1 、P2 、及P3 獨立地為選自式(P-1)至式(P-5)所表示的聚合性基的群組中的基,式(P-1)至式(P-5)中,M1 、M2 、及M3 獨立地為氫、氟、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。The liquid crystal composition according to item 13 of the scope of patent application, wherein in formula (4), P 1 , P 2 , and P 3 are independently selected from the group consisting of formulas (P-1) to (P-5) Radicals in the group of polymerizable radicals, In the formulae (P-1) to (P-5), M 1 , M 2 , and M 3 are independently hydrogen, fluorine, an alkyl group having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine. Alkyl having 1 to 5 carbons. 如申請專利範圍第13項所述的液晶組成物,其含有選自式(4-1)至式(4-27)所表示的聚合性化合物的群組中的至少一種化合物作為第二添加物, 式(4-1)至式(4-27)中,P4 、P5 、及P6 獨立地為選自式(P-1)至式(P-3)所表示的聚合性基的群組中的基,此處,M1 、M2 、及M3 獨立地為氫、氟、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;Sp1 、Sp2 、及Sp3 獨立地為單鍵或碳數1至10的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCO-、或-OCOO-取代,至少一個-CH2 CH2 -可經-CH=CH-或-C≡C-取代,該些基中,至少一個氫可經氟或氯取代。The liquid crystal composition according to item 13 of the scope of patent application, which contains at least one compound selected from the group of polymerizable compounds represented by formula (4-1) to formula (4-27) as a second additive. , In Formulas (4-1) to (4-27), P 4 , P 5 , and P 6 are independently selected from the group consisting of polymerizable groups represented by Formulas (P-1) to (P-3) Base in group, Here, M 1 , M 2 , and M 3 are independently hydrogen, fluorine, an alkyl group having 1 to 5 carbons, or an alkyl group having 1 to 5 carbons in which at least one hydrogen is replaced with fluorine or chlorine; Sp 1 , Sp 2 and Sp 3 are independently a single bond or an alkylene group having 1 to 10 carbon atoms. Among the alkylene groups, at least one of -CH 2 -may pass through -O-, -COO-, -OCO-, or -OCOO- substituted, at least one -CH 2 CH 2 -may be substituted with -CH = CH- or -C≡C-, and among these groups, at least one hydrogen may be substituted with fluorine or chlorine. 如申請專利範圍第13項所述的液晶組成物,其中第二添加物的比例為0.03重量%至10重量%的範圍。The liquid crystal composition according to item 13 of the scope of patent application, wherein the ratio of the second additive is in a range of 0.03% by weight to 10% by weight. 一種液晶顯示元件,其含有如申請專利範圍第5項至第16項中任一項所述的液晶組成物。A liquid crystal display element comprising the liquid crystal composition according to any one of claims 5 to 16 of the scope of patent application. 如申請專利範圍第17項所述的液晶顯示元件,其中液晶顯示元件的運作模式為面內切換模式、垂直配向模式、邊緣場切換模式、或電場感應光反應配向模式,液晶顯示元件的驅動方式為主動矩陣方式。The liquid crystal display element according to item 17 of the scope of the patent application, wherein the operation mode of the liquid crystal display element is an in-plane switching mode, a vertical alignment mode, a fringe field switching mode, or an electric field induced light reaction alignment mode, and a driving mode of the liquid crystal display element. Active matrix method. 一種聚合物穩定配向型的液晶顯示元件,其含有如申請專利範圍第13項至第16項中任一項所述的液晶組成物,且所述液晶組成物中所含有的第二添加物進行聚合。A polymer-stable alignment type liquid crystal display element includes the liquid crystal composition according to any one of claims 13 to 16 of the scope of application for a patent, and a second additive contained in the liquid crystal composition is subjected to polymerization. 一種液晶組成物的用途,所述液晶組成物為如申請專利範圍第5項至第16項中任一項所述的液晶組成物,其用於液晶顯示元件中。A use of a liquid crystal composition, which is the liquid crystal composition according to any one of items 5 to 16 of the scope of application for a patent, which is used in a liquid crystal display element. 一種液晶組成物的用途,所述液晶組成物為如申請專利範圍第5項至第16項中任一項所述的液晶組成物,其用於聚合物穩定配向型的液晶顯示元件中。A use of a liquid crystal composition, which is the liquid crystal composition according to any one of items 5 to 16 of the scope of application for a patent, which is used in a polymer-stabilized alignment type liquid crystal display element.
TW106129135A 2016-08-29 2017-08-28 Piperidine derivatives, liquid-crystal composition, and liquid-crystal display element TW201806942A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016-166473 2016-08-29
JP2016166473 2016-08-29

Publications (1)

Publication Number Publication Date
TW201806942A true TW201806942A (en) 2018-03-01

Family

ID=57835065

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106129135A TW201806942A (en) 2016-08-29 2017-08-28 Piperidine derivatives, liquid-crystal composition, and liquid-crystal display element

Country Status (5)

Country Link
JP (1) JP6690647B2 (en)
KR (1) KR102576757B1 (en)
CN (1) CN109641839B (en)
TW (1) TW201806942A (en)
WO (1) WO2017014326A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080101B2 (en) 2010-12-24 2015-07-14 Dic Corporation Polymerizable compound-containing liquid crystal composition and liquid crystal display device using the same
CN108373923A (en) * 2017-02-01 2018-08-07 捷恩智株式会社 Liquid-crystal composition and application thereof, liquid crystal display element and stabilizing polymer alignment-type liquid crystal display device
JP2018123296A (en) * 2017-02-01 2018-08-09 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP6787202B2 (en) * 2017-03-21 2020-11-18 東洋インキScホールディングス株式会社 Active energy ray-polymerizable composition
WO2018235713A1 (en) * 2017-06-23 2018-12-27 Dic株式会社 Liquid crystal composition and liquid crystal display element using same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2755340A1 (en) * 1976-12-23 1978-06-29 Ciba Geigy Ag NEW POLYALKYLPIPERIDE DERIVATIVES
JPS60226553A (en) * 1984-04-24 1985-11-11 Sumitomo Chem Co Ltd Stabilized synthetic resin composition
IT1214600B (en) * 1985-04-22 1990-01-18 Ciba Geigy Spa PIPERIDINE COMPOUNDS USABLE AS STABILIZERS FOR SYNTHETIC POLYMERS.
EP0461206B1 (en) * 1989-09-09 1994-03-02 Sandoz-Patent-Gmbh Synthetic polyamides and their salts
IT1240690B (en) * 1990-04-30 1993-12-17 Ciba Geigy Ag PIPERDIN-TRIAZIN COMPOUNDS SUITABLE FOR USE AS STABILIZERS FOR ORGANIC MATERIALS
JPH05271190A (en) * 1992-03-24 1993-10-19 Mitsubishi Petrochem Co Ltd Amine compound
IT1256636B (en) * 1992-12-10 1995-12-12 Ciba Geigy Spa PROCESS FOR THE PREPARATION OF 2,2,6,6-TETRAMETYL-4- PIPERIDYLOXY-1,3,5-TRIAZINES CONTAINING TWO OR MORE TRIAZINIC RINGS
IT1264945B1 (en) * 1993-07-16 1996-10-17 Ciba Geigy Spa PIPERIDINE COMPOUNDS SUITABLE FOR USE AS STABILIZERS FOR ORGANIC MATERIALS
SI1807395T1 (en) * 2004-11-02 2016-04-29 Basf Se Process for the synthesis of n-alkoxyamines
WO2010089230A1 (en) * 2009-02-04 2010-08-12 Basf Se Stabilizers
CN101591331B (en) * 2009-06-25 2014-05-21 中国乐凯胶片集团公司 Method for preparing hindered amine light stabilizer
EP2630137B1 (en) * 2010-10-20 2015-04-01 Basf Se Sterically hindered amine light stabilizers with mixed functionalization
JP6491410B2 (en) 2010-12-07 2019-03-27 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Liquid crystal medium and electro-optic display
EP3327103B1 (en) 2012-10-18 2020-10-14 Merck Patent GmbH Liquid crystal medium, method for the stabilisation thereof and liquid crystal display
JP6402907B2 (en) * 2014-09-24 2018-10-10 Jnc株式会社 Piperidine derivatives, liquid crystal compositions, and liquid crystal display devices
MX2016000701A (en) * 2015-01-22 2016-11-24 Evonik Degussa Gmbh Method for producing an n-methyl substituted triacetone amine compound.
GB2539908B (en) * 2015-06-30 2018-06-27 Merck Patent Gmbh Process for the stabilisation of liquid crystal media

Also Published As

Publication number Publication date
JPWO2017014326A1 (en) 2019-06-27
WO2017014326A3 (en) 2017-03-16
KR20190046760A (en) 2019-05-07
JP6690647B2 (en) 2020-04-28
CN109641839B (en) 2022-07-01
CN109641839A (en) 2019-04-16
KR102576757B1 (en) 2023-09-07
WO2017014326A2 (en) 2017-01-26

Similar Documents

Publication Publication Date Title
JPWO2017010281A1 (en) Liquid crystal composition and liquid crystal display element
JP6485106B2 (en) Liquid crystal composition and liquid crystal display element
JP7331686B2 (en) Liquid crystal composition and liquid crystal display element
JP6702299B2 (en) Liquid crystal composition and liquid crystal display device
JP6642445B2 (en) Liquid crystal composition and liquid crystal display device
JPWO2017141671A1 (en) Liquid crystal composition and liquid crystal display element
TW201823434A (en) Liquid crystal composition and liquid crystal display device
TW201806942A (en) Piperidine derivatives, liquid-crystal composition, and liquid-crystal display element
TW201835310A (en) Liquid-crystal composition and liquid-crystal display element
TW201905179A (en) Liquid crystal display element, liquid crystal composition and use thereof
WO2015133194A1 (en) Liquid crystal display element and liquid crystal composition
TW201638315A (en) Liquid crystal composition and use thereof, liquid crystal display device and polymer stable alignment type liquid crystal display device
TW202000868A (en) Liquid crystal composition and use thereof, and liquid crystal display device
WO2015025604A1 (en) Liquid crystal composition and liquid crystal display element
JP6690114B2 (en) Liquid crystal composition and liquid crystal display device
JPWO2016185793A1 (en) Liquid crystal composition and liquid crystal display element
TW201809235A (en) Liquid crystal composition and use thereof, liquid crystal display device, polymer sustained alignment type liquid crystal display device and liquid crystal display device without alignment film
JP2018141033A (en) Liquid crystal composition, and liquid crystal display element
JP2017145384A (en) Liquid crystal composition and liquid crystal display element
TW201625777A (en) Liquid crystal composition and liquid crystal display element
JP6627733B2 (en) Liquid crystal composition and liquid crystal display device
TWI835934B (en) Liquid crystal compositions and their uses, and liquid crystal display elements
TWI795543B (en) Liquid crystal composition, use thereof, and liquid crystal display device
JP6564495B1 (en) Liquid crystal composition and liquid crystal display element
JP2020075968A (en) Liquid crystal composition and liquid crystal display element